#!/usr/bin/env python3
"""Complete lesson data for G09L3-L01 through G09L3-L10 (Grade 9 Level 3: Biotech Modeling and Simulation)"""

L01 = {
    "id": "G09L3-L01",
    "title": "Designing a Cancer Drug That Actually Works",
    "subtitle": "Multi-Scale Pharmacokinetic Modeling from Molecule to Patient",
    "ngss": "HS-LS1-4, HS-ETS1-2",
    "ngss_desc": "Use a model to illustrate the role of cellular division in producing and maintaining complex organisms; design a solution to a complex real-world problem by breaking it down into smaller, more manageable problems.",
    "big_question": "Why do most cancer drugs fail in clinical trials — and how can computational modeling help us design ones that actually work?",
    "objectives": [
        "Build a multi-scale pharmacokinetic model that traces drug behavior from molecular absorption to organism-level outcomes",
        "Analyze how drug dosage, absorption rate, and metabolism interact across biological scales to determine therapeutic effectiveness",
        "Optimize dosage parameters to maximize tumor destruction while minimizing damage to healthy tissues",
        "Evaluate the concept of a therapeutic window and explain why most cancer drugs have dangerously narrow ones"
    ],
    "vocabulary": [
        ("Pharmacokinetics", "The study of how a drug moves through the body over time — including absorption, distribution, metabolism, and excretion (ADME) — which determines whether a drug reaches its target at the right concentration"),
        ("Therapeutic Window", "The narrow range of drug concentration in the blood that is high enough to kill cancer cells but low enough to avoid destroying healthy tissue — too low means ineffective, too high means toxic"),
        ("Multi-Scale Modeling", "A computational approach that connects molecular-level interactions (drug binding to receptors) to cellular-level effects (tumor cell death) to organism-level outcomes (patient survival) in a single integrated model"),
        ("Pharmacodynamics", "The study of what a drug does to the body once it reaches its target — including receptor binding, signal disruption, and the cascade of cellular responses that follow drug exposure")
    ],
    "components": [
        ("Drug Dosage", "The amount of chemotherapy drug administered to the patient per treatment cycle, measured in milligrams per square meter of body surface area", True),
        ("Absorption Rate", "The speed at which the drug crosses from the administration site into the bloodstream, influenced by drug formulation, route of delivery, and patient physiology", False),
        ("Blood Concentration", "The measured level of active drug molecules circulating in the patient's bloodstream at any given time, which rises after dosing and falls as the drug is metabolized", False),
        ("Tumor Uptake", "The rate and amount of drug that successfully crosses from the bloodstream into the tumor microenvironment and binds to cancer cell targets", False),
        ("Healthy Cell Damage", "The degree of collateral destruction to normal, non-cancerous cells caused by drug exposure — the primary source of chemotherapy side effects", False),
        ("Metabolism Rate", "The speed at which the liver enzymatically breaks down the active drug into inactive metabolites, reducing the effective drug concentration over time", False),
        ("Kidney Clearance", "The rate at which the kidneys filter drug metabolites and waste products from the blood for excretion in urine, which determines how quickly the drug leaves the body", False),
        ("Therapeutic Window", "The calculated range between the minimum effective concentration (enough to kill cancer cells) and the maximum tolerated concentration (before organ toxicity occurs)", False),
        ("Side Effect Severity", "The overall burden of adverse effects experienced by the patient — from nausea and fatigue to organ damage and immunosuppression — scored on a clinical severity scale", False)
    ],
    "think_about_it": "When Drug Dosage is increased, Blood Concentration rises — but so does Healthy Cell Damage. Meanwhile, Metabolism Rate and Kidney Clearance are constantly pulling the drug OUT of the blood. How do you find the sweet spot where Tumor Uptake is maximized but Side Effect Severity stays manageable? That's the therapeutic window — and for most cancer drugs, it's razor thin.",
    "scenarios": [
        ("Standard Dosage Protocol", "Set Drug Dosage to the recommended clinical level — observe how Blood Concentration changes over time and whether it stays within the Therapeutic Window"),
        ("Aggressive High-Dose Treatment", "Increase Drug Dosage significantly above standard — observe Tumor Uptake increase but also track Healthy Cell Damage and Side Effect Severity escalation"),
        ("Optimized Metronomic Dosing", "Use lower, more frequent doses instead of one large dose — compare Tumor Uptake consistency while monitoring Side Effect Severity reduction")
    ],
    "sim_scenarios": [
        ("Standard Dosage", "Recommended clinical dose, normal metabolism", "What do you predict will happen to Blood Concentration over a 24-hour period after a single standard dose?"),
        ("High-Dose Aggressive", "Double the standard dose", "What do you predict happens to the ratio of Tumor Uptake versus Healthy Cell Damage when the dose is doubled?"),
        ("Metronomic Optimization", "Half-dose given twice as frequently", "Do you predict that frequent low doses will maintain more consistent Tumor Uptake than a single high dose?")
    ],
    "discoveries": [
        "Drug concentration in the blood follows a predictable curve — rising after administration, peaking, then declining as metabolism and clearance remove the drug from circulation",
        "The therapeutic window for most cancer drugs is extremely narrow — the dose needed to kill cancer cells is dangerously close to the dose that damages healthy tissue",
        "Metabolism rate and kidney clearance vary significantly between patients, meaning the same dose can be therapeutic in one person and toxic in another",
        "Metronomic dosing (lower, more frequent doses) can maintain drug levels within the therapeutic window more consistently than traditional high-dose protocols"
    ],
    "answer": "Most cancer drugs fail because the therapeutic window is incredibly narrow. The drug must reach a concentration high enough to penetrate the tumor microenvironment and kill cancer cells, but not so high that it destroys healthy tissue and overwhelms the patient with toxic side effects. Computational pharmacokinetic modeling allows researchers to simulate thousands of dosing strategies — optimizing absorption, predicting metabolism, and accounting for individual patient variation — before ever testing the drug in a human. Multi-scale modeling connects molecular drug-receptor interactions to cellular tumor response to whole-patient outcomes, making drug design more rational and less trial-and-error.",
    "stem_title": "Design an Adaptive Chemotherapy Dosing Algorithm",
    "stem_mission": "Design a computational algorithm that adjusts chemotherapy dosing in real time based on patient biomarker data, optimizing tumor destruction while minimizing side effects.",
    "stem_scenario": "A pharmaceutical company is developing a next-generation adaptive dosing system for cancer treatment. Instead of giving every patient the same dose on a fixed schedule, the system would use real-time blood biomarker data to adjust doses automatically. Your team has been hired to design the algorithm that determines when and how much drug to administer.",
    "stem_questions": [
        "What biomarkers would your algorithm monitor to decide when to adjust the dose?",
        "How would you program the system to respond differently to patients with fast versus slow metabolisms?",
        "What safety thresholds would trigger an automatic dose reduction or treatment pause?"
    ],
    "stem_design_qs": [
        "How frequently should the system sample blood biomarkers — continuously or at intervals?",
        "What machine learning approach could improve dosing predictions over multiple treatment cycles?",
        "How would you validate your algorithm before testing it on real patients?",
        "What ethical considerations arise from automating medical dosing decisions?"
    ],
    "career": "Pharmacokineticists and Computational Pharmacologists design drug dosing protocols using mathematical models and computer simulations. They work for pharmaceutical companies, the FDA, and academic medical centers, earning $90,000–$180,000/year. Clinical Pharmacologists who manage cancer drug protocols earn $150,000–$300,000/year.",
    "images": {
        "cover": ("G09L3-L01-cover.png", "A photorealistic, cinematic image of diverse 14-15 year old students in an advanced biotech lab examining molecular drug models on holographic displays, with a pharmacokinetic concentration-time curve visible on a large monitor, dramatic lighting with blue and purple lab glow"),
        "landscape": ("G09L3-L01-landscape.png", "A diverse group of 14-15 year old students in a cutting-edge computational biology lab, analyzing drug absorption curves on dual-monitor workstations, molecular structure visualizations on screens, modern lab with glass walls and advanced equipment"),
        "modeling": ("G09L3-L01-modeling.png", "A diverse group of 14-15 year old students working intensely on laptops building multi-scale pharmacokinetic models, whiteboards behind them filled with ADME diagrams and concentration-time curves, collaborative advanced lab setting"),
        "discussion": ("G09L3-L01-discussion.png", "A teacher leading a sophisticated discussion with diverse 14-15 year old students about drug therapeutic windows, a complex pharmacokinetic graph displayed on a smartboard showing drug concentration curves with therapeutic and toxic thresholds marked"),
        "stem": ("G09L3-L01-stem.png", "Diverse 14-15 year old students presenting adaptive dosing algorithm designs on large displays, flowcharts and decision trees visible, professional biotech presentation setting with modern technology")
    },
    "pre_assessment": [
        "Why do you think cancer treatment often makes patients extremely sick — sometimes sicker than the cancer itself?",
        "What do you think determines whether a drug dose is 'just right' versus 'too much' or 'too little'?",
        "Draw a diagram showing how you think a drug travels through the body from the moment it's administered to the moment it reaches a tumor.",
        "What is a therapeutic window and why might it matter for cancer treatment?"
    ],
    "extend_components": [
        ("Tumor Blood Supply", "The density and permeability of blood vessels feeding the tumor, which determines how much circulating drug can actually reach cancer cells — tumors with poor blood supply may be resistant even at high doses"),
        ("Drug Resistance Factor", "The probability that cancer cells develop molecular mechanisms to pump the drug out or deactivate it, reducing effectiveness over multiple treatment cycles"),
        ("Patient Liver Function", "The individual patient's liver enzyme activity, which determines how quickly the drug is metabolized — liver impairment can cause dangerous drug accumulation")
    ],
    "reflections": [
        "How does your multi-scale model demonstrate the challenge of connecting molecular drug behavior to patient-level outcomes?",
        "Why does the same drug dose produce different outcomes in different patients, according to your model?",
        "What trade-offs did you discover between maximizing Tumor Uptake and minimizing Side Effect Severity?",
        "How could your model be used to personalize cancer treatment for individual patients?",
        "What are the limitations of modeling a 9-component pharmacokinetic system compared to the full complexity of cancer biology?"
    ],
    "dimensions": [
        ("Science Practice", "Developing and Using Models", "Students develop a multi-scale computational model that connects molecular pharmacokinetics to cellular tumor response to organism-level treatment outcomes."),
        ("Disciplinary Core Idea", "LS1.A Structure and Function / ETS1.B Developing Possible Solutions", "Cellular processes including drug metabolism operate at multiple biological scales; engineering design requires systematic optimization of competing constraints."),
        ("Crosscutting Concept", "Systems and System Models", "Students model the human body as a complex system where drug behavior at the molecular scale produces emergent outcomes at the organism scale through multiple interacting subsystems.")
    ],
    "cast_items": [
        "Model multi-scale pharmacokinetic behavior from molecular absorption through cellular uptake to organism-level treatment outcomes",
        "Optimize drug dosage parameters to maximize therapeutic effectiveness while minimizing toxic side effects",
        "Analyze the therapeutic window concept and explain why most cancer drugs have dangerously narrow effective ranges"
    ],
    "cast_questions": [
        ("Multiple Choice:", "A cancer patient's blood work shows their liver metabolism rate is 40% faster than average. Based on your pharmacokinetic model, what is the most likely clinical consequence?"),
        ("Constructed Response:", "Using your multi-scale model, explain why a drug that kills 99% of cancer cells in a petri dish might fail completely in a human patient. Reference at least three model components in your explanation.")
    ],
    "background_intro": "This lesson introduces students to multi-scale pharmacokinetic modeling — one of the most powerful tools in modern drug development. Biotech skill focus: Multi-scale modeling (molecular to cellular to organism). The pharmaceutical industry loses billions of dollars annually on drugs that fail in clinical trials because researchers couldn't predict how molecular-level drug behavior would translate to patient-level outcomes. Computational pharmacokinetic models bridge this gap by integrating absorption, distribution, metabolism, and excretion (ADME) processes across biological scales.",
    "background_sections": [
        ("Pharmacokinetics: The ADME Framework", "Every drug's journey through the body follows four phases: Absorption (drug enters the bloodstream from the administration site — oral drugs must survive stomach acid and cross the intestinal wall, IV drugs bypass this entirely), Distribution (drug travels through the bloodstream and crosses into tissues — the blood-brain barrier, tumor vasculature, and protein binding all affect distribution), Metabolism (primarily in the liver, cytochrome P450 enzymes chemically modify the drug, usually inactivating it — genetic variation in CYP enzymes causes 10-fold differences in metabolism between patients), and Excretion (kidneys filter metabolites from blood into urine; some drugs are also excreted in bile, sweat, or exhaled air). The concentration-time curve that results from these four processes determines everything about whether a drug works or kills the patient."),
        ("The Therapeutic Window Problem in Oncology", "Cancer drugs face a unique pharmacokinetic challenge: cancer cells are human cells. Unlike antibiotics, which target bacterial proteins absent in human cells, chemotherapy drugs must exploit the subtle differences between cancer cells and normal cells — usually faster division rates. This means the concentration required to kill cancer cells (minimum effective concentration, or MEC) is often dangerously close to the concentration that causes organ toxicity (maximum tolerated concentration, or MTC). The therapeutic window (MTC minus MEC) for drugs like doxorubicin, cisplatin, and paclitaxel can be as narrow as a 2-fold range, compared to 10-fold or wider for common antibiotics. This is why chemotherapy has such devastating side effects."),
        ("Multi-Scale Modeling in Drug Development", "Traditional pharmacokinetic models operate at a single scale — tracking drug concentration in blood over time. Modern multi-scale models integrate three levels simultaneously: molecular scale (drug-receptor binding kinetics, enzyme-substrate interactions, protein conformational changes), cellular scale (signal transduction cascades, cell cycle arrest, apoptosis induction, resistance mechanism activation), and organism scale (organ function, immune response, clinical symptoms, survival probability). Physiologically-based pharmacokinetic (PBPK) models represent each organ as a compartment with its own blood flow, volume, and metabolic capacity. These models can predict drug behavior in populations that were never tested — pediatric patients, patients with liver disease, or patients taking multiple drugs simultaneously."),
        ("Metronomic Chemotherapy: A Modeling Success Story", "Computational pharmacokinetic modeling led to a paradigm shift in cancer treatment called metronomic chemotherapy. Traditional protocols give the maximum tolerated dose (MTD) on an infrequent schedule (e.g., every 3 weeks) to allow the patient to recover from side effects between cycles. Models predicted that lower doses given more frequently could maintain drug levels within the therapeutic window more consistently, reducing the peaks that cause toxicity and the troughs where the drug drops below effective levels. Clinical trials confirmed this — metronomic dosing showed equal or better tumor control with dramatically fewer side effects for several cancer types. This is multi-scale modeling literally saving lives.")
    ],
    "lever_L": "Students identify nine pharmacokinetic components operating across molecular, cellular, and organism scales — from Drug Dosage input through absorption, blood concentration, tumor uptake, healthy cell damage, metabolism, clearance, therapeutic window, to side effect severity output.",
    "lever_E": "Students determine that Drug Dosage drives Blood Concentration through Absorption Rate, which simultaneously enables Tumor Uptake (desired) and Healthy Cell Damage (undesired), while Metabolism Rate and Kidney Clearance continuously remove the drug — creating the fundamental pharmacokinetic tension.",
    "lever_V": "Students build a computational model connecting all nine components across biological scales, visualizing the concentration-time curve and the therapeutic window where the drug is effective but not toxic.",
    "lever_Ev": "Students run standard dosage, high-dose aggressive, and metronomic optimization scenarios to find dosing strategies that maximize time within the therapeutic window.",
    "lever_R": "Students add Tumor Blood Supply, Drug Resistance Factor, or Patient Liver Function to explore personalized pharmacokinetics and treatment optimization.",
    "slides_guide": [
        {"num": "Slide 1", "title": "Cover", "visual": "Title slide with dramatic image of molecular drug structures and pharmacokinetic curves", "say": "Over 95% of experimental cancer drugs fail in clinical trials. Not because they can't kill cancer cells — most of them can. They fail because we can't get them to kill cancer without killing the patient. Today, you're going to try to solve that problem.", "do": "Display a statistic about cancer drug failure rates. Let the magnitude sink in before continuing.", "time": "2 min"},
        {"num": "Slide 2", "title": "Learning Objectives", "visual": "Learning goals and advanced pharmacokinetic vocabulary", "say": "You're going to build a multi-scale pharmacokinetic model — the same type of computational tool that pharmaceutical companies use to design drug dosing protocols. This is real biotech.", "do": "Pre-teach pharmacokinetics and therapeutic window. Have students write their own definitions before revealing the formal ones.", "time": "3 min"},
        {"num": "Slide 3", "title": "Big Question", "visual": "Why do most cancer drugs fail — and how can modeling fix it?", "say": "A drug kills 99% of cancer cells in a petri dish. Six years and two billion dollars later, it fails in human trials. What went wrong between the dish and the patient?", "do": "Think-pair-share: Students brainstorm why a drug that works in a dish might fail in a body. Collect ideas on the board.", "time": "3 min"},
        {"num": "Slide 4", "title": "LEVER Framework", "visual": "LEVER steps with pharmacokinetic context", "say": "We're going to connect molecular-level drug behavior to cellular-level tumor response to patient-level outcomes. That's multi-scale modeling — and it's how real drug companies design chemotherapy protocols.", "do": "Preview each LEVER step. Emphasize that this model spans three biological scales simultaneously.", "time": "2 min"},
        {"num": "Slide 5", "title": "Activity 1: Components", "visual": "Nine pharmacokinetic component cards across molecular, cellular, and organism scales", "say": "These nine components represent the complete journey of a cancer drug through the body. Only ONE of them is truly under the doctor's control — which one?", "do": "Guide identification of Drug Dosage as the only external component. Discuss why all other components are internal responses. Sort components by biological scale.", "time": "8 min"},
        {"num": "Slide 6", "title": "Activity 2: Connections", "visual": "Relationship arrows showing the pharmacokinetic cascade from dosage to side effects", "say": "Here's the cruel paradox of cancer treatment: the same pathway that delivers drug to the tumor also delivers it to every other organ in the body. How do you maximize one and minimize the other?", "do": "Students trace the pathway from Drug Dosage through Blood Concentration to both Tumor Uptake and Healthy Cell Damage. Identify the therapeutic window as the narrow zone where the drug works without killing.", "time": "8 min"},
        {"num": "Slide 7", "title": "Activity 3: Simulation", "visual": "Concentration-time curves and therapeutic window visualization", "say": "You're now the pharmacokineticist. Run these three scenarios and find the dosing strategy that keeps the drug inside the therapeutic window the longest.", "do": "Students predict outcomes first, then run standard, aggressive, and metronomic dosing scenarios. Track time-within-therapeutic-window as the key metric.", "time": "10 min"},
        {"num": "Slide 8", "title": "Discoveries", "visual": "Key pharmacokinetic findings and multi-scale insights", "say": "You just discovered what took the pharmaceutical industry decades to figure out — sometimes less is more. Metronomic dosing, predicted by computational models, is now saving real cancer patients' lives.", "do": "Connect simulation findings to real clinical practice. Discuss how modeling predicted metronomic chemotherapy before clinical trials proved it.", "time": "5 min"},
        {"num": "Slide 9", "title": "STEM Challenge", "visual": "Adaptive chemotherapy dosing algorithm design challenge", "say": "A pharmaceutical company just hired your team. Design an algorithm that adjusts chemotherapy doses in real time based on patient biomarkers. This is the future of cancer treatment.", "do": "Groups design adaptive dosing algorithms. Must include biomarker inputs, decision logic, and safety thresholds. Present and defend designs.", "time": "12 min"}
    ],
    "sort_reasoning": "Drug Dosage is the only external component because it represents the physician's direct control over the amount of drug administered. All other eight components — Absorption Rate, Blood Concentration, Tumor Uptake, Healthy Cell Damage, Metabolism Rate, Kidney Clearance, Therapeutic Window, and Side Effect Severity — are internal responses determined by the patient's physiology interacting with the drug. The doctor cannot directly control how fast the liver metabolizes the drug or how much drug reaches the tumor.",
    "relationships": [
        ("Drug Dosage to Blood Concentration", "POSITIVE (+)", "Higher drug dosage increases the amount of drug entering the bloodstream through absorption, raising blood concentration proportionally to the dose administered."),
        ("Blood Concentration to Tumor Uptake", "POSITIVE (+)", "Higher blood concentration creates a steeper concentration gradient between blood and tumor tissue, driving more drug molecules across the tumor vasculature into cancer cells."),
        ("Blood Concentration to Healthy Cell Damage", "POSITIVE (+)", "Higher blood concentration simultaneously exposes healthy tissues to more drug, increasing collateral damage to rapidly-dividing normal cells like bone marrow, gut lining, and hair follicles."),
        ("Metabolism Rate to Blood Concentration", "NEGATIVE (-)", "Faster liver metabolism breaks down more drug per unit time, actively reducing blood concentration and shortening the duration of therapeutic drug levels."),
        ("Kidney Clearance to Blood Concentration", "NEGATIVE (-)", "More efficient kidney filtration removes drug metabolites and some active drug from circulation faster, accelerating the decline of blood concentration after dosing."),
        ("Healthy Cell Damage to Side Effect Severity", "POSITIVE (+)", "Greater healthy cell damage directly increases the severity of clinical side effects — nausea from gut lining damage, immunosuppression from bone marrow damage, hair loss from follicle damage.")
    ],
    "sim_answers": [
        ("Standard Dosage Scenario", "With the standard clinical dose, Blood Concentration rises sharply after administration, peaks within 1-4 hours, then gradually declines as Metabolism Rate and Kidney Clearance remove the drug. The concentration enters the Therapeutic Window for a limited period — typically 6-12 hours — during which Tumor Uptake is effective. However, the peak concentration also causes a spike in Healthy Cell Damage, producing moderate Side Effect Severity."),
        ("Metronomic Optimization Scenario", "With half-dose given twice as frequently, Blood Concentration never peaks as high (reducing the Healthy Cell Damage spike) but also never drops as low (maintaining consistent Tumor Uptake). The drug spends more total time within the Therapeutic Window per treatment cycle. Side Effect Severity is lower because the concentration peaks never reach the toxic threshold, even though the same total drug amount is administered.")
    ],
    "reflection_exemplars": [
        ("Why does the same dose produce different outcomes in different patients?", "The model reveals that Blood Concentration is not determined by Drug Dosage alone — it's the result of Absorption Rate, Metabolism Rate, and Kidney Clearance all acting simultaneously. A patient with fast liver metabolism (high Metabolism Rate) will clear the drug before it accumulates to therapeutic levels, while a patient with impaired kidneys (low Kidney Clearance) may accumulate toxic concentrations from the same dose. Personalizing treatment requires knowing each patient's individual pharmacokinetic parameters."),
        ("What trade-offs exist between Tumor Uptake and Side Effect Severity?", "The fundamental pharmacokinetic dilemma is that Tumor Uptake and Healthy Cell Damage both increase with Blood Concentration. The model shows that traditional high-dose protocols maximize Tumor Uptake but also maximize Side Effect Severity. Metronomic dosing represents a different trade-off — slightly lower peak Tumor Uptake but dramatically lower Side Effect Severity and more consistent drug levels. The optimal strategy depends on the specific cancer type, drug characteristics, and patient tolerance.")
    ],
    "stem_intro": "Present the challenge: A pharmaceutical company is developing an adaptive dosing system that adjusts chemotherapy in real time based on patient biomarkers. Your team will design the algorithm that decides when and how much drug to give — replacing the one-size-fits-all approach with precision oncology.",
    "stem_concepts": [
        ("Adaptive Dosing", "Traditional chemotherapy uses fixed doses on a fixed schedule. Adaptive dosing uses real-time feedback — blood drug levels, tumor marker changes, white blood cell counts — to adjust doses dynamically. Computational models predict how each adjustment will cascade through the pharmacokinetic system."),
        ("Biomarker-Driven Decision Making", "Biomarkers like circulating tumor DNA (ctDNA), drug metabolite ratios, and inflammatory markers provide real-time windows into how a patient is responding. An adaptive algorithm processes these inputs and adjusts dosing to keep the drug within the therapeutic window."),
        ("Safety-First Algorithm Design", "Medical algorithms must be fail-safe. If sensor data is lost, the system must default to a safe state. Dose escalation rules must include hard upper limits. The algorithm must account for drug-drug interactions, organ function changes, and cumulative toxicity across treatment cycles.")
    ],
    "stem_eval": [
        ("Expert (4)", "Algorithm integrates multiple biomarker inputs, uses patient-specific pharmacokinetic parameters, includes graduated response logic, hard safety limits, and evidence-based justification from model simulations"),
        ("Proficient (3)", "Algorithm monitors key biomarkers and adjusts dosing with reasonable logic and safety thresholds based on model findings"),
        ("Developing (2)", "Algorithm monitors some indicators but adjustment logic is simplistic or safety thresholds are not well justified"),
        ("Beginning (1)", "Algorithm is incomplete or does not connect biomarker monitoring to the pharmacokinetic model")
    ],
    "support": [
        "Provide a visual diagram of the ADME framework showing the drug's journey through the body",
        "Use a concentration-time curve template where students can sketch predicted drug levels before running simulations",
        "Scaffold multi-scale thinking: 'At the molecular level, the drug ___. At the cellular level, this causes ___. At the organism level, the patient experiences ___.'"
    ],
    "extensions": [
        "Research how pharmacogenomics (genetic testing for drug metabolism enzymes) is personalizing cancer treatment dosing protocols",
        "Investigate antibody-drug conjugates (ADCs) — 'smart missiles' that deliver chemotherapy directly to tumors — and model how they change the therapeutic window",
        "Compare the pharmacokinetics of oral versus intravenous chemotherapy and explain the trade-offs for patient quality of life"
    ],
    "cross_curr": [
        ("Math", "Calculate area-under-the-curve (AUC) for different dosing strategies and compare total drug exposure versus time within the therapeutic window"),
        ("ELA", "Research and write a policy brief arguing for or against FDA approval of adaptive dosing algorithms that partially automate medical decisions"),
        ("Health/Bioethics", "Debate the ethics of computational models making life-and-death dosing decisions — who is responsible when an algorithm makes a mistake?")
    ],
    "misconceptions": [
        ("More drug always means more effective treatment", "Increasing drug dosage beyond the therapeutic window does NOT improve outcomes — it increases toxicity and side effects without proportionally increasing tumor kill. Cancer cells that survive the initial drug exposure are often the resistant ones, so higher doses kill more healthy cells while selecting for resistant cancer cells. The relationship between dose and effectiveness plateaus while the relationship between dose and toxicity continues to climb.", "Model it: Double the Drug Dosage and compare the ratio of Tumor Uptake increase versus Side Effect Severity increase. The toxicity outpaces the benefit."),
        ("Cancer drugs specifically target cancer cells", "Most traditional chemotherapy drugs do NOT specifically target cancer cells. They target rapidly-dividing cells — which includes cancer but also bone marrow, gut lining, hair follicles, and immune cells. This is why chemotherapy causes hair loss, nausea, and immunosuppression. The drug cannot tell the difference between a dividing cancer cell and a dividing healthy cell.", "Ask: If the drug kills 'rapidly dividing cells,' what other cells in your body divide rapidly? Make a list — that's your side effects list."),
        ("Computer models can perfectly predict drug outcomes", "Pharmacokinetic models are powerful but imperfect. They simplify the staggering complexity of human biology into manageable mathematical equations. Real patients have genetic variation, comorbidities, microbiome differences, psychological stress responses, and countless other factors no model fully captures. Models are tools for better decision-making, not crystal balls.", "Discuss: What factors does our 9-component model leave out? Make a list of things that could affect drug outcomes that aren't in the model.")
    ]
}

L02 = {
    "id": "G09L3-L02",
    "title": "Engineering a Superbug Killer",
    "subtitle": "Optimizing Bacteriophage Therapy Against Antibiotic-Resistant Bacteria",
    "ngss": "HS-LS1-2, HS-LS4-2",
    "ngss_desc": "Develop and use a model to illustrate the hierarchical organization of interacting systems that provide specific functions within multicellular organisms; construct an explanation based on evidence that the process of evolution primarily results from natural selection.",
    "big_question": "Antibiotics are failing. Can we engineer viruses to kill the superbugs that antibiotics can't?",
    "objectives": [
        "Build an optimization model for bacteriophage therapy that balances phage specificity, bacterial resistance evolution, and microbiome safety",
        "Analyze how phage-bacteria population dynamics interact with the human immune system across treatment timelines",
        "Optimize treatment timing and dosage to maximize bacterial kill while minimizing disruption to beneficial gut flora",
        "Evaluate how natural selection drives bacterial resistance to phage therapy and design strategies to counter it"
    ],
    "vocabulary": [
        ("Bacteriophage", "A virus that exclusively infects and kills bacteria by injecting its genetic material, hijacking the cell's machinery to produce copies of itself, and bursting the cell open — the most abundant biological entity on Earth with over 10^31 phages globally"),
        ("Antibiotic Resistance", "The evolved ability of bacteria to survive exposure to antibiotics through mechanisms like drug efflux pumps, enzyme degradation of the drug, or target site modification — driven by natural selection under antibiotic pressure"),
        ("Phage Specificity", "The precision with which a bacteriophage targets a particular bacterial species or strain, determined by the molecular fit between phage tail proteins and bacterial surface receptors — high specificity means fewer collateral effects on beneficial bacteria"),
        ("Microbiome", "The complex community of trillions of bacteria, archaea, fungi, and viruses living in and on the human body — particularly dense in the gut — that plays critical roles in digestion, immunity, vitamin synthesis, and mental health")
    ],
    "components": [
        ("Phage Population", "The total number of active bacteriophage particles in the patient's system, which increases through successful replication inside bacterial hosts and decreases through immune clearance and natural degradation", False),
        ("Target Bacteria Population", "The count of pathogenic antibiotic-resistant bacteria causing the infection, which decreases as phages successfully infect and lyse cells but increases through bacterial reproduction", False),
        ("Phage Specificity", "The engineered precision of the phage's targeting system — how well it distinguishes the pathogenic bacteria from beneficial microbiome species, adjustable through bioengineering of tail fiber proteins", True),
        ("Bacterial Resistance Rate", "The speed at which the target bacterial population evolves resistance to the phage through mutations in surface receptor proteins, preventing phage attachment and infection", False),
        ("Immune System Response", "The patient's innate and adaptive immune activity against both the infecting bacteria AND the therapeutic phages — the immune system may clear phages before they complete their work", False),
        ("Phage Replication Rate", "The number of new phage particles produced per lysis event (burst size) multiplied by the infection frequency — determines how fast the phage population amplifies in the presence of target bacteria", False),
        ("Healthy Microbiome Impact", "The degree of collateral damage to beneficial gut bacteria caused by off-target phage activity — lower Phage Specificity increases microbiome disruption", False),
        ("Treatment Timing", "When in the infection timeline the phage therapy is initiated — early intervention targets smaller, less diverse bacterial populations while late intervention faces larger, potentially more resistant populations", True),
        ("Dosage Optimization", "The calculated initial phage dose administered to the patient, which must be sufficient to establish a self-amplifying phage population before the immune system clears the therapeutic phages", True)
    ],
    "think_about_it": "Phage therapy has a remarkable feature: the treatment amplifies itself. Unlike antibiotics that degrade after administration, phages replicate inside the very bacteria they're killing. But the bacteria are evolving resistance in real time, and the patient's immune system may clear the phages. How do you optimize Dosage, Timing, and Specificity to win this three-way race?",
    "scenarios": [
        ("Standard Phage Therapy Protocol", "Set moderate Dosage Optimization, medium Phage Specificity, and early Treatment Timing — observe the phage-bacteria population dynamics and immune interaction"),
        ("Delayed Treatment with High Resistance", "Set late Treatment Timing with an already-resistant bacterial subpopulation — observe whether phage therapy can overcome established resistance"),
        ("High-Specificity Engineered Phage Cocktail", "Maximize Phage Specificity and Dosage Optimization with early Treatment Timing — observe the impact on Healthy Microbiome and bacterial resistance evolution")
    ],
    "sim_scenarios": [
        ("Standard Protocol", "Moderate dose, medium specificity, early treatment", "What do you predict happens to the Phage Population as it encounters a growing bacterial population?"),
        ("Delayed Treatment", "Late timing, established bacterial resistance", "What do you predict happens to the race between Phage Replication Rate and Bacterial Resistance Rate when treatment starts late?"),
        ("Optimized Cocktail", "High specificity, high dose, early timing", "Do you predict that maximizing all three external parameters eliminates bacterial resistance evolution entirely?")
    ],
    "discoveries": [
        "Phage therapy is self-amplifying — phage populations grow exponentially when target bacteria are abundant, then decline naturally when the infection clears, making it inherently self-limiting",
        "Bacterial resistance to phages evolves rapidly but often comes with a fitness cost — resistant bacteria may lose virulence factors or become re-sensitized to antibiotics",
        "The immune system is both ally and obstacle — it helps clear the infection but may also neutralize therapeutic phages before they complete their work",
        "Treatment timing is critical because early intervention targets smaller, more genetically homogeneous populations that are less likely to contain pre-existing resistant mutants"
    ],
    "answer": "Bacteriophage therapy works by exploiting the natural predator-prey relationship between viruses and bacteria. Unlike antibiotics, phages are self-amplifying — they reproduce inside the bacteria they kill, so the treatment literally grows as the infection grows. The optimization challenge is a three-way race: phages must kill bacteria faster than bacteria evolve resistance, while the patient's immune system tolerates the phages long enough for them to work. Engineering high-specificity phages, optimizing initial dosage, and treating early in the infection timeline are the key variables. Remarkably, when bacteria evolve resistance to phages, they often lose the very surface receptors that made them antibiotic-resistant in the first place — a phenomenon called phage-antibiotic synergy.",
    "stem_title": "Design a Personalized Phage Therapy Protocol",
    "stem_mission": "Design a treatment protocol that matches engineered phage cocktails to specific patient infections, optimizing timing, dosage, and specificity for maximum effectiveness.",
    "stem_scenario": "A biotech startup is developing a phage therapy clinic for patients with antibiotic-resistant infections. Each patient's infection is different — different bacterial strains, different resistance profiles, different immune status. Your team must design the decision-making protocol that determines which phages to use, when to start treatment, and how to adjust the approach if resistance emerges.",
    "stem_questions": [
        "How would you rapidly identify which phages are effective against a specific patient's bacterial infection?",
        "What patient factors would you assess before designing the treatment protocol?",
        "How would you monitor treatment progress and detect emerging phage resistance?"
    ],
    "stem_design_qs": [
        "Would you use a single phage or a cocktail of multiple phages — and what are the trade-offs?",
        "How would you sequence phage therapy with existing antibiotic treatments?",
        "What backup strategies would you include if the first phage cocktail encounters resistance?",
        "How would you ensure phage specificity is high enough to protect the patient's microbiome?"
    ],
    "career": "Phage Biologists and Phage Therapy Researchers develop bacteriophage treatments for antibiotic-resistant infections. They work for biotech startups, academic medical centers, and government agencies like DARPA, earning $75,000–$150,000/year. Synthetic Biologists who engineer phage genomes for therapeutic applications earn $100,000–$200,000/year.",
    "images": {
        "cover": ("G09L3-L02-cover.png", "A photorealistic, cinematic image of diverse 14-15 year old students in an advanced microbiology lab examining electron microscope images of bacteriophages attacking bacteria on large display screens, with phage therapy diagrams and bacterial culture plates visible, dramatic blue-green laboratory lighting"),
        "landscape": ("G09L3-L02-landscape.png", "A diverse group of 14-15 year old students in a state-of-the-art biotech lab working with bacterial culture analysis equipment, phage-bacteria interaction animations on screens, modern research facility setting"),
        "modeling": ("G09L3-L02-modeling.png", "A diverse group of 14-15 year old students building population dynamics models on laptops, graphs showing predator-prey phage-bacteria curves on screens, whiteboards with evolutionary resistance diagrams"),
        "discussion": ("G09L3-L02-discussion.png", "A teacher leading an advanced discussion with diverse 14-15 year old students about phage-bacteria co-evolution, a population dynamics graph and phage lifecycle diagram on a smartboard, students engaged in debate"),
        "stem": ("G09L3-L02-stem.png", "Diverse 14-15 year old students presenting phage therapy protocol designs with clinical decision flowcharts on large screens, professional biotech presentation with pathogen profiles visible")
    },
    "pre_assessment": [
        "Why are antibiotic-resistant bacteria considered one of the greatest threats to human health in the 21st century?",
        "What is a bacteriophage and how is it different from the viruses that make humans sick?",
        "Draw a diagram showing how you think a virus could be used as a medical treatment instead of a disease.",
        "What do you think happens when bacteria evolve resistance to a treatment — does the bacteria 'decide' to become resistant?"
    ],
    "extend_components": [
        ("Phage-Antibiotic Synergy", "The phenomenon where bacteria that evolve resistance to phages become re-sensitized to antibiotics, and vice versa — creating a therapeutic one-two punch"),
        ("Biofilm Penetration", "The ability of phages to penetrate bacterial biofilms — dense protective communities that antibiotics cannot reach — using phage-encoded depolymerase enzymes"),
        ("Phage Engineering Level", "The degree of genetic modification applied to the phage genome — from wild-type phages to CRISPR-enhanced phages with expanded host range and resistance-countering capabilities")
    ],
    "reflections": [
        "How does your model demonstrate the predator-prey dynamics between phages and bacteria?",
        "Why is phage therapy described as 'self-amplifying' and how does this differ from antibiotic treatment?",
        "What trade-offs did you discover between Phage Specificity and treatment speed?",
        "How does natural selection drive bacterial resistance to phages, and why might this resistance come with a fitness cost?",
        "What are the limitations of modeling phage therapy with nine components when real infections involve thousands of bacterial strains and immune factors?"
    ],
    "dimensions": [
        ("Science Practice", "Constructing Explanations and Designing Solutions", "Students construct evidence-based explanations of phage-bacteria co-evolution and design optimized therapeutic protocols using model-derived data."),
        ("Disciplinary Core Idea", "LS1.A Structure and Function / LS4.B Natural Selection", "Organisms have complex hierarchical structures that determine function; natural selection acts on heritable variation, driving bacterial resistance evolution under phage pressure."),
        ("Crosscutting Concept", "Cause and Effect / Stability and Change", "Students analyze the causal chain from phage infection to bacterial lysis to resistance evolution, and identify conditions that shift the system toward treatment success or failure.")
    ],
    "cast_items": [
        "Model the population dynamics of bacteriophage-bacteria interactions including immune system interference and resistance evolution",
        "Optimize phage therapy treatment parameters (timing, dosage, specificity) to maximize pathogen clearance while preserving microbiome health",
        "Analyze how natural selection drives real-time bacterial resistance to therapeutic phages and evaluate counter-strategies"
    ],
    "cast_questions": [
        ("Multiple Choice:", "A patient's phage therapy is started 5 days after infection instead of 1 day. Based on your model, which outcome is most likely and why?"),
        ("Constructed Response:", "Using your model, explain the 'arms race' between bacteriophages and bacteria. Why does bacterial resistance to phages sometimes make the bacteria more vulnerable to antibiotics? Reference at least three model components.")
    ],
    "background_intro": "This lesson introduces students to predictive modeling and optimization in the context of bacteriophage therapy — one of the most promising alternatives to antibiotics. Biotech skill focus: Predictive modeling and optimization. With antibiotic resistance killing over 1.27 million people annually and the pipeline for new antibiotics nearly dry, phage therapy represents a paradigm shift in infectious disease treatment that students must understand.",
    "background_sections": [
        ("The Antibiotic Resistance Crisis", "Antibiotic-resistant bacteria kill more people than HIV/AIDS or malaria. The WHO has declared antimicrobial resistance one of the top 10 global public health threats. Resistance arises through natural selection: when antibiotics are used, susceptible bacteria die while naturally resistant mutants survive and reproduce. Hospitals harbor 'superbugs' like MRSA (methicillin-resistant Staphylococcus aureus), CRE (carbapenem-resistant Enterobacteriaceae), and extensively drug-resistant tuberculosis that are resistant to nearly all available antibiotics. The pharmaceutical industry has largely abandoned antibiotic development because it's not profitable — a new antibiotic costs $1-2 billion to develop and is used sparingly (to prevent resistance), generating far less revenue than drugs taken daily for chronic conditions."),
        ("Bacteriophage Biology", "Bacteriophages are viruses that exclusively infect bacteria — they cannot infect human cells because they require bacterial surface receptors for attachment. Phages follow a lytic cycle: (1) attachment to specific bacterial surface receptors, (2) injection of phage DNA into the bacterium, (3) hijacking of bacterial protein synthesis machinery to produce new phage components, (4) assembly of 50-200 new phage particles inside the cell, (5) lysis — the bacterial cell bursts, releasing new phages to infect more bacteria. This specificity is both a strength (precision targeting) and a challenge (each phage only kills specific bacterial strains). Phage cocktails — mixtures of multiple phage types — address this limitation."),
        ("Phage-Bacteria Co-Evolution: The Red Queen Hypothesis", "Bacteria and phages have been co-evolving for 3.5 billion years in the longest-running arms race on Earth. Bacteria evolve phage resistance primarily by modifying surface receptors (so phages can't attach), producing restriction enzymes (that cut foreign DNA), or using CRISPR-Cas systems (bacterial immune memory). But resistance often comes at a cost: the surface receptors that phages use for attachment are frequently the same receptors bacteria use for virulence or antibiotic resistance. When bacteria modify these receptors to escape phages, they may lose their antibiotic resistance — a phenomenon called 'phage-antibiotic synergy' or 'evolutionary trade-offs.' This creates a therapeutic strategy: use phages to force bacteria into an evolutionary corner where they become vulnerable to antibiotics again."),
        ("Clinical Phage Therapy: From Compassionate Use to Precision Medicine", "Phage therapy has been used clinically in the Republic of Georgia for over 100 years, but Western medicine largely abandoned it when antibiotics were discovered. Now, with antibiotics failing, phage therapy is experiencing a renaissance. The FDA has approved compassionate-use phage therapy for patients with untreatable infections. Notable cases include Tom Patterson (2016), who survived a multi-drug-resistant Acinetobacter infection after personalized phage therapy when all antibiotics failed. Modern phage therapy uses genomic sequencing to match phages to patient-specific bacterial strains, synthetic biology to engineer phages with expanded host ranges, and computational models to optimize dosing and treatment timing. The challenge is that each treatment is essentially a custom-designed biological product — very different from mass-produced antibiotic pills.")
    ],
    "lever_L": "Students identify nine components spanning phage biology, bacterial evolution, immune response, and treatment parameters — including three externally controllable variables (Phage Specificity, Treatment Timing, Dosage Optimization) and six internal dynamic responses.",
    "lever_E": "Students determine that Dosage Optimization establishes the initial Phage Population, which interacts with Target Bacteria Population through predator-prey dynamics while Bacterial Resistance Rate and Immune System Response work against the therapy — and that Phage Specificity controls the trade-off between targeting precision and Healthy Microbiome Impact.",
    "lever_V": "Students build a computational model showing the three-way race between phage replication, bacterial resistance evolution, and immune clearance, with treatment outcome determined by which process dominates.",
    "lever_Ev": "Students run standard, delayed-treatment, and optimized-cocktail scenarios to identify the parameter combinations that maximize bacterial clearance while minimizing resistance emergence and microbiome damage.",
    "lever_R": "Students add Phage-Antibiotic Synergy, Biofilm Penetration, or Phage Engineering Level to explore advanced therapeutic strategies.",
    "slides_guide": [
        {"num": "Slide 1", "title": "Cover", "visual": "Title slide with electron microscope images of phages attacking bacteria", "say": "Antibiotic-resistant bacteria killed 1.27 million people last year — more than HIV and malaria combined. The drugs are failing. But there's an ancient weapon we forgot about for 80 years: viruses that eat bacteria.", "do": "Show the WHO antibiotic resistance infographic. Let students react to the death toll before introducing phages.", "time": "2 min"},
        {"num": "Slide 2", "title": "Learning Objectives", "visual": "Learning goals and phage biology vocabulary", "say": "Today you're going to engineer a treatment protocol using something that's been killing bacteria for 3.5 billion years — bacteriophages. And you're going to optimize it using computational modeling.", "do": "Pre-teach bacteriophage and antibiotic resistance. Show a 30-second phage lysis animation to establish the biological mechanism.", "time": "3 min"},
        {"num": "Slide 3", "title": "Big Question", "visual": "Antibiotics are failing — can we engineer viruses to kill superbugs?", "say": "Every antibiotic we've ever invented, bacteria have evolved resistance to. Every single one. So why would phage therapy be any different — or would it?", "do": "Quick-write: Students predict whether bacteria can evolve resistance to phages and what might be different about viral versus chemical treatment. Share predictions.", "time": "3 min"},
        {"num": "Slide 4", "title": "LEVER Framework", "visual": "LEVER steps with phage therapy optimization context", "say": "We're going to optimize a living treatment — one that reproduces, evolves, and interacts with the patient's immune system in real time. This is nothing like designing a pill.", "do": "Preview LEVER steps. Emphasize that phage therapy involves optimizing a dynamic biological system, not just finding the right dose.", "time": "2 min"},
        {"num": "Slide 5", "title": "Activity 1: Components", "visual": "Nine component cards spanning phage, bacteria, and patient biology", "say": "Three of these components are under the doctor's control. Six are determined by biology and evolution. Which is which — and why does that distinction matter?", "do": "Guide sorting of external versus internal components. Discuss why Phage Specificity is controllable through engineering but Bacterial Resistance Rate is not.", "time": "8 min"},
        {"num": "Slide 6", "title": "Activity 2: Connections", "visual": "Complex relationship web showing predator-prey dynamics and evolutionary feedback", "say": "This model has something none of our previous models had: the treatment reproduces inside the disease. Trace what happens when phages meet bacteria.", "do": "Students map the self-amplifying feedback loop. Identify the three-way race between phage replication, bacterial resistance, and immune clearance.", "time": "8 min"},
        {"num": "Slide 7", "title": "Activity 3: Simulation", "visual": "Population dynamics graphs and optimization dashboards", "say": "You're the biotech engineer. Find the combination of specificity, timing, and dosage that clears the infection. But watch what evolution does in real time.", "do": "Students predict outcomes, then run all three scenarios. Track bacterial clearance rate, resistance emergence, and microbiome impact as key metrics.", "time": "10 min"},
        {"num": "Slide 8", "title": "Discoveries", "visual": "Key findings about optimization and evolutionary trade-offs", "say": "Here's the twist: when bacteria evolve resistance to phages, they sometimes lose their antibiotic resistance. The phage forces them into an evolutionary trap. This is phage-antibiotic synergy — and your model just predicted it.", "do": "Connect model findings to the real evolutionary trade-off in phage therapy. Discuss how this changes the treatment strategy.", "time": "5 min"},
        {"num": "Slide 9", "title": "STEM Challenge", "visual": "Personalized phage therapy protocol design challenge", "say": "A patient walks into your phage therapy clinic with an infection that no antibiotic can touch. Design their treatment protocol.", "do": "Groups design personalized protocols including phage selection, cocktail composition, timing, dosage, and resistance monitoring. Present and defend.", "time": "12 min"}
    ],
    "sort_reasoning": "Phage Specificity, Treatment Timing, and Dosage Optimization are external components because they represent parameters that clinicians and bioengineers directly control. Phage Specificity can be engineered through synthetic biology; Treatment Timing is a clinical decision; Dosage Optimization determines how many phages are initially administered. All other components — Phage Population, Target Bacteria Population, Bacterial Resistance Rate, Immune System Response, Phage Replication Rate, and Healthy Microbiome Impact — are internal biological responses that emerge from the dynamic interactions between phages, bacteria, and the patient's body.",
    "relationships": [
        ("Dosage Optimization to Phage Population", "POSITIVE (+)", "Higher initial phage dose establishes a larger starting Phage Population, increasing the probability that phages encounter and infect target bacteria before the immune system clears them."),
        ("Phage Population to Target Bacteria Population", "NEGATIVE (-)", "More phages infecting and lysing target bacteria directly reduces the Target Bacteria Population through predator-prey dynamics."),
        ("Target Bacteria Population to Phage Replication Rate", "POSITIVE (+)", "More abundant target bacteria provide more hosts for phage replication, increasing Phage Replication Rate — this is the self-amplifying nature of phage therapy."),
        ("Phage Specificity to Healthy Microbiome Impact", "NEGATIVE (-)", "Higher Phage Specificity means the phages more precisely target only the pathogenic bacteria, reducing off-target damage to beneficial gut microbiome species."),
        ("Target Bacteria Population to Bacterial Resistance Rate", "POSITIVE (+)", "Larger bacterial populations contain more genetic diversity through random mutation, increasing the probability that resistance-conferring mutations exist and are selected for under phage pressure.")
    ],
    "sim_answers": [
        ("Standard Protocol Scenario", "With moderate dosage, medium specificity, and early treatment, the Phage Population quickly amplifies using the smaller bacterial population as hosts. Target Bacteria Population drops sharply as phage predation outpaces bacterial reproduction. Bacterial Resistance Rate increases modestly but remains manageable because the population was small at treatment onset. Immune System Response clears remaining phages after bacteria are depleted. Healthy Microbiome Impact is moderate due to medium specificity."),
        ("Optimized Cocktail Scenario", "With high specificity, high dose, and early timing, the initial Phage Population is large enough to rapidly overwhelm the bacterial population before significant resistance can evolve. High Phage Specificity dramatically reduces Healthy Microbiome Impact. The key insight is that early timing prevents the bacterial population from reaching the size where resistance-conferring mutations become statistically likely. However, even under optimal conditions, some resistance evolution is observed — the arms race is never fully won.")
    ],
    "reflection_exemplars": [
        ("Why is phage therapy described as self-amplifying?", "Unlike antibiotics — which are administered at a fixed dose and steadily degrade — phages reproduce inside the bacteria they kill. Each lysis event releases 50-200 new phage particles that immediately seek new bacterial hosts. The model shows that Phage Population can increase exponentially when Target Bacteria Population is high, creating a self-reinforcing treatment cycle. When bacteria are eliminated, phages lose their reproduction substrate and the population naturally declines. This makes phage therapy inherently self-limiting — the treatment stops when the infection stops."),
        ("How does natural selection create the resistance trade-off?", "The model shows Bacterial Resistance Rate increasing under phage pressure as natural selection favors mutants with modified surface receptors. But these surface receptors serve other bacterial functions — they may be the same proteins used for nutrient uptake, antibiotic efflux, or virulence. When bacteria modify these receptors to escape phages, they may lose these other capabilities. This is the evolutionary trade-off: resistance to phages comes at the cost of fitness in other dimensions, potentially re-sensitizing the bacteria to antibiotics.")
    ],
    "stem_intro": "Present the challenge: A biotech startup is opening a phage therapy clinic for patients with untreatable antibiotic-resistant infections. Each patient's infection is unique. Your team must design the clinical decision-making protocol — from bacterial strain identification through phage selection to treatment monitoring and resistance management.",
    "stem_concepts": [
        ("Personalized Phage Selection", "Unlike mass-produced antibiotics, phage therapy can be customized to each patient's specific bacterial infection. Rapid genome sequencing identifies the pathogen; phage libraries are screened for activity; cocktails of 3-5 complementary phages are assembled to reduce resistance risk."),
        ("Treatment Monitoring", "Phage therapy requires real-time monitoring of bacterial counts (are they decreasing?), phage titers (are phages replicating?), resistance markers (are bacteria evolving escape?), and patient inflammatory markers (is the immune system interfering?). Computational models predict expected trajectories and flag deviations."),
        ("Resistance Management Strategy", "The 'phage-antibiotic synergy' strategy deliberately uses phage therapy to force bacteria to evolve in predictable directions — trading phage resistance for antibiotic susceptibility — then follows up with targeted antibiotics to eliminate the now-vulnerable population.")
    ],
    "stem_eval": [
        ("Expert (4)", "Protocol includes systematic phage selection, cocktail design rationale, monitoring schedule with specific biomarkers, resistance contingency plan with phage-antibiotic synergy strategy, and model-derived evidence"),
        ("Proficient (3)", "Protocol includes phage selection, monitoring, and basic resistance management based on model findings"),
        ("Developing (2)", "Protocol covers basic treatment steps but lacks monitoring detail or resistance contingency planning"),
        ("Beginning (1)", "Protocol is incomplete or does not connect treatment decisions to the population dynamics model")
    ],
    "support": [
        "Provide a simplified phage lytic cycle diagram showing the five steps from attachment to lysis",
        "Use predator-prey graph templates (Lotka-Volterra style) where students can sketch predicted population trajectories before simulating",
        "Scaffold evolutionary thinking: 'If phages kill all bacteria EXCEPT those with ___ mutation, what happens to the next generation?'"
    ],
    "extensions": [
        "Research the Tom Patterson case — the first FDA-approved compassionate-use phage therapy in the US — and analyze what made his treatment protocol successful",
        "Investigate how CRISPR-enhanced phages are being engineered to overcome bacterial defense systems and expand host range",
        "Compare the economic models of phage therapy (personalized per patient) versus antibiotics (mass produced) and debate which is more sustainable"
    ],
    "cross_curr": [
        ("Math", "Model phage-bacteria population dynamics using Lotka-Volterra predator-prey equations and compare mathematical predictions to simulation results"),
        ("ELA", "Research and write a feature article for a science magazine explaining why phage therapy, abandoned 80 years ago, is making a comeback in the antibiotic resistance crisis"),
        ("Social Studies", "Investigate why phage therapy thrived in the Soviet Union/Georgia while the West pursued antibiotics — how do political and economic systems shape scientific priorities?")
    ],
    "misconceptions": [
        ("Phages are dangerous because they're viruses", "Bacteriophages CANNOT infect human cells — period. They require specific bacterial surface receptors that human cells do not have. Phages have been part of the human microbiome since birth; you carry approximately 10^12 phages in your gut right now. They are the most abundant biological entities on Earth and have never caused a human infection. The word 'virus' triggers fear, but phages are fundamentally different from human-infecting viruses.", "Ask: What would a phage need to infect a human cell? It would need to recognize human surface receptors — but phage tail proteins evolved over 3.5 billion years to recognize BACTERIAL receptors. That's like trying to use a USB-C cable to charge a gas-powered car."),
        ("Bacteria can become resistant to everything eventually", "While bacteria can evolve resistance to any single selective pressure, resistance always comes at a cost. The model shows that phage resistance often requires modifying surface receptors that serve other essential functions. Phage cocktails (multiple phages targeting different receptors) make it exponentially harder for bacteria to evolve resistance to ALL phages simultaneously — the same principle behind HIV combination therapy.", "Calculate: If resistance to one phage occurs at a rate of 1 in 10^6, what's the probability of simultaneous resistance to three phages targeting different receptors? 1 in 10^18 — more bacteria than exist in the patient."),
        ("We should just develop new antibiotics instead", "New antibiotic development has nearly stopped because it's economically unviable — $1-2 billion to develop a drug that's used sparingly and becomes obsolete when resistance emerges. Only 2 new antibiotic classes have been discovered in the last 50 years. Phage therapy offers a fundamentally different approach: instead of chemical warfare against bacteria, it uses a co-evolved biological weapon that adapts alongside its target.", "Discuss: Why would a pharmaceutical company prefer to develop a blood pressure medication taken daily for life versus an antibiotic taken for 10 days? Follow the money.")
    ]
}

L03 = {
    "id": "G09L3-L03",
    "title": "CRISPR Gene Drive: Should We Eliminate Malaria?",
    "subtitle": "Systems Biology Modeling of Gene Drive Ecology and Ethics",
    "ngss": "HS-LS3-2, HS-LS4-5",
    "ngss_desc": "Make and defend a claim based on evidence that inheritable genetic variations may result from new genetic combinations through meiosis, viable errors occurring during replication, or mutations caused by environmental factors; evaluate the evidence supporting claims that changes in environmental conditions may result in increases in the number of individuals of some species, the emergence of new species over time, and the extinction of other species.",
    "big_question": "We have the technology to make mosquitoes extinct and end malaria forever — but should we?",
    "objectives": [
        "Build a systems biology model that traces gene drive propagation from molecular genetic mechanisms through mosquito populations to ecosystem-level consequences",
        "Analyze how gene drive efficiency, resistance evolution, and ecological dependencies interact across scales to determine system-wide outcomes",
        "Evaluate the trade-offs between eliminating malaria (saving hundreds of thousands of human lives) and the ecological risks of driving a species toward extinction",
        "Predict long-term unintended consequences of gene drive deployment using multi-generation simulation modeling"
    ],
    "vocabulary": [
        ("Gene Drive", "A genetic engineering technology that biases inheritance to spread a modified gene through a population at rates far exceeding normal Mendelian genetics — from 50% inheritance to over 99% — capable of altering or eliminating entire wild species within a few generations"),
        ("CRISPR-Cas9", "A molecular tool adapted from bacterial immune systems that allows precise cutting and editing of DNA at specific locations — the 'molecular scissors' that make gene drives technically possible by cutting the wild-type gene and forcing the cell to copy the drive sequence"),
        ("Ecological Cascade", "A chain reaction through an ecosystem where the removal or addition of one species triggers population changes in multiple other species — predators, prey, competitors, pollinators, and decomposers — that ripple through the entire food web"),
        ("Resistance Evolution", "The inevitable process by which natural selection favors organisms that develop genetic resistance to the gene drive — mutations that prevent CRISPR from cutting the target site, potentially rendering the drive ineffective before the goal is achieved")
    ],
    "components": [
        ("Gene Drive Efficiency", "The percentage of offspring that inherit the gene drive construct rather than the wild-type gene — in theory 99%+ but reduced by drive resistance mutations, mating competition, and molecular failure rates", True),
        ("Mosquito Population", "The total number of Anopheles mosquitoes in the target region, including both gene-drive-carrying individuals and wild-type individuals, which determines malaria transmission capacity", False),
        ("Malaria Transmission Rate", "The number of new human malaria infections per mosquito per unit time, which decreases as gene-drive-carrying mosquitoes replace wild-type vectors or as the overall mosquito population declines", False),
        ("Wild-Type Gene Frequency", "The proportion of natural, unmodified genes in the mosquito population — as the gene drive spreads, Wild-Type Gene Frequency decreases and the population shifts toward the engineered genotype", False),
        ("Ecological Dependence", "The degree to which other species in the ecosystem depend on mosquitoes as a food source, pollinator, or ecological role — bats, birds, fish, and other organisms that would be affected by mosquito population collapse", False),
        ("Resistance Evolution", "The rate at which natural selection produces mosquitoes with mutations that block the CRISPR gene drive mechanism — the molecular arms race between the engineered drive and natural genetic variation", False),
        ("Geographic Spread Rate", "The speed at which gene-drive-carrying mosquitoes expand beyond the initial release area through natural dispersal, wind patterns, and human-mediated transport — gene drives cannot be geographically contained", False),
        ("Human Malaria Cases", "The number of clinical malaria cases in the human population, which decreases as the gene drive reduces mosquito vectoring capacity but may rebound if resistance evolves or if other vector species fill the niche", False),
        ("Ecosystem Disruption Risk", "The overall magnitude of ecological consequences from mosquito population decline — measured by food web stability, pollination changes, freshwater ecosystem impacts, and cascading species population shifts", False)
    ],
    "think_about_it": "When Gene Drive Efficiency is set very high, the drive spreads rapidly through the Mosquito Population, causing Wild-Type Gene Frequency to plummet and Human Malaria Cases to drop dramatically. But Ecological Dependence means other species suffer as mosquitoes disappear, and the drive keeps spreading geographically because it cannot be recalled. Meanwhile, Resistance Evolution is working against the drive. Is there a setting where you save the most human lives with the least ecological damage — or is this an impossible trade-off?",
    "scenarios": [
        ("Moderate Gene Drive Deployment", "Set Gene Drive Efficiency to 95% in a single region — observe the spread through Mosquito Population, the decline in Human Malaria Cases, and the rise in Ecosystem Disruption Risk over multiple generations"),
        ("High Resistance Evolution Scenario", "Set Gene Drive Efficiency to 85% with elevated Resistance Evolution — observe whether the drive achieves population suppression before resistance renders it ineffective"),
        ("Maximum Efficiency Global Release", "Set Gene Drive Efficiency to 99.5% with global Geographic Spread — observe the complete ecological cascade as mosquitoes approach extinction and evaluate whether the malaria elimination justifies the ecosystem impact")
    ],
    "sim_scenarios": [
        ("Moderate Regional Deployment", "95% efficiency, single region release", "What do you predict happens to Wild-Type Gene Frequency over 20 mosquito generations with a 95% efficient gene drive?"),
        ("Resistance Race", "85% efficiency, elevated resistance evolution", "Do you predict the gene drive will suppress the mosquito population before resistance mutations spread through the population?"),
        ("Global Maximum Release", "99.5% efficiency, global spread", "What do you predict the ecosystem looks like 50 generations after a near-perfect gene drive is released globally?")
    ],
    "discoveries": [
        "Gene drives can theoretically spread a modified gene to an entire wild population within 10-20 generations, far faster than any natural evolutionary process — but this speed also means mistakes cannot be undone",
        "Resistance evolution is nearly inevitable — natural genetic variation ensures that some mosquitoes will carry mutations blocking the CRISPR mechanism, and selection will amplify these resistant genotypes",
        "The ecological consequences of mosquito elimination are uncertain but potentially significant — mosquitoes serve as food for thousands of species and as pollinators in some ecosystems",
        "Gene drives cannot be geographically contained — once released, the engineered gene will spread wherever the target species exists, making deployment an irreversible global decision"
    ],
    "answer": "CRISPR gene drives give us the power to eliminate malaria by engineering mosquitoes to either die before transmitting the disease or to become unable to carry the parasite. The technology works because gene drives bias inheritance — instead of the normal 50/50 chance, over 99% of offspring inherit the engineered gene, allowing it to sweep through wild populations in just a few generations. But this power comes with profound risks: gene drives cannot be recalled once released, resistance evolution may undermine the effort, and driving mosquitoes extinct could trigger unpredictable ecological cascades. Systems biology modeling reveals that this isn't a simple yes/no decision — it's a complex optimization problem balancing human lives saved against ecological disruption, with deep uncertainty about long-term consequences. This is perhaps the most consequential bioethics question of the 21st century.",
    "stem_title": "Design a Gene Drive Governance Framework",
    "stem_mission": "Design a comprehensive governance framework that determines when, where, and how gene drive technology should be deployed — balancing human health benefits against ecological risks using systems biology evidence.",
    "stem_scenario": "The United Nations has convened a special panel on gene drive technology. Malaria kills 600,000 people per year, mostly children under 5 in sub-Saharan Africa. Gene drive technology could potentially eliminate the disease. But the technology is irreversible once deployed and could have unpredictable ecological consequences. Your team has been appointed to design the governance framework that will determine global policy on gene drive deployment.",
    "stem_questions": [
        "What evidence threshold should be required before approving gene drive deployment?",
        "Who should have the authority to decide whether to release a gene drive — and should affected communities have veto power?",
        "What monitoring systems would you require to detect unintended ecological consequences?"
    ],
    "stem_design_qs": [
        "How would you design a 'kill switch' or recall mechanism for the gene drive if unintended consequences are detected?",
        "What international agreements would need to exist before a gene drive that crosses national borders is released?",
        "How do you weigh 600,000 human deaths per year against uncertain ecological risks that may or may not materialize?",
        "What role should the communities most affected by malaria play in the decision-making process?"
    ],
    "career": "Gene Drive Researchers and Conservation Geneticists work at the intersection of genetic engineering and ecology. They develop and evaluate gene drive technologies at institutions like the Target Malaria consortium, DARPA, and academic research labs, earning $80,000–$160,000/year. Bioethicists who evaluate the societal implications of these technologies earn $70,000–$140,000/year.",
    "images": {
        "cover": ("G09L3-L03-cover.png", "A photorealistic, cinematic image of diverse 14-15 year old students in an advanced genetics lab examining CRISPR gene drive diagrams on holographic displays, with a mosquito specimen under a high-powered microscope visible, dramatic green and gold lighting suggesting the tension between biotech power and ecological responsibility"),
        "landscape": ("G09L3-L03-landscape.png", "A diverse group of 14-15 year old students in a modern computational ecology lab analyzing gene drive spread simulations on large displays showing maps and population genetics graphs, ecological food web diagrams on the walls"),
        "modeling": ("G09L3-L03-modeling.png", "A diverse group of 14-15 year old students building systems biology models on laptops showing gene frequency changes across generations, whiteboards with ecological network diagrams and CRISPR mechanisms, intense collaborative atmosphere"),
        "discussion": ("G09L3-L03-discussion.png", "A teacher leading a passionate ethics debate with diverse 14-15 year old students about gene drive deployment, a world malaria map and ecological cascade diagram on a smartboard, students showing strong engagement and different viewpoints"),
        "stem": ("G09L3-L03-stem.png", "Diverse 14-15 year old students presenting gene drive governance framework proposals with policy flowcharts and risk-benefit analysis displays, professional United Nations simulation setting with flags and formal presentation boards")
    },
    "pre_assessment": [
        "What do you know about CRISPR and how it is used to edit genes?",
        "Malaria kills about 600,000 people per year — mostly children. If we could eliminate the disease by making mosquitoes extinct, should we?",
        "Draw a food web that includes mosquitoes — what other species would be affected if mosquitoes disappeared?",
        "What does it mean for a gene to 'drive' through a population, and how is this different from normal inheritance?"
    ],
    "extend_components": [
        ("Alternative Vector Species", "Other mosquito species or biting insects that could potentially fill the ecological niche and become new malaria vectors if Anopheles mosquitoes are suppressed"),
        ("Gene Drive Reversal Mechanism", "An engineered 'daisy chain' or 'kill switch' system designed to halt or reverse gene drive spread — still theoretical and unproven in wild populations"),
        ("Climate Change Interaction", "The effect of changing temperature and precipitation patterns on mosquito range, breeding habitats, and gene drive spread dynamics — climate change is expanding malaria zones regardless of gene drive deployment")
    ],
    "reflections": [
        "How does your systems biology model reveal the tension between saving human lives and protecting ecosystem stability?",
        "Why is it important that gene drives cannot be geographically contained — what makes this different from other genetic engineering applications?",
        "What role does Resistance Evolution play in determining whether the gene drive succeeds or fails, and how predictable is this outcome?",
        "How would adding a Gene Drive Reversal Mechanism change your model's predictions and the governance conversation?",
        "What are the ethical implications of a technology that makes irreversible changes to wild species — who has the right to make that decision?"
    ],
    "dimensions": [
        ("Science Practice", "Engaging in Argument from Evidence", "Students evaluate competing claims about gene drive deployment using systems biology model data, ecological evidence, and ethical reasoning to construct and defend evidence-based positions."),
        ("Disciplinary Core Idea", "LS3.B Variation of Traits / LS4.C Adaptation", "Genetic variation arises through mutation and is shaped by natural selection; gene drives exploit and override natural inheritance mechanisms, with evolutionary consequences for both target and non-target species."),
        ("Crosscutting Concept", "Cause and Effect / Systems and System Models", "Students trace causal chains from molecular CRISPR mechanisms through population genetics to ecosystem-level consequences, modeling the system across multiple scales and timescales.")
    ],
    "cast_items": [
        "Model gene drive propagation from molecular CRISPR mechanisms through mosquito population genetics to ecosystem-scale ecological consequences",
        "Analyze the trade-offs between malaria elimination and ecological disruption using multi-generation systems biology simulations",
        "Evaluate the role of resistance evolution in determining gene drive outcomes and the implications for technology deployment decisions"
    ],
    "cast_questions": [
        ("Multiple Choice:", "A gene drive with 95% efficiency is released in a mosquito population. After 15 generations, Wild-Type Gene Frequency begins to increase instead of decrease. Based on your model, what is the most likely explanation?"),
        ("Constructed Response:", "Using your systems biology model, construct an argument for OR against deploying a CRISPR gene drive to eliminate malaria. You must address at least two benefits, two risks, and the role of uncertainty in your recommendation. Reference specific model components and simulation results.")
    ],
    "background_intro": "This lesson introduces students to systems biology and synthetic design in the context of gene drive technology — arguably the most powerful and controversial application of CRISPR genetic engineering. Biotech skill focus: Systems biology and synthetic design. Gene drives have the theoretical capacity to alter or eliminate entire wild species, forcing us to confront questions at the intersection of molecular biology, ecology, evolution, and ethics.",
    "background_sections": [
        ("CRISPR Gene Drive Mechanism", "A CRISPR gene drive works by encoding the Cas9 protein and a guide RNA within the modified gene itself. When a gene-drive-carrying mosquito mates with a wild-type mosquito, the Cas9 protein cuts the wild-type copy of the gene on the partner chromosome. The cell's DNA repair machinery then uses the gene drive copy as a template, converting the heterozygous cell to homozygous for the drive. This means that instead of inheriting the modified gene 50% of the time (Mendelian), offspring inherit it 99%+ of the time. Over multiple generations, the drive spreads exponentially through the population. Two strategies exist: population suppression drives (carrying genes that reduce female fertility, crashing the population) and population modification drives (carrying genes that make mosquitoes unable to transmit the malaria parasite while maintaining population size)."),
        ("Malaria: The Scale of the Problem", "Malaria kills approximately 600,000 people per year — a child dies every minute. Over 95% of malaria deaths occur in sub-Saharan Africa, and 80% of victims are children under 5. The disease is caused by Plasmodium parasites transmitted by female Anopheles mosquitoes. Despite billions of dollars invested in bed nets, insecticides, and antimalarial drugs, malaria has proven extraordinarily difficult to control because the parasite has evolved resistance to every drug we've developed, and the mosquito has evolved resistance to every insecticide. Gene drives offer a fundamentally different approach — instead of trying to outpace evolution with new chemicals, they co-opt evolution itself to spread the desired trait through the vector population."),
        ("Ecological Risk Assessment", "The ecological consequences of driving Anopheles mosquitoes extinct are genuinely uncertain. Mosquitoes serve as food for bats, birds, dragonflies, frogs, fish, and spiders. Mosquito larvae are a significant food source in freshwater ecosystems. Some mosquito species pollinate plants (primarily in Arctic regions). However, ecologists are divided on whether mosquitoes are a 'keystone species' whose removal would trigger cascading extinctions, or a replaceable food source whose ecological niche would be filled by other insects. The honest scientific answer is: we don't know. Models can simulate potential cascades, but the complexity of real ecosystems means our predictions carry substantial uncertainty — and the consequences of being wrong are irreversible."),
        ("The Gene Drive Governance Challenge", "Gene drives present an unprecedented governance challenge because they are inherently transboundary — mosquitoes don't respect national borders. A gene drive released in one country will inevitably spread to neighboring countries and potentially the entire species range. This means the decision to deploy affects every nation in the species' range, yet there is no international body with the authority to make or enforce such decisions. The Convention on Biological Diversity has debated gene drive moratoriums; the African Union has studied the issue extensively; the Target Malaria consortium conducts community engagement in Burkina Faso, Mali, and Uganda. The core ethical tension: children are dying NOW from malaria, but deploying an irreversible technology based on uncertain ecological models risks unforeseen consequences that could last forever. Who decides — and on what evidence basis?")
    ],
    "lever_L": "Students identify nine components spanning molecular genetics (Gene Drive Efficiency, Wild-Type Gene Frequency), population biology (Mosquito Population, Resistance Evolution, Geographic Spread Rate), human health (Malaria Transmission Rate, Human Malaria Cases), and ecology (Ecological Dependence, Ecosystem Disruption Risk).",
    "lever_E": "Students determine that Gene Drive Efficiency drives the decline in Wild-Type Gene Frequency, which suppresses Mosquito Population, reducing Malaria Transmission Rate and Human Malaria Cases — while simultaneously increasing Ecosystem Disruption Risk through Ecological Dependence, with Resistance Evolution working to counteract the drive.",
    "lever_V": "Students build a systems biology model connecting molecular gene drive mechanics to population-level dynamics to ecosystem-scale consequences, visualizing the multi-generational spread and its cascading effects.",
    "lever_Ev": "Students run moderate, high-resistance, and maximum-efficiency scenarios to map the outcome space — identifying parameter regions where malaria is eliminated, where resistance halts the drive, and where ecological cascades become severe.",
    "lever_R": "Students add Alternative Vector Species, Gene Drive Reversal Mechanism, or Climate Change Interaction to explore more realistic and nuanced scenarios.",
    "slides_guide": [
        {"num": "Slide 1", "title": "Cover", "visual": "Title slide with split image — child with malaria on one side, thriving ecosystem on the other", "say": "A child dies of malaria every 60 seconds. We have the technology to stop it — by engineering mosquitoes to carry a self-spreading genetic modification that could wipe them out. But there's a catch: once we release it, we can never take it back.", "do": "Start a 60-second timer. Tell students that by the time it ends, another child will have died from malaria. Let the silence speak.", "time": "2 min"},
        {"num": "Slide 2", "title": "Learning Objectives", "visual": "Learning goals and gene drive vocabulary", "say": "Today you're going to model a technology that can rewrite the genetics of an entire wild species. And then you're going to decide whether we should use it.", "do": "Pre-teach gene drive and CRISPR-Cas9. Show a simple animation of gene drive inheritance versus normal Mendelian inheritance.", "time": "3 min"},
        {"num": "Slide 3", "title": "Big Question", "visual": "We can eliminate malaria forever — but should we?", "say": "If you could press a button that saves 600,000 lives a year but might permanently alter ecosystems in ways we can't predict — would you press it?", "do": "Anonymous poll: Press or don't press? Record the class results. Tell them the model will help them make a more informed decision.", "time": "3 min"},
        {"num": "Slide 4", "title": "LEVER Framework", "visual": "LEVER steps with systems biology context spanning molecules to ecosystems", "say": "We're building a systems biology model that connects a molecular event — CRISPR cutting DNA — to the extinction of a species and the potential collapse of ecosystems. That's four scales in one model.", "do": "Preview LEVER steps. Map the four scales: molecular, population, human health, ecosystem. Emphasize that systems biology integrates all of them.", "time": "2 min"},
        {"num": "Slide 5", "title": "Activity 1: Components", "visual": "Nine component cards spanning molecular to ecosystem scales", "say": "Only ONE of these nine components is truly under human control — the efficiency of the gene drive we engineer. Everything else is biology responding to our intervention. What does that tell you about the risks?", "do": "Guide component sorting. Discuss why Gene Drive Efficiency is the only truly controllable variable. Map each component to its biological scale.", "time": "8 min"},
        {"num": "Slide 6", "title": "Activity 2: Connections", "visual": "Complex systems biology web connecting genes to ecosystems", "say": "Trace the cascade: A molecular edit in a mosquito embryo leads to the potential extinction of a species and the collapse of food webs. Map every connection.", "do": "Students trace the full causal chain from Gene Drive Efficiency through population suppression to ecological cascade. Identify where Resistance Evolution acts as a brake on the system.", "time": "8 min"},
        {"num": "Slide 7", "title": "Activity 3: Simulation", "visual": "Multi-generation population dynamics and ecological impact dashboards", "say": "Run these three scenarios and find out: Is there a gene drive setting that eliminates malaria without devastating the ecosystem? Or is that impossible?", "do": "Students predict outcomes for all three scenarios, then run simulations. Track Human Malaria Cases and Ecosystem Disruption Risk simultaneously to visualize the trade-off.", "time": "10 min"},
        {"num": "Slide 8", "title": "Discoveries", "visual": "Key systems biology findings and ethical dimensions", "say": "Your model just showed you what the world's top geneticists and ecologists are debating right now. There may not be a setting that gives us everything we want. So what do we do?", "do": "Revisit the opening poll. Has anyone changed their mind? Discuss what model evidence changed perspectives. Introduce the concept of irreversible decisions under uncertainty.", "time": "5 min"},
        {"num": "Slide 9", "title": "STEM Challenge", "visual": "Gene drive governance framework design challenge — UN simulation", "say": "The United Nations just appointed your team to design the rules for gene drive deployment. 600,000 lives hang in the balance — and so does the integrity of Earth's ecosystems. Design the framework.", "do": "Groups design governance frameworks including evidence thresholds, decision-making authority, monitoring requirements, and reversal strategies. Present and debate.", "time": "12 min"}
    ],
    "sort_reasoning": "Gene Drive Efficiency is the sole external component because it represents the only parameter that bioengineers directly control — the molecular design of the CRISPR construct determines how efficiently it converts wild-type alleles. All other eight components are internal responses of the biological and ecological system: Mosquito Population, Malaria Transmission Rate, Wild-Type Gene Frequency, Ecological Dependence, Resistance Evolution, Geographic Spread Rate, Human Malaria Cases, and Ecosystem Disruption Risk all emerge from the dynamic interactions between the engineered gene, the mosquito population, the malaria parasite, the ecosystem, and evolution.",
    "relationships": [
        ("Gene Drive Efficiency to Wild-Type Gene Frequency", "NEGATIVE (-)", "Higher Gene Drive Efficiency means more offspring inherit the drive construct instead of wild-type alleles, directly decreasing the frequency of natural genes in the population."),
        ("Wild-Type Gene Frequency to Mosquito Population", "POSITIVE (+)", "As Wild-Type Gene Frequency drops (more mosquitoes carry the suppression drive), Mosquito Population declines because drive-carrying females have reduced fertility or the population is modified to prevent malaria transmission."),
        ("Mosquito Population to Malaria Transmission Rate", "POSITIVE (+)", "Fewer mosquitoes means fewer opportunities for the Plasmodium parasite to be transmitted between human and mosquito hosts, directly reducing malaria transmission."),
        ("Mosquito Population to Ecosystem Disruption Risk", "NEGATIVE (-)", "Declining Mosquito Population increases Ecosystem Disruption Risk as species that depend on mosquitoes for food lose a critical resource, triggering potential cascade effects through the food web."),
        ("Resistance Evolution to Gene Drive Efficiency", "NEGATIVE (-)", "As Resistance Evolution increases in the mosquito population, the effective Gene Drive Efficiency decreases because resistant mosquitoes produce offspring that inherit wild-type alleles instead of the drive construct.")
    ],
    "sim_answers": [
        ("Moderate Regional Deployment Scenario", "With 95% Gene Drive Efficiency in a single region, Wild-Type Gene Frequency drops rapidly over the first 5-10 generations as the drive spreads through the local Mosquito Population. Human Malaria Cases decline substantially. However, Resistance Evolution begins to accumulate, and by generation 15-20, resistant mosquitoes represent a growing fraction of the population, slowing the drive's progress. Ecosystem Disruption Risk increases moderately as mosquito populations decline. Geographic Spread Rate carries the drive beyond the initial release region."),
        ("Global Maximum Release Scenario", "With 99.5% efficiency and global release, the gene drive overwhelms resistance evolution in most populations, driving Wild-Type Gene Frequency toward zero across the species range. Human Malaria Cases plummet toward elimination. However, Ecosystem Disruption Risk escalates dramatically as mosquito populations crash globally — triggering food web disruptions in freshwater and terrestrial ecosystems. The model reveals that complete malaria elimination comes at the cost of significant ecological uncertainty, and the change is irreversible.")
    ],
    "reflection_exemplars": [
        ("Why can't gene drives be geographically contained?", "Gene drives spread through reproduction, and mosquitoes do not respect political borders. Once a gene-drive-carrying mosquito mates with a wild-type mosquito from a neighboring region, the drive enters that population and begins spreading there too. The Geographic Spread Rate in the model shows that containment is impossible because mosquitoes naturally disperse through flight and human transport. This means a release decision in one country is effectively a decision for every country in the species' range — making it an inherently global action."),
        ("How should we handle the ethical trade-off between human lives and ecological risk?", "The model reveals that there is no setting that maximizes human health benefits while eliminating ecological risk. Every scenario that significantly reduces Human Malaria Cases also increases Ecosystem Disruption Risk. This forces a genuine ethical trade-off: 600,000 real human deaths per year versus uncertain but potentially significant ecological consequences. The uncertainty itself is a key factor — we know with certainty that malaria kills, but we don't know with certainty what ecosystem consequences would follow mosquito suppression. How we weigh certain harm against uncertain risk is a values question, not a purely scientific one.")
    ],
    "stem_intro": "Present the challenge: The United Nations has convened a special panel on CRISPR gene drive technology for malaria elimination. Your team will design the governance framework that determines global policy — including evidence requirements, decision-making authority, monitoring systems, and reversal strategies. The stakes could not be higher.",
    "stem_concepts": [
        ("Risk-Benefit Analysis Under Uncertainty", "Gene drive decisions involve comparing known, quantifiable benefits (malaria deaths prevented) against uncertain, difficult-to-quantify risks (ecological cascade effects). Governance frameworks must establish how much uncertainty is acceptable before deployment and what monitoring evidence would trigger intervention."),
        ("Stakeholder Analysis", "Gene drive deployment affects different communities differently. Sub-Saharan African nations bear the burden of malaria but may also depend on mosquito-linked ecosystems. Scientific institutions control the technology. Environmental organizations advocate for ecological caution. A governance framework must determine whose voices count and how conflicts are resolved."),
        ("Precautionary Principle vs. Proactionary Principle", "The precautionary principle argues that technologies with irreversible consequences should not be deployed until proven safe. The proactionary principle argues that inaction also has consequences — every year of delay means 600,000 more deaths. Gene drive governance must navigate between these philosophies with explicit criteria for action thresholds.")
    ],
    "stem_eval": [
        ("Expert (4)", "Framework includes explicit evidence thresholds, inclusive stakeholder process, multi-scale monitoring systems, reversal contingencies, and nuanced treatment of the certainty-uncertainty trade-off, supported by systems biology model evidence"),
        ("Proficient (3)", "Framework addresses evidence requirements, decision authority, and monitoring, with reasoning connected to model findings"),
        ("Developing (2)", "Framework covers basic governance elements but lacks specificity on evidence thresholds or stakeholder inclusion"),
        ("Beginning (1)", "Framework is incomplete or does not connect governance decisions to the systems biology model evidence")
    ],
    "support": [
        "Provide a simplified gene drive inheritance diagram comparing normal 50/50 Mendelian inheritance to 99%+ gene drive inheritance",
        "Use a food web template pre-populated with mosquitoes so students can trace ecological cascades from mosquito population decline",
        "Scaffold ethical reasoning: 'The benefit is ___ (quantified as ___). The risk is ___ (uncertain because ___). I recommend ___ because ___.'"
    ],
    "extensions": [
        "Research the Target Malaria project in Burkina Faso — how is the consortium engaging local communities in gene drive governance decisions?",
        "Investigate 'daisy chain' gene drives — self-limiting drives designed to spread through a local population but not persist indefinitely — and model how they change the risk-benefit calculus",
        "Compare gene drive mosquito suppression to other malaria control strategies (bed nets, insecticides, vaccines) in terms of cost-effectiveness, scalability, and reversibility"
    ],
    "cross_curr": [
        ("Math", "Calculate gene drive spread rates using Hardy-Weinberg equilibrium models modified for non-Mendelian inheritance and compare predicted versus simulated allele frequencies"),
        ("ELA", "Write a position paper for the UN panel arguing for or against gene drive deployment, using systems biology model evidence and ethical reasoning frameworks"),
        ("Social Studies/Ethics", "Analyze the colonial history of malaria research in Africa and debate who should have authority over gene drive decisions that primarily affect African communities")
    ],
    "misconceptions": [
        ("Gene drives are like GMO crops — contained and controllable", "Gene drives are fundamentally different from GMO crops in one critical way: they are designed to spread. GMO crops contain modifications that follow normal Mendelian inheritance and stay in cultivated populations. Gene drives override Mendelian genetics and actively propagate through wild populations across generations and geographic boundaries. There is currently no proven technology to recall a gene drive once released.", "Analogy: A GMO crop is like painting your own house a new color. A gene drive is like releasing a paint that automatically repaints every house in the neighborhood — and you can't undo it."),
        ("If we eliminate mosquitoes, nothing bad will happen because they're just pests", "Mosquitoes play multiple ecological roles beyond being human pests. They are a primary food source for bats, birds, dragonflies, fish, and frogs. Mosquito larvae are a major component of freshwater food webs. Some mosquito species are pollinators. While individual ecological roles might be filled by other species, the cascading effects of removing an entire taxon from global ecosystems are genuinely unpredictable. Ecologists are genuinely divided on this question.", "Challenge: Name 5 species that eat mosquitoes. Now imagine those species losing a significant food source. What happens to THEIR populations? And what eats THEM?"),
        ("CRISPR is perfectly precise and gene drives will work exactly as designed", "CRISPR is remarkably precise but not perfect. Off-target cuts occur, resistance mutations evolve, and molecular mechanisms can fail in ways not predicted by laboratory experiments. The model's Resistance Evolution component captures this reality — natural selection is relentless and creative. Every gene drive experiment in laboratory mosquito populations has observed resistance evolution within 10-25 generations. The question is whether the drive suppresses the population before resistance spreads, not whether resistance will emerge at all.", "Show: In lab experiments, CRISPR gene drives reached only 60-80% of the wild mosquito population before resistance plateaued the effect. What does that mean for malaria elimination?")
    ]
}

L04 = {
    "id": "G09L3-L04",
    "title": "Growing Meat Without the Animal",
    "subtitle": "Optimizing Cultured Meat Bioreactor Systems from Cell to Steak",
    "ngss": "HS-LS1-2, HS-ETS1-3",
    "ngss_desc": "Develop and use a model to illustrate the hierarchical organization of interacting systems that provide specific functions within multicellular organisms; evaluate a solution to a complex real-world problem based on prioritized criteria and trade-offs.",
    "big_question": "Can we grow a steak in a lab that tastes, feels, and costs the same as one from a cow — and should we?",
    "objectives": [
        "Build an optimization model for cultured meat production that balances cell growth, nutrient efficiency, and product quality across a bioreactor system",
        "Analyze how bioreactor conditions (temperature, oxygen, nutrients) interact to determine cell proliferation rate, tissue quality, and production cost",
        "Optimize multiple competing parameters simultaneously to achieve viable commercial-scale cultured meat production",
        "Evaluate the trade-offs between production cost, texture quality, and environmental sustainability in cellular agriculture"
    ],
    "vocabulary": [
        ("Cellular Agriculture", "The production of animal products — meat, dairy, leather — directly from cell cultures rather than from whole animals, using techniques borrowed from tissue engineering and bioprocessing"),
        ("Bioreactor", "A controlled vessel that maintains optimal conditions for cell growth — temperature, pH, oxygen, nutrients — while removing waste products and providing mechanical stimulation for tissue development at industrial scale"),
        ("Scaffold", "A three-dimensional structural framework (made from plant proteins, hydrogels, or decellularized tissue) that provides physical support for muscle cells to attach, align, and develop the fibrous texture characteristic of real meat"),
        ("Growth Factor", "Signaling proteins (like FGF2, TGF-beta, and IGF-1) added to the nutrient medium that instruct cells to proliferate, differentiate into muscle fibers, or organize into tissue — the most expensive component of cultured meat production")
    ],
    "components": [
        ("Cell Growth Rate", "The speed at which muscle satellite cells divide and increase in number within the bioreactor, measured in population doublings per day — determines production throughput", False),
        ("Nutrient Medium Concentration", "The formulation and concentration of amino acids, glucose, vitamins, minerals, and growth factors in the liquid medium that feeds the growing cells — the primary input and cost driver", True),
        ("Bioreactor Temperature", "The precisely controlled temperature of the culture environment, typically maintained at 37°C for mammalian cells — deviations of even 1-2°C can dramatically affect cell behavior", True),
        ("Oxygen Supply", "The rate of dissolved oxygen delivery to cells throughout the bioreactor volume — critical because cells deep inside tissue structures can become oxygen-starved (hypoxic) without active perfusion", True),
        ("Waste Product Accumulation", "The buildup of metabolic byproducts (ammonia, lactate, carbon dioxide) that cells produce as they grow and consume nutrients — these toxins inhibit further growth if not removed", False),
        ("Scaffold Structure", "The engineered three-dimensional framework that guides cell organization into muscle-like tissue architecture — determines whether the final product has the fibrous texture of steak or the mush of a paste", True),
        ("Texture Quality", "The sensory and structural properties of the final cultured meat product — fiber alignment, marbling, tenderness, and mouthfeel — compared to conventionally produced meat", False),
        ("Energy Input", "The total energy required to maintain bioreactor conditions — heating, mixing, oxygenation, pumping, sterilization — which determines the environmental footprint and operational cost", True),
        ("Production Cost", "The calculated cost per kilogram of final cultured meat product, incorporating nutrient medium, energy, labor, equipment depreciation, and quality control — must approach $10-20/kg for commercial viability", False),
        ("Scale Factor", "The ratio of production volume to cost efficiency — larger bioreactors can be more cost-effective but face challenges in maintaining uniform conditions throughout the vessel", False)
    ],
    "think_about_it": "Increasing Nutrient Medium Concentration boosts Cell Growth Rate but drives up Production Cost. Raising Bioreactor Temperature to exactly 37°C optimizes growth but increases Energy Input. Improving Scaffold Structure enhances Texture Quality but adds complexity and cost. And as Scale Factor increases, maintaining uniform Oxygen Supply and Waste Product removal becomes exponentially harder. How do you optimize everything simultaneously when improving one parameter often worsens another?",
    "scenarios": [
        ("Small-Scale Lab Prototype", "Set all parameters to lab-scale conditions — observe baseline Cell Growth Rate, Texture Quality, and Production Cost before scaling up"),
        ("Maximum Growth Optimization", "Maximize Nutrient Medium Concentration, Bioreactor Temperature precision, and Oxygen Supply — observe how fast cells grow but also track Waste Product Accumulation and Production Cost escalation"),
        ("Commercial Scale-Up", "Increase Scale Factor significantly while attempting to maintain growth conditions — observe how Production Cost changes and where Oxygen Supply and Waste Product removal become limiting factors")
    ],
    "sim_scenarios": [
        ("Lab Prototype", "Small-scale, optimized conditions", "What do you predict Production Cost per kilogram will be at lab scale, and why?"),
        ("Maximum Growth", "All inputs maximized for fastest cell division", "What do you predict happens to Waste Product Accumulation when Cell Growth Rate is maximized?"),
        ("Commercial Scale-Up", "Large bioreactor, cost-minimized inputs", "Do you predict that scaling up 1000x will reduce per-kilogram cost, and what new problems emerge?")
    ],
    "discoveries": [
        "The primary cost driver in cultured meat is the nutrient medium — particularly growth factors that currently cost thousands of dollars per gram and must be produced through recombinant protein technology",
        "Oxygen delivery is the critical scaling bottleneck — cells more than 200 micrometers from an oxygen source become hypoxic, limiting how thick cultured meat tissue can grow without vascularization",
        "Waste product accumulation creates a negative feedback loop — as cells grow and metabolize, they produce toxins that inhibit further growth, requiring continuous medium perfusion or replacement",
        "Texture quality requires both scaffold engineering and mechanical stimulation — without aligned fibers and exercised muscle cells, cultured meat lacks the sensory experience consumers expect from conventional meat"
    ],
    "answer": "Growing meat without animals is technically possible but commercially challenging. The optimization problem is multidimensional: nutrient medium must be rich enough to support rapid cell growth but affordable enough for commercial viability; oxygen must reach every cell in a three-dimensional tissue but diffusion limits tissue thickness to about 200 micrometers; waste products must be removed continuously as they accumulate; and scaffold structures must guide cells into forming the aligned fibers that give meat its texture. The key insight is that this is fundamentally an engineering optimization problem — every parameter improvement in one dimension creates constraints in others. Computational modeling allows researchers to find the narrow operating window where all parameters are simultaneously viable, dramatically accelerating the path from lab prototype to commercial reality.",
    "stem_title": "Design a Commercial-Scale Cultured Meat Bioreactor",
    "stem_mission": "Design a bioreactor system that can produce cultured meat at commercial scale ($15/kg) while maintaining texture quality comparable to conventional beef.",
    "stem_scenario": "A cellular agriculture startup has proven they can grow cultured beef at lab scale — but it costs $400/kg. They need to reduce costs by 96% while maintaining quality. Your engineering team has been hired to design the bioreactor system that bridges the gap between lab and commercial production.",
    "stem_questions": [
        "What is the single biggest cost driver in your bioreactor system and how would you reduce it?",
        "How would you solve the oxygen delivery problem as you scale from milliliters to thousands of liters?",
        "What trade-offs between texture quality and production cost are acceptable for a commercial product?"
    ],
    "stem_design_qs": [
        "What bioreactor configuration would you use — stirred tank, hollow fiber, perfusion, or a novel design?",
        "How would you monitor cell health and product quality in real time inside the bioreactor?",
        "What recycling or recovery systems would you include to reduce nutrient medium waste?",
        "How would you incorporate scaffold structures at commercial scale?"
    ],
    "career": "Bioprocess Engineers design and optimize bioreactor systems for cellular agriculture, biopharmaceutical production, and industrial biotechnology. They work for cultured meat companies (Upside Foods, GOOD Meat, Mosa Meat), biotech firms, and food technology startups, earning $80,000–$150,000/year. Tissue Engineers who specialize in edible scaffold design earn $90,000–$170,000/year.",
    "images": {
        "cover": ("G09L3-L04-cover.png", "A photorealistic, cinematic image of diverse 14-15 year old students in a cutting-edge cellular agriculture lab examining bioreactors with pink cell culture media visible, cultured meat tissue samples on plates nearby, with bioprocess monitoring screens showing growth curves, modern clean-room aesthetic with white and chrome"),
        "landscape": ("G09L3-L04-landscape.png", "A diverse group of 14-15 year old students in a food technology lab analyzing cultured meat samples under microscopes while comparing them to conventional meat samples, bioreactor diagrams on wall displays, bright modern laboratory"),
        "modeling": ("G09L3-L04-modeling.png", "A diverse group of 14-15 year old students building bioreactor optimization models on laptops, graphs showing cell growth curves and cost projections on screens, whiteboards with bioreactor schematics and nutrient flow diagrams"),
        "discussion": ("G09L3-L04-discussion.png", "A teacher leading an optimization discussion with diverse 14-15 year old students about cultured meat production trade-offs, a multi-parameter optimization graph displayed on a smartboard showing cost versus quality versus scale curves"),
        "stem": ("G09L3-L04-stem.png", "Diverse 14-15 year old students presenting bioreactor designs with engineering schematics and cost analyses on large displays, 3D-printed bioreactor models on tables, professional bioengineering presentation setting")
    },
    "pre_assessment": [
        "What do you think 'lab-grown meat' actually means — how do you grow meat without an animal?",
        "Why do you think cultured meat currently costs hundreds of dollars per kilogram while conventional beef costs about $10/kg?",
        "Draw a diagram of what you think a bioreactor for growing meat would look like and what conditions it would need to maintain.",
        "What factors do you think determine whether cultured meat tastes and feels like real meat?"
    ],
    "extend_components": [
        ("Fat Cell Integration", "The inclusion of adipocyte (fat) cells alongside muscle cells to create the marbling and flavor profile that makes meat taste rich — requiring different growth conditions from muscle cells"),
        ("Mechanical Stimulation", "The application of cyclic stretching or electrical pulses to cultured muscle cells, mimicking exercise to promote fiber alignment, protein production, and the textural properties of real muscle tissue"),
        ("Serum-Free Medium Development", "The replacement of fetal bovine serum (FBS) — an expensive, animal-derived, and ethically problematic component — with plant-derived or recombinant growth factors, which is essential for both cost reduction and consumer acceptance")
    ],
    "reflections": [
        "How does your model reveal the multi-dimensional optimization challenge of cultured meat production?",
        "Which parameter do you think is the most critical bottleneck for commercial viability, and what does your model suggest?",
        "What trade-offs between Production Cost and Texture Quality did you discover, and which compromises are acceptable?",
        "How would adding Fat Cell Integration change the bioreactor requirements and production complexity?",
        "What are the environmental implications of cultured meat compared to conventional livestock farming according to your model's Energy Input data?"
    ],
    "dimensions": [
        ("Science Practice", "Developing and Using Models / Constructing Explanations and Designing Solutions", "Students develop a computational bioreactor model and use it to design optimized solutions that balance competing production constraints."),
        ("Disciplinary Core Idea", "LS1.A Structure and Function / ETS1.C Optimizing the Design Solution", "Multicellular organisms have hierarchical organization; engineering optimization requires systematically testing and refining solutions against multiple criteria and constraints."),
        ("Crosscutting Concept", "Systems and System Models / Stability and Change", "Students model the bioreactor as a complex system where multiple interacting variables must be simultaneously optimized, and small changes in one parameter cascade through the entire system.")
    ],
    "cast_items": [
        "Model the multi-parameter optimization challenge of scaling cultured meat production from lab to commercial viability",
        "Analyze trade-offs between cell growth rate, texture quality, oxygen delivery, and production cost in bioreactor systems",
        "Evaluate how scaling factor affects the balance between cost efficiency and product quality in cellular agriculture"
    ],
    "cast_questions": [
        ("Multiple Choice:", "A cultured meat company scales their bioreactor from 10 liters to 10,000 liters. Which problem is most likely to worsen at larger scale, based on your model?"),
        ("Constructed Response:", "Using your bioreactor optimization model, explain why cultured meat that tastes identical to conventional beef is so difficult to produce at affordable prices. Reference at least three model components and the trade-offs between them.")
    ],
    "background_intro": "This lesson introduces students to predictive modeling and multi-parameter optimization in the context of cellular agriculture — one of the most ambitious bioengineering challenges of the 21st century. Biotech skill focus: Predictive modeling and optimization. Growing meat from cell cultures requires simultaneously optimizing biological, engineering, and economic parameters — a perfect application for computational modeling.",
    "background_sections": [
        ("Cellular Agriculture Fundamentals", "Cultured meat begins with a small biopsy of muscle stem cells (satellite cells) from a living animal — a painless procedure that yields enough cells to theoretically produce tons of meat. These cells are placed in nutrient-rich media inside bioreactors where they proliferate, differentiate into muscle fibers, and organize into tissue. The process mirrors what happens naturally in an animal's body: cells divide, consume nutrients, produce waste, and organize into structured tissues. The difference is that engineers must artificially provide everything the animal's body normally supplies — nutrients, oxygen, waste removal, structural support, growth signals, and mechanical stimulation. The current state of the art can produce small quantities of cultured meat that is safe to eat and reasonably similar to conventional meat, but at costs that are 10-40x higher than conventional production."),
        ("The Bioreactor Engineering Challenge", "Bioreactors for cultured meat must maintain mammalian cell culture conditions (37°C, pH 7.4, 20% dissolved oxygen, specific nutrient concentrations) while scaling to thousands of liters. The critical engineering challenge is mass transfer — getting oxygen and nutrients TO cells and waste products AWAY from cells throughout the entire volume. In a small flask, diffusion handles this naturally. In a 10,000-liter bioreactor, cells in the center can be centimeters from the nearest oxygen source, far beyond the ~200 micrometer diffusion limit for mammalian cells. Solutions include perfusion bioreactors (continuous medium flow), hollow-fiber systems (oxygen delivered through permeable tubes), and microcarrier cultures (cells growing on small beads suspended in circulating medium). Each approach has trade-offs in cost, scalability, and product quality."),
        ("The Growth Factor Cost Problem", "The single biggest cost barrier in cultured meat is the growth medium — specifically, the growth factors (signaling proteins like FGF2, TGF-beta, IGF-1, and transferrin) that instruct cells to proliferate and differentiate. In research labs, these are purchased at costs of $500-$50,000 per gram. Traditional cell culture uses fetal bovine serum (FBS) as a growth factor source, but FBS costs $300-500/liter, is derived from unborn calves (defeating the ethical purpose), and varies batch-to-batch. The industry is racing to develop serum-free, animal-free media using recombinant growth factors produced by engineered bacteria or yeast, edible plant-derived alternatives, or genetic engineering of the meat cells themselves to produce their own growth factors (autocrine signaling). Reducing medium cost from ~$400/liter to under $1/liter is necessary for commercial viability."),
        ("Texture: The Final Frontier", "The biggest quality challenge in cultured meat is texture. Ground meat products (burgers, nuggets, sausages) are relatively straightforward because they don't require organized tissue structure. But whole-cut products (steaks, chicken breasts, pork chops) require aligned muscle fibers, intramuscular fat marbling, connective tissue, and the complex architecture that gives meat its 'bite.' Achieving this requires three-dimensional scaffolds (made from plant proteins, alginate, or decellularized plant tissue), mechanical stimulation (cyclic stretching that mimics exercise), and co-culture of multiple cell types (muscle, fat, fibroblasts). Current prototypes achieve reasonable texture in thin products (<5mm thickness) but struggle with thick cuts where oxygen delivery and structural integrity become limiting factors.")
    ],
    "lever_L": "Students identify ten components spanning cell biology (Cell Growth Rate, Waste Product Accumulation), engineering (Bioreactor Temperature, Oxygen Supply, Scaffold Structure, Energy Input), medium chemistry (Nutrient Medium Concentration), and economics (Production Cost, Scale Factor, Texture Quality).",
    "lever_E": "Students determine that Nutrient Medium Concentration, Bioreactor Temperature, Oxygen Supply, Scaffold Structure, and Energy Input are the controllable inputs that drive Cell Growth Rate and Texture Quality — while Waste Product Accumulation acts as a growth inhibitor, and Production Cost and Scale Factor represent the economic constraints.",
    "lever_V": "Students build a computational model connecting all ten components, visualizing how changing one parameter cascades through the system and affects multiple outputs simultaneously.",
    "lever_Ev": "Students run lab-scale, maximum-growth, and commercial-scale scenarios to discover that optimizing for one metric (speed, quality, or cost) often degrades the others — and search for the narrow window where all three are acceptable.",
    "lever_R": "Students add Fat Cell Integration, Mechanical Stimulation, or Serum-Free Medium Development to explore more realistic cultured meat production challenges.",
    "slides_guide": [
        {"num": "Slide 1", "title": "Cover", "visual": "Title slide with dramatic side-by-side of conventional slaughterhouse versus clean bioreactor lab", "say": "By 2050, the world needs to feed 10 billion people. Conventional livestock uses 77% of agricultural land but produces only 18% of calories. What if we could grow the same meat — same taste, same texture — without a single animal?", "do": "Show the land use statistic with a visual comparison. Ask students to react before introducing cultured meat.", "time": "2 min"},
        {"num": "Slide 2", "title": "Learning Objectives", "visual": "Learning goals and cellular agriculture vocabulary", "say": "Today you're bioprocess engineers. Your job is to optimize a bioreactor that grows real beef from cells — and figure out how to make it affordable enough for everyone.", "do": "Pre-teach bioreactor and scaffold. Show a 30-second time-lapse of cells growing in culture to establish the biological basis.", "time": "3 min"},
        {"num": "Slide 3", "title": "Big Question", "visual": "Can we grow a steak in a lab that's affordable and delicious?", "say": "The first cultured beef burger cost $330,000 to produce in 2013. Today it's down to around $10-50 per burger. But conventional beef burgers cost $1. How do we close that gap — and what has to be sacrificed along the way?", "do": "Quick-write: Students list what they think makes cultured meat expensive. Compile class predictions on the board.", "time": "3 min"},
        {"num": "Slide 4", "title": "LEVER Framework", "visual": "LEVER steps with bioreactor optimization context", "say": "We're going to optimize ten interacting parameters simultaneously — cell biology, engineering, and economics all at once. Welcome to multi-parameter optimization.", "do": "Preview LEVER steps. Emphasize that this model has five external (controllable) variables — the most of any model we've built.", "time": "2 min"},
        {"num": "Slide 5", "title": "Activity 1: Components", "visual": "Ten component cards spanning biology, engineering, and economics", "say": "Five of these ten components are controllable — you set them. The other five are responses. Identify them and think about why the controllable ones are the expensive ones.", "do": "Guide sorting of external versus internal components. Note that four of five externals represent costs (nutrients, energy, temperature control, scaffolds) — this is why cultured meat is expensive.", "time": "8 min"},
        {"num": "Slide 6", "title": "Activity 2: Connections", "visual": "Complex web of bioreactor parameter interactions", "say": "Here's the optimization nightmare: making cells grow faster increases waste. Improving texture adds cost. Scaling up breaks oxygen delivery. Everything is connected to everything.", "do": "Students map relationships, identifying trade-offs and constraints. Highlight the fundamental tension between quality, speed, and cost.", "time": "8 min"},
        {"num": "Slide 7", "title": "Activity 3: Simulation", "visual": "Multi-parameter optimization dashboard with cost, quality, and growth metrics", "say": "Find the sweet spot. The bioreactor configuration where cells grow fast enough, meat tastes good enough, and the price is low enough. Spoiler: it's a very small target.", "do": "Students predict outcomes, then run lab-scale, max-growth, and commercial-scale scenarios. Track the three-way trade-off between growth rate, texture quality, and production cost.", "time": "10 min"},
        {"num": "Slide 8", "title": "Discoveries", "visual": "Key optimization findings and real-world cost trajectories", "say": "The industry has already brought costs down 99.9% from $330,000 to about $10 per burger. Your model shows the same optimization principles the real companies are using.", "do": "Connect model findings to the real cost trajectory of cultured meat. Discuss which remaining bottlenecks your model identified.", "time": "5 min"},
        {"num": "Slide 9", "title": "STEM Challenge", "visual": "Commercial-scale bioreactor design challenge", "say": "A startup just raised $50 million to build the world's first commercial cultured meat factory. Design their bioreactor.", "do": "Groups design commercial bioreactor systems including vessel type, monitoring systems, waste management, and cost projections. Present engineering proposals.", "time": "12 min"}
    ],
    "sort_reasoning": "Nutrient Medium Concentration, Bioreactor Temperature, Oxygen Supply, Scaffold Structure, and Energy Input are external components because they represent engineering parameters that bioprocess engineers directly control and set. Cell Growth Rate, Waste Product Accumulation, Texture Quality, Production Cost, and Scale Factor are internal components because they emerge as outcomes of the bioreactor system — they respond to the external inputs but cannot be directly set by the engineer.",
    "relationships": [
        ("Nutrient Medium Concentration to Cell Growth Rate", "POSITIVE (+)", "Higher nutrient concentration provides more amino acids, glucose, and growth factors for cell metabolism and division, directly increasing the cell proliferation rate."),
        ("Cell Growth Rate to Waste Product Accumulation", "POSITIVE (+)", "Faster-growing cells metabolize more nutrients per unit time, producing proportionally more waste products (ammonia, lactate) that accumulate in the medium."),
        ("Waste Product Accumulation to Cell Growth Rate", "NEGATIVE (-)", "As metabolic waste accumulates, it creates an increasingly toxic environment that inhibits cell division — this is the primary negative feedback loop in bioreactor systems."),
        ("Oxygen Supply to Cell Growth Rate", "POSITIVE (+)", "Adequate dissolved oxygen is essential for aerobic cellular metabolism; insufficient oxygen causes cells to switch to inefficient anaerobic pathways or die from hypoxia."),
        ("Scaffold Structure to Texture Quality", "POSITIVE (+)", "Better scaffold design provides more appropriate physical cues for cell alignment, fiber formation, and tissue architecture, directly improving the textural properties of the final product."),
        ("Nutrient Medium Concentration to Production Cost", "POSITIVE (+)", "Growth medium — especially growth factors — is the primary cost driver; higher concentration and more frequent replacement directly increase per-kilogram production costs.")
    ],
    "sim_answers": [
        ("Lab Prototype Scenario", "At lab scale, all conditions can be precisely controlled. Cell Growth Rate is optimized because Oxygen Supply reaches every cell through diffusion, Waste Product Accumulation is managed through frequent medium changes, and Nutrient Medium Concentration is high. Texture Quality is moderate with basic scaffolds. However, Production Cost is astronomical — estimated at $100-400/kg due to expensive growth factors, intensive labor, and no economies of scale. Scale Factor is too small for commercial viability."),
        ("Commercial Scale-Up Scenario", "At 1000x scale, Production Cost per kilogram decreases due to economies of scale (Scale Factor effect), but new problems emerge. Oxygen Supply becomes the critical bottleneck — cells in the center of large bioreactors are oxygen-starved, reducing Cell Growth Rate in those regions. Waste Product Accumulation is harder to manage in large volumes. Texture Quality may decrease because scaffold structures are difficult to maintain uniformly at scale. The model reveals that the path to commercial viability requires solving the oxygen delivery and waste removal problems simultaneously.")
    ],
    "reflection_exemplars": [
        ("Which parameter is the most critical bottleneck for commercial viability?", "The model suggests that Nutrient Medium Concentration (specifically growth factor cost) is the primary economic bottleneck, while Oxygen Supply is the primary engineering bottleneck for scaling. At lab scale, cost dominates — growth medium accounts for 55-95% of production expense. At commercial scale, oxygen delivery becomes the limiting factor because cells more than 200 micrometers from an oxygen source become hypoxic. Solving both simultaneously is the key challenge: you need cheap medium AND effective oxygen delivery at scale."),
        ("What environmental trade-offs exist between cultured and conventional meat?", "The model shows that Energy Input is a significant component of Production Cost, and this energy largely comes from electricity for heating, mixing, and oxygenation. Cultured meat eliminates the massive land use, water use, and methane emissions of conventional livestock — but replaces them with industrial energy consumption. Whether cultured meat is environmentally superior depends on the energy source: if powered by renewable energy, the environmental savings are dramatic; if powered by fossil fuels, the advantage narrows. The model helps quantify this trade-off.")
    ],
    "stem_intro": "Present the challenge: A cellular agriculture startup has raised $50 million to build the world's first commercial-scale cultured meat factory. Your engineering team must design the bioreactor system — vessel type, capacity, monitoring, medium management, scaffold integration, and waste handling — that produces beef-quality cultured meat at $15/kg or less.",
    "stem_concepts": [
        ("Perfusion Bioreactor Design", "Unlike batch reactors (where medium is added once and replaced periodically), perfusion bioreactors continuously flow fresh medium through the culture while removing spent medium and waste products. This maintains more stable growth conditions and supports higher cell densities — critical for commercial-scale production."),
        ("Real-Time Bioprocess Monitoring", "Commercial bioreactors use sensors for pH, dissolved oxygen, temperature, glucose, lactate, and cell density — feeding data to control systems that automatically adjust conditions. Advanced facilities use Raman spectroscopy for real-time medium composition analysis and machine learning for predictive process control."),
        ("Techno-Economic Modeling", "Before building a factory, engineers create techno-economic models that calculate production costs based on medium consumption, energy use, equipment depreciation, labor, quality control, and facility costs. These models identify which cost reductions have the greatest impact on per-kilogram price — guiding R&D investment priorities.")
    ],
    "stem_eval": [
        ("Expert (4)", "Design includes detailed bioreactor specification with justified vessel type, monitoring system, medium management strategy, scaffold integration plan, cost projection based on model data, and analysis of scaling challenges"),
        ("Proficient (3)", "Design includes bioreactor type selection, basic monitoring, and cost considerations linked to model findings"),
        ("Developing (2)", "Design covers basic bioreactor concepts but lacks specificity on monitoring, medium management, or cost analysis"),
        ("Beginning (1)", "Design is incomplete or does not connect engineering decisions to the bioreactor optimization model")
    ],
    "support": [
        "Provide a simplified bioreactor diagram showing inputs (nutrients, oxygen, heat) and outputs (waste, product) with labeled flows",
        "Use a cost breakdown template where students can estimate the contribution of each component to total production cost",
        "Scaffold optimization thinking: 'If I increase ___, it improves ___ but worsens ___ because ___.'"
    ],
    "extensions": [
        "Research the current state of the cultured meat industry — which companies are closest to commercial production and what are their remaining technical challenges?",
        "Investigate how 3D bioprinting could be used to create structured cultured meat products with realistic marbling and fiber alignment",
        "Compare the life cycle environmental analysis of cultured meat versus conventional beef, poultry, and plant-based meat alternatives"
    ],
    "cross_curr": [
        ("Math", "Build a techno-economic model calculating production cost per kilogram as a function of medium cost, bioreactor volume, cell density, and cycle time — determine the cost reduction needed for commercial viability"),
        ("ELA", "Research and write a consumer communication strategy explaining cultured meat technology to the public — addressing safety, ethics, and taste concerns"),
        ("Economics/Business", "Develop a business plan for a cultured meat startup including market analysis, pricing strategy, regulatory pathway, and competitive positioning against conventional and plant-based meat")
    ],
    "misconceptions": [
        ("Lab-grown meat is 'fake' or 'artificial' meat", "Cultured meat is real animal meat — it contains the same muscle cells, proteins, and fats as conventional meat because it IS animal cells. The only difference is where the cells grew: in a bioreactor instead of inside an animal. At the molecular level, a cultured beef cell is identical to a cell from a cow's muscle. Calling it 'fake' is like calling ice from a freezer 'fake ice' because it wasn't made by a glacier.", "Ask: If you took a muscle cell from a cow and grew it in a dish, is it still a cow cell? If you grew a trillion of them, is it still beef? Where does 'real' end and 'fake' begin?"),
        ("Cultured meat must be unhealthy because it's 'unnatural'", "Cultured meat can be engineered to be HEALTHIER than conventional meat. Producers can control fat content, reduce saturated fat, add omega-3 fatty acids, eliminate antibiotics and growth hormones, and ensure zero pathogen contamination (no Salmonella, E. coli, or prions). The 'unnatural' criticism ignores that most modern food production — from cheese to bread to yogurt — involves controlled biological processes.", "Comparison: Yogurt is made by adding bacteria to milk in controlled conditions. Cheese is made by adding enzymes and microbes. Beer is made by yeast in a bioreactor. These are all 'lab-grown' products that nobody considers 'fake.'"),
        ("Cultured meat will be available and affordable within a few years", "While progress has been extraordinary ($330,000/burger in 2013 to ~$10-50 today), achieving true commercial viability ($5-15/kg at millions of tons/year) requires solving several fundamental engineering challenges that the model reveals: growth factor cost reduction by 100-1000x, oxygen delivery at industrial scale, waste management for massive bioreactors, and texture engineering for whole-cut products. Most industry experts estimate 5-15 years for cost-competitive commodity products, though premium products may arrive sooner.", "Model it: Even if you solve every other problem, growth factor cost alone makes cultured meat 3-5x more expensive than conventional beef. What breakthrough would change that equation?")
    ]
}

L05 = {
    "id": "G09L3-L05",
    "title": "Predicting the Next Pandemic",
    "subtitle": "Predictive Modeling of Zoonotic Spillover and Pandemic Emergence",
    "ngss": "HS-LS2-6, HS-ETS1-4",
    "ngss_desc": "Evaluate claims, evidence, and reasoning that the complex interactions in ecosystems maintain relatively consistent numbers and types of organisms in stable conditions, but changing conditions may result in a new ecosystem; use a computer simulation to model the impact of proposed solutions to a complex real-world problem.",
    "big_question": "COVID-19 killed millions. The next pandemic is already brewing in a bat cave, a wet market, or an industrial pig farm — can we predict where and when it will emerge?",
    "objectives": [
        "Build a predictive model for pandemic emergence that traces the pathway from wildlife-human contact through zoonotic spillover to global spread",
        "Analyze how wildlife contact rates, viral mutation, surveillance detection, and population connectivity interact to determine pandemic risk",
        "Predict which conditions are most likely to produce the next pandemic emergence event using multi-variable simulation",
        "Evaluate early warning surveillance systems and intervention strategies that could prevent the next pandemic before it starts"
    ],
    "vocabulary": [
        ("Zoonotic Spillover", "The event where a pathogen jumps from an animal host species to a human — the critical first step in pandemic emergence that occurs when humans come into contact with infected wildlife through hunting, farming, habitat destruction, or live animal markets"),
        ("Viral Mutation Rate", "The frequency at which random errors occur during viral genome replication — RNA viruses like influenza and coronaviruses have high mutation rates that generate genetic variation, some of which may enable human infection or human-to-human transmission"),
        ("Immune Naivety", "The absence of pre-existing immunity in a human population to a novel pathogen — when a virus jumps from animals to humans, the entire human population is immunologically naive, allowing explosive spread because no one has protective antibodies"),
        ("Pandemic Preparedness", "The systems, infrastructure, and protocols designed to detect, contain, and respond to emerging infectious diseases before they spread globally — including surveillance networks, stockpiled countermeasures, and international coordination agreements")
    ],
    "components": [
        ("Wildlife-Human Contact Rate", "The frequency and intensity of interactions between humans and wild animal species that harbor novel viruses — increased by deforestation, bushmeat hunting, wildlife trade, and agricultural expansion into wild habitats", True),
        ("Viral Mutation Rate", "The inherent rate at which the pathogen accumulates genetic changes during replication, some of which may enhance human infectivity, transmissibility, or immune evasion — determined by the virus's replication machinery", False),
        ("Zoonotic Spillover Probability", "The calculated likelihood that a virus successfully jumps from animal to human during any given contact event — determined by viral compatibility with human cell receptors, dose of exposure, and individual immune status", False),
        ("Surveillance Detection Speed", "The time between the first human infection and the moment public health authorities detect and identify the novel pathogen — faster detection enables earlier containment", True),
        ("Population Density", "The concentration of people in the geographic area where spillover occurs, which determines how many potential secondary contacts an infected person has before detection", True),
        ("Travel Connectivity", "The number and frequency of transportation links (flights, roads, shipping) connecting the spillover location to other population centers — determines how quickly a local outbreak becomes global", True),
        ("Immune Naivety", "The proportion of the human population with zero pre-existing immunity to the novel pathogen — for truly novel zoonotic viruses, this is effectively 100%, enabling explosive epidemic growth", False),
        ("Healthcare Capacity", "The ability of the local and national healthcare system to identify, isolate, treat, and contact-trace infected individuals — determines whether early cases are contained or amplified through nosocomial transmission", False),
        ("Intervention Speed", "The time between outbreak detection and implementation of effective containment measures — quarantine, travel restrictions, vaccination campaigns, therapeutic deployment — the single most critical determinant of pandemic versus contained outbreak", False)
    ],
    "think_about_it": "Wildlife-Human Contact Rate is increasing every year as deforestation pushes humans deeper into animal habitats. Each contact event has a small Zoonotic Spillover Probability that depends on Viral Mutation Rate producing a human-compatible variant. Once spillover occurs, the race begins: Surveillance Detection Speed versus Population Density and Travel Connectivity determine whether the world catches it early or learns about it after it's already everywhere. What combination of conditions turns a single sick person in a remote village into a global catastrophe?",
    "scenarios": [
        ("Slow Burn Emergence", "Set moderate Wildlife-Human Contact Rate, average Viral Mutation Rate, and moderate Surveillance Detection Speed — observe how long it takes for a zoonotic spillover to escalate"),
        ("COVID-19 Analog Scenario", "Set high Wildlife-Human Contact Rate, high Population Density, high Travel Connectivity, and slow Surveillance Detection Speed — observe explosive pandemic emergence"),
        ("Optimized Early Warning", "Maximize Surveillance Detection Speed with moderate contact and connectivity — observe whether early detection can prevent pandemic emergence even with high-risk conditions")
    ],
    "sim_scenarios": [
        ("Slow Burn", "Moderate contact, average mutation, moderate surveillance", "How many spillover events do you predict will occur before one leads to sustained human-to-human transmission?"),
        ("COVID-19 Analog", "High contact, high density, high travel, slow detection", "What do you predict the infection curve looks like when surveillance is slow and travel connectivity is high?"),
        ("Early Warning Optimized", "Fast surveillance, moderate risk factors", "Do you predict that fast detection alone can prevent a pandemic, even if all other risk factors are elevated?")
    ],
    "discoveries": [
        "Zoonotic spillover events happen far more frequently than pandemics — most cross-species jumps lead to dead-end infections that don't transmit between humans, but each one is a roll of the evolutionary dice",
        "The critical window for containment is extremely narrow — once a novel virus achieves sustained human-to-human transmission in a connected population, pandemic spread is nearly inevitable with current infrastructure",
        "Surveillance detection speed is the single most impactful intervention point — the difference between detecting an outbreak in week 1 versus week 4 can mean the difference between 100 cases and 100,000 cases",
        "Pandemic risk is not random — it clusters in predictable geographic hotspots where high wildlife diversity, rapid deforestation, dense human populations, and limited healthcare infrastructure overlap"
    ],
    "answer": "Pandemics are not random acts of nature — they emerge through a predictable sequence of events that can be modeled and potentially prevented. Wildlife-human contact creates opportunities for zoonotic spillover. Viral mutation generates variants capable of human infection. Population density and travel connectivity determine whether a local outbreak goes global. The model reveals that the most impactful intervention is surveillance — detecting novel outbreaks within days rather than weeks. COVID-19 demonstrated that a delay of just a few weeks in detection and response transformed a containable outbreak in one city into a global pandemic that killed millions. Predictive models can identify the geographic hotspots, seasonal windows, and viral lineages most likely to produce the next pandemic — enabling preemptive surveillance deployment rather than reactive response.",
    "stem_title": "Design a Global Pandemic Early Warning System",
    "stem_mission": "Design a surveillance network that detects zoonotic spillover events within 72 hours of the first human infection, anywhere on Earth.",
    "stem_scenario": "The World Health Organization has commissioned your team to design the next-generation pandemic early warning system. COVID-19 demonstrated that existing surveillance was too slow — the virus circulated for weeks or months before being identified. Your system must detect novel zoonotic viruses within 72 hours of the first human case, in any country, regardless of local healthcare infrastructure.",
    "stem_questions": [
        "What data streams would your surveillance system monitor — clinical data, wastewater, wildlife sampling, or something else?",
        "How would you detect a novel pathogen before it's even been identified and named?",
        "What triggers would cause your system to escalate from 'signal detected' to 'global alert'?"
    ],
    "stem_design_qs": [
        "How would you deploy surveillance in remote areas with limited healthcare infrastructure?",
        "What role would artificial intelligence play in detecting outbreak signals in noisy real-world data?",
        "How would you overcome the political barriers to rapid international outbreak reporting?",
        "What genomic sequencing capacity would your system need, and where would you locate it?"
    ],
    "career": "Epidemiologists and Pandemic Preparedness Specialists design and operate disease surveillance systems. They work for the WHO, CDC, national health agencies, and organizations like PREDICT and the Global Virome Project, earning $70,000–$150,000/year. Computational Epidemiologists who build predictive outbreak models earn $90,000–$180,000/year.",
    "images": {
        "cover": ("G09L3-L05-cover.png", "A photorealistic, cinematic image of diverse 14-15 year old students in an advanced epidemiology command center, analyzing global outbreak maps and viral phylogenetic trees on multiple large screens, dramatic red and blue lighting suggesting urgency, world maps with outbreak hotspots illuminated"),
        "landscape": ("G09L3-L05-landscape.png", "A diverse group of 14-15 year old students in a modern biosurveillance lab examining zoonotic spillover risk maps and viral genome data on workstations, wildlife-human interface photographs on walls, high-tech research environment"),
        "modeling": ("G09L3-L05-modeling.png", "A diverse group of 14-15 year old students building pandemic prediction models on laptops, epidemic curves and network transmission diagrams on screens, whiteboards with spillover pathway flowcharts and risk factor matrices"),
        "discussion": ("G09L3-L05-discussion.png", "A teacher leading an urgent discussion with diverse 14-15 year old students about pandemic preparedness, a global pandemic risk map and timeline of historical pandemics on a smartboard, students showing intense engagement"),
        "stem": ("G09L3-L05-stem.png", "Diverse 14-15 year old students presenting global surveillance system designs with network diagrams, satellite deployment maps, and detection workflow charts on large displays, professional WHO simulation setting")
    },
    "pre_assessment": [
        "Where do you think new pandemic viruses come from — do they just appear, or is there a predictable process?",
        "What do you think determines whether a new virus causes a local outbreak versus a global pandemic?",
        "Draw a diagram showing the chain of events from a virus in a bat to a global pandemic — what steps have to occur?",
        "What would an ideal pandemic early warning system look like, and why don't we have one?"
    ],
    "extend_components": [
        ("Seasonal Climate Patterns", "Temperature and precipitation cycles that affect wildlife breeding, migration, and habitat overlap with human populations — creating predictable seasonal windows of elevated spillover risk"),
        ("Viral Recombination Events", "The exchange of genetic material between different viral strains co-infecting the same host cell, which can rapidly create novel viruses with pandemic potential — especially concerning in intermediate hosts like pigs"),
        ("Global Supply Chain Disruption", "The cascade of economic, food security, and social consequences that follow pandemic-related lockdowns and travel restrictions — the secondary disaster that amplifies the human toll beyond direct disease mortality")
    ],
    "reflections": [
        "How does your predictive model identify the conditions that distinguish a contained outbreak from a global pandemic?",
        "Which intervention point in your model has the greatest leverage for preventing pandemics — why is surveillance speed so critical?",
        "Why do you think pandemic risk is concentrated in specific geographic hotspots rather than distributed randomly?",
        "How would adding Seasonal Climate Patterns change your model's ability to predict spillover timing?",
        "What are the ethical implications of predictive pandemic models — should governments restrict wildlife contact in areas your model identifies as high-risk?"
    ],
    "dimensions": [
        ("Science Practice", "Using Mathematics and Computational Thinking", "Students use computational simulation to model the probabilistic chain of events from zoonotic spillover to pandemic emergence, varying parameters to predict outbreak trajectories."),
        ("Disciplinary Core Idea", "LS2.C Ecosystem Dynamics / ETS1.B Developing Possible Solutions", "Changing conditions in ecosystems affect organism interactions; engineering solutions to pandemic preparedness require modeling complex, multi-variable systems."),
        ("Crosscutting Concept", "Cause and Effect / Scale, Proportion, and Quantity", "Students trace the causal chain from local wildlife contact to global pandemic, analyzing how small changes in early-stage parameters produce vastly different outcomes at global scale.")
    ],
    "cast_items": [
        "Model the multi-step pathway from zoonotic spillover through sustained human transmission to global pandemic emergence",
        "Analyze how surveillance speed, population connectivity, and immune naivety interact to determine whether an outbreak becomes a pandemic",
        "Predict pandemic risk hotspots by identifying geographic regions where wildlife contact, population density, and limited surveillance overlap"
    ],
    "cast_questions": [
        ("Multiple Choice:", "A novel virus is detected in a remote village 4 weeks after the first case, compared to a scenario where it's detected in 3 days. Based on your model, how does this delay affect pandemic probability?"),
        ("Constructed Response:", "Using your predictive model, explain why deforestation in tropical regions increases pandemic risk. Trace the full causal chain from land-use change to potential pandemic emergence, referencing at least three model components.")
    ],
    "background_intro": "This lesson introduces students to predictive epidemiological modeling — the computational approach that can identify where and when the next pandemic is most likely to emerge. Biotech skill focus: Predictive modeling and optimization. COVID-19 demonstrated both the devastating consequences of failed pandemic prediction and the power of computational models to guide response. Students will build models that identify the conditions under which zoonotic spillover escalates to global catastrophe.",
    "background_sections": [
        ("Zoonotic Spillover: Where Pandemics Begin", "Approximately 75% of emerging infectious diseases are zoonotic — they originate in animals. HIV came from chimpanzees, Ebola from bats, SARS-CoV-1 from civets (originally bats), MERS from camels (originally bats), COVID-19 likely from bats (possibly through an intermediate host). The spillover process requires three conditions: contact (humans must encounter infected animals), compatibility (the virus must be able to infect human cells), and transmission (the virus must be able to spread between humans). Most zoonotic spillover events are dead ends — the virus infects one person and stops. But occasionally, mutation or recombination produces a variant that achieves sustained human-to-human transmission, and a pandemic is born. The PREDICT project identified over 1,000 novel viruses in wildlife, including 160+ coronaviruses, before it was defunded in 2019 — months before COVID-19 emerged."),
        ("The Pandemic Prediction Problem", "Pandemic emergence is a low-probability, high-consequence event that follows a multi-step stochastic process. Each step has its own probability: the chance of a spillover event during any given contact (~0.001-1%), the chance that the virus achieves human-to-human transmission (~0.1-10% of spillover events), the chance of sustained transmission before containment (~10-50% depending on response speed), and the chance of global spread (~50-90% once sustained transmission is established in a connected population). Predictive models don't forecast specific pandemic dates — they identify the conditions, locations, and viral families where the compound probability is highest. This is analogous to earthquake prediction: we can't say exactly when, but we can identify the fault lines."),
        ("Surveillance: The Critical Intervention Window", "The single most important determinant of pandemic prevention is surveillance speed — the time between the first human case and public health detection. COVID-19 circulated in Wuhan for an estimated 4-8 weeks before being identified and reported. By that time, the virus had infected thousands and spread to multiple countries through air travel. Models consistently show that detecting and responding to a novel pathogen within the first week of human cases — when the infected population is still small and geographically contained — can reduce pandemic probability by 90%+. Modern surveillance tools include wastewater genomic monitoring (detecting viral RNA in sewage before clinical cases are reported), syndromic surveillance (AI analysis of hospital admissions and symptom patterns), and metagenomic sequencing of clinical samples (identifying any pathogen, known or novel, directly from patient specimens)."),
        ("Pandemic Risk Mapping: Predicting Hotspots", "The geographic distribution of pandemic risk is not random — it clusters in predictable hotspots. The highest-risk zones are tropical and subtropical regions with high wildlife biodiversity (especially bat species diversity), rapid deforestation and agricultural expansion (increasing wildlife-human contact), dense human populations near wildlife interfaces, live animal markets, intensive livestock farming (particularly pigs, which can serve as 'mixing vessels' for influenza reassortment), limited public health surveillance infrastructure, and high international travel connectivity. South and Southeast Asia, Central and West Africa, and parts of South America are consistently identified as the highest-risk regions. Predictive models integrate these risk factors into geographic risk maps that can guide targeted surveillance deployment.")
    ],
    "lever_L": "Students identify nine components spanning ecological (Wildlife-Human Contact Rate), virological (Viral Mutation Rate, Zoonotic Spillover Probability), epidemiological (Population Density, Immune Naivety, Travel Connectivity), and public health (Surveillance Detection Speed, Healthcare Capacity, Intervention Speed) domains.",
    "lever_E": "Students determine that Wildlife-Human Contact Rate creates spillover opportunities, Viral Mutation Rate generates human-compatible variants, and the chain from Zoonotic Spillover Probability through Population Density and Travel Connectivity to global spread is modulated by Surveillance Detection Speed, Healthcare Capacity, and Intervention Speed.",
    "lever_V": "Students build a predictive model connecting the spillover-to-pandemic pathway, visualizing how changes in surveillance and connectivity parameters shift the probability of pandemic emergence.",
    "lever_Ev": "Students run slow-burn, COVID-19-analog, and optimized-early-warning scenarios to identify the parameter combinations that produce pandemics versus contained outbreaks.",
    "lever_R": "Students add Seasonal Climate Patterns, Viral Recombination Events, or Global Supply Chain Disruption to explore more realistic and consequential pandemic dynamics.",
    "slides_guide": [
        {"num": "Slide 1", "title": "Cover", "visual": "Title slide with dramatic global pandemic risk map and COVID-19 timeline", "say": "COVID-19 was not a surprise to epidemiologists — they had been warning about exactly this scenario for decades. The virus, the location, even the timing were all predictable in hindsight. Today you're going to build the model that predicts the next one.", "do": "Show a timeline of pandemic warnings that were ignored before COVID-19. Let students process the pattern.", "time": "2 min"},
        {"num": "Slide 2", "title": "Learning Objectives", "visual": "Learning goals and pandemic science vocabulary", "say": "You're going to build a predictive model for pandemic emergence — the same type of computational tool that organizations like the WHO and CDC use to assess global health threats.", "do": "Pre-teach zoonotic spillover and immune naivety. Show a simple animation of a virus jumping from bat to human to illustrate the spillover concept.", "time": "3 min"},
        {"num": "Slide 3", "title": "Big Question", "visual": "The next pandemic is already brewing — can we predict where?", "say": "Somewhere in the world right now, a virus is mutating inside an animal. One day — maybe tomorrow, maybe in ten years — it will jump into a human. What determines whether that becomes a footnote or a catastrophe?", "do": "Think-pair-share: Students list conditions that would make a spillover event more likely to become a pandemic. Compile and categorize.", "time": "3 min"},
        {"num": "Slide 4", "title": "LEVER Framework", "visual": "LEVER steps with pandemic prediction context", "say": "We're building a predictive model — one that identifies WHERE pandemics are most likely to start and WHAT conditions enable their spread. This is proactive science.", "do": "Preview LEVER steps. Distinguish between prediction (knowing the future) and preparedness (being ready for it). Both require models.", "time": "2 min"},
        {"num": "Slide 5", "title": "Activity 1: Components", "visual": "Nine component cards spanning ecology, virology, and public health", "say": "Four of these components are things governments can actually control — investments they can make RIGHT NOW to prevent the next pandemic. Which four? And which five are determined by nature?", "do": "Guide sorting of external versus internal components. Emphasize that the controllable variables represent policy decisions — funding surveillance, managing wildlife contact, regulating travel.", "time": "8 min"},
        {"num": "Slide 6", "title": "Activity 2: Connections", "visual": "Causal chain from wildlife contact to global pandemic", "say": "Trace the pathway from a bat in a cave to a global pandemic. Every link in this chain is a potential intervention point — a place where we could break the chain if we were watching.", "do": "Students map the full causal chain. Identify which connections represent the best intervention points (surveillance, containment) versus immutable factors (viral mutation rate).", "time": "8 min"},
        {"num": "Slide 7", "title": "Activity 3: Simulation", "visual": "Pandemic probability dashboards and outbreak trajectory projections", "say": "Run these three scenarios and find the answer: Can we prevent the next pandemic if we invest in the right interventions — or are pandemics inevitable?", "do": "Students predict outcomes, then run all three scenarios. Compare pandemic probability across scenarios, focusing on how surveillance speed changes outcomes.", "time": "10 min"},
        {"num": "Slide 8", "title": "Discoveries", "visual": "Key predictive findings and surveillance evidence", "say": "Your model shows what epidemiologists have been saying for years: pandemics are predictable and preventable — but only if we invest in surveillance BEFORE the next one starts, not after.", "do": "Connect model findings to COVID-19 timeline. Show how early detection could have changed the trajectory. Discuss why surveillance funding was cut before the pandemic.", "time": "5 min"},
        {"num": "Slide 9", "title": "STEM Challenge", "visual": "Global pandemic early warning system design challenge", "say": "The WHO just hired your team. Design the surveillance system that detects the next pandemic virus within 72 hours of the first human case. This is the most important engineering challenge of our generation.", "do": "Groups design early warning systems including data streams, detection algorithms, alert protocols, and deployment strategies for resource-limited settings. Present and evaluate.", "time": "12 min"}
    ],
    "sort_reasoning": "Wildlife-Human Contact Rate, Surveillance Detection Speed, Population Density, and Travel Connectivity are external components because they represent factors that can be influenced by policy decisions and infrastructure investments — governments can regulate deforestation, fund surveillance systems, manage urban planning, and implement travel screening. Viral Mutation Rate, Zoonotic Spillover Probability, Immune Naivety, Healthcare Capacity, and Intervention Speed are internal components — they are properties of the biological system or emergent responses that cannot be directly set but are influenced by the external conditions.",
    "relationships": [
        ("Wildlife-Human Contact Rate to Zoonotic Spillover Probability", "POSITIVE (+)", "More frequent contact between humans and wildlife creates more opportunities for cross-species viral transmission — each contact event is a probabilistic opportunity for spillover."),
        ("Viral Mutation Rate to Zoonotic Spillover Probability", "POSITIVE (+)", "Higher viral mutation rate generates more genetic variants, increasing the probability that a human-compatible variant emerges that can infect human cells and achieve human-to-human transmission."),
        ("Population Density to Intervention Speed", "NEGATIVE (-)", "Higher population density makes containment more difficult because infected individuals have more contacts before isolation, increasing the number of cases that must be traced and requiring more resources for intervention."),
        ("Travel Connectivity to Geographic Spread Rate", "POSITIVE (+)", "More transportation links from the outbreak origin accelerate the geographic spread of the pathogen to new population centers, reducing the time window for containment."),
        ("Surveillance Detection Speed to Intervention Speed", "POSITIVE (+)", "Faster surveillance detection enables faster intervention — you cannot contain what you haven't detected. Every day of detection delay exponentially increases the infected population that must be contained.")
    ],
    "sim_answers": [
        ("COVID-19 Analog Scenario", "With high Wildlife-Human Contact Rate, high Population Density, high Travel Connectivity, and slow Surveillance Detection Speed, the model predicts explosive pandemic emergence. Zoonotic Spillover Probability generates periodic successful jumps to humans, and once sustained transmission begins in a dense, connected population, global spread occurs within weeks. Immune Naivety near 100% means the entire population is susceptible. Healthcare Capacity is quickly overwhelmed. This closely mirrors the COVID-19 trajectory where weeks of undetected transmission in a high-density, internationally connected city enabled global spread before meaningful intervention."),
        ("Early Warning Optimized Scenario", "With maximized Surveillance Detection Speed but otherwise moderate risk conditions, the model shows that early detection dramatically changes outcomes. When a novel pathogen is identified within 3 days of the first human case, the infected population is still small enough for aggressive contact tracing and isolation to contain the outbreak. Healthcare Capacity is not overwhelmed because case numbers remain manageable. The critical insight is that surveillance speed has outsized impact — it's the highest-leverage intervention point in the pandemic pathway.")
    ],
    "reflection_exemplars": [
        ("Why is surveillance speed the most impactful intervention?", "The model reveals that epidemic growth is exponential — each infected person infects multiple others, who each infect multiple others. The infected population doubles on a timescale determined by the pathogen's generation time (2-7 days for most respiratory viruses). This means a 1-week detection delay doesn't just add one week of cases — it allows multiple doubling events. If the doubling time is 3 days, a 3-week delay means the infected population is 2^7 = 128 times larger than it would have been with immediate detection. Containment that would have required tracing 10 contacts now requires tracing 1,280."),
        ("Why do pandemics cluster in predictable hotspots?", "Pandemic risk is the product of multiple independent factors, all of which must align for a pandemic to emerge. Tropical forests have the highest bat diversity (and bats are the reservoir for most pandemic-potential viruses). Deforestation in these regions increases wildlife-human contact. Dense populations near these interfaces provide fuel for transmission. Limited healthcare infrastructure delays detection. International airports enable global spread. The hotspots are where ALL of these factors overlap simultaneously — South and Southeast Asia, Central and West Africa, and parts of South America.")
    ],
    "stem_intro": "Present the challenge: The World Health Organization has commissioned your team to design the next-generation Global Pandemic Early Warning System. COVID-19 proved that existing surveillance was inadequate. Your system must detect novel zoonotic pathogens within 72 hours of the first human case, anywhere on Earth, and trigger a rapid containment response.",
    "stem_concepts": [
        ("Wastewater Genomic Surveillance", "Analyzing sewage for pathogen RNA provides population-level data without requiring individual testing. A single wastewater sample can detect a novel virus circulating in a community days before clinical cases are reported — it's the fastest passive surveillance technology available."),
        ("Metagenomic Sequencing", "Rather than testing for specific known pathogens, metagenomic sequencing analyzes ALL genetic material in a sample — identifying any virus, bacterium, or parasite present, including completely novel organisms. This is the only surveillance approach that can detect a pathogen that hasn't been discovered yet."),
        ("Network Analysis for Outbreak Prediction", "Pandemic models use airline flight data, mobile phone movement patterns, and trade networks to predict how a pathogen would spread from any given starting location. These network models can identify 'superspreader' locations — airports and transportation hubs that would amplify global spread.")
    ],
    "stem_eval": [
        ("Expert (4)", "System includes multiple complementary surveillance streams, AI-powered anomaly detection, rapid genomic sequencing capacity, international reporting protocols, and deployment strategy for low-resource settings, supported by model-derived evidence for design choices"),
        ("Proficient (3)", "System includes surveillance technology selection, detection protocol, and alert system with reasoning connected to model findings"),
        ("Developing (2)", "System covers basic surveillance concepts but lacks detail on detection technology or international coordination"),
        ("Beginning (1)", "System is incomplete or does not connect surveillance design to the pandemic prediction model")
    ],
    "support": [
        "Provide a simplified spillover pathway diagram showing the steps from animal reservoir to global pandemic",
        "Use an epidemic curve template where students can sketch predicted outbreak trajectories for different surveillance speed scenarios",
        "Scaffold predictive thinking: 'The risk is highest when ___ AND ___ AND ___ because each factor multiplies the probability of ___.'"
    ],
    "extensions": [
        "Research the Global Virome Project — the effort to identify every virus on Earth before the next pandemic — and evaluate its feasibility and impact potential",
        "Investigate how climate change is expanding the geographic range of disease vectors (mosquitoes, ticks) and creating new pandemic risk zones",
        "Compare the surveillance systems that detected SARS (2003, contained in 8 months) versus COVID-19 (2019, became a pandemic) and identify what was different"
    ],
    "cross_curr": [
        ("Math", "Calculate compound probabilities of spillover → transmission → pandemic using the model's parameter values, and determine how much each intervention reduces total pandemic probability"),
        ("ELA", "Write a policy brief to Congress arguing for increased pandemic preparedness funding, using model predictions and COVID-19 as evidence of the consequences of underfunding"),
        ("Social Studies", "Analyze how global inequality affects pandemic risk — why do most pandemics originate in regions with the least surveillance infrastructure, and what does this mean for global health equity?")
    ],
    "misconceptions": [
        ("Pandemics are unpredictable 'acts of God'", "Pandemics follow a predictable sequence: zoonotic spillover, adaptation to human transmission, spread through connected populations. The specific pathogen and exact timing are uncertain, but the geographic hotspots, risk factors, and transmission dynamics are well understood. Epidemiologists predicted a novel coronavirus pandemic from a bat reservoir in a densely populated Asian region years before COVID-19 — the surprise was not THAT it happened but that the world wasn't ready.", "Timeline exercise: Show students the published pandemic predictions from 2015-2018 that described almost exactly what happened in 2020. Ask: Was this unpredictable, or was it unheeded?"),
        ("COVID-19 was a once-in-a-century event", "The frequency of pandemic-potential zoonotic spillover events is INCREASING, not decreasing. Deforestation is accelerating wildlife-human contact. Climate change is shifting animal ranges. Global travel connectivity is increasing. Industrial livestock farming creates massive pathogen amplification opportunities. The conditions that produced COVID-19 are more common today than they were in 2019, making the next pandemic more likely, not less.", "Data point: Novel zoonotic virus discoveries have increased 4-fold since 1980. Ask: What's changed in the world since 1980 that would explain this trend?"),
        ("We just need better drugs and vaccines to stop pandemics", "Drugs and vaccines are response tools — they help AFTER a pandemic has started. By the time a vaccine is developed, tested, manufactured, and distributed (12-18 months minimum), millions may already be infected. The model shows that prevention through surveillance and early containment is orders of magnitude more effective and cheaper than response. The COVID-19 vaccine was the fastest ever developed, yet 5 million people died before it was widely available.", "Compare costs: Global pandemic surveillance costs ~$4 billion/year. COVID-19 cost the global economy ~$16 TRILLION. Which investment makes more sense?")
    ]
}

L06 = {
    "id": "G09L3-L06",
    "title": "Designing Organisms That Eat Plastic",
    "subtitle": "Synthetic Biology and Metabolic Engineering for Environmental Remediation",
    "ngss": "HS-LS1-5, HS-ETS1-2",
    "ngss_desc": "Use a model to illustrate how photosynthesis transforms light energy into stored chemical energy; design a solution to a complex real-world problem by breaking it down into smaller, more manageable problems.",
    "big_question": "8 million tons of plastic enter the ocean every year. Can we engineer a living organism that breaks it down?",
    "objectives": [
        "Build a synthetic biology model that integrates enzyme engineering, metabolic pathway design, and organism behavior for environmental plastic degradation",
        "Analyze how enzyme activity, substrate concentration, metabolic efficiency, and environmental conditions interact in an engineered biodegradation system",
        "Optimize organism design parameters to maximize plastic degradation rate while minimizing toxic byproduct generation and ecological risk",
        "Evaluate the trade-offs between degradation speed, organism containment, and environmental safety in synthetic biology applications"
    ],
    "vocabulary": [
        ("Synthetic Biology", "The engineering discipline that designs and constructs new biological systems — or redesigns existing ones — for useful purposes, using standardized genetic parts (promoters, genes, terminators) assembled like engineering components"),
        ("Metabolic Engineering", "The targeted modification of an organism's metabolic pathways to enhance production of desired compounds or enable new biochemical capabilities — such as breaking down synthetic polymers that no natural organism evolved to degrade"),
        ("PETase", "A naturally occurring enzyme discovered in the bacterium Ideonella sakaiensis that can break down PET plastic (polyethylene terephthalate) — the first known enzyme capable of degrading a synthetic polymer, now being engineered for enhanced activity"),
        ("Bioremediation", "The use of living organisms — bacteria, fungi, plants, or engineered microbes — to clean up environmental pollutants, including oil spills, heavy metals, pesticides, and increasingly, plastic waste")
    ],
    "components": [
        ("Enzyme Activity Level", "The catalytic efficiency of the engineered plastic-degrading enzyme (PETase or engineered variants), measured by turnover rate — how many plastic molecules each enzyme molecule processes per second", False),
        ("Substrate Concentration", "The amount of plastic material available for degradation in the environment — determined by plastic waste density, surface area exposure, and the physical form of the plastic (film, fiber, particle, microplastic)", True),
        ("Metabolic Pathway Efficiency", "The completeness and efficiency of the engineered metabolic pathway that converts plastic breakdown products (terephthalic acid, ethylene glycol) into energy and biomass rather than accumulating toxic intermediates", False),
        ("Byproduct Toxicity", "The harmful effects of intermediate chemical compounds produced during plastic degradation — incomplete breakdown can generate compounds more toxic than the original plastic", False),
        ("Organism Growth Rate", "The proliferation speed of the engineered organism in environmental conditions, which determines how quickly the degradation capacity scales up in a contaminated site", False),
        ("Environmental Temperature", "The ambient temperature of the degradation environment, which critically affects enzyme activity (PETase is most active at 30-65°C) and organism survival", True),
        ("pH Tolerance", "The engineered organism's ability to function across a range of environmental pH conditions — ocean water (pH 8.1), soil (pH 4-9), and landfill leachate (pH 5-9) present different challenges", False),
        ("Oxygen Requirements", "The amount of dissolved oxygen the engineered organism needs for aerobic metabolism and enzyme function — determines whether the system works in oxygen-rich surface environments or oxygen-poor deep ocean/landfill conditions", True),
        ("Degradation Rate", "The overall speed at which plastic is broken down into harmless products in the environment, measured in grams per liter per day — the key performance metric for the engineered system", False),
        ("Containment Level", "The degree of biological containment engineered into the organism — kill switches, auxotrophies (dependence on lab-supplied nutrients), or geographic barriers that prevent uncontrolled spread into natural ecosystems", True)
    ],
    "think_about_it": "Engineering an organism that eats plastic sounds like a perfect solution — until you consider the complications. Higher Enzyme Activity Level increases Degradation Rate, but it also increases Byproduct Toxicity if the Metabolic Pathway Efficiency isn't high enough to completely process the breakdown products. The organism needs to grow in real-world conditions (variable Environmental Temperature, pH, and Oxygen), not just a controlled lab. And there's the containment paradox: you WANT the organism to spread to where the plastic is, but you DON'T want an engineered organism spreading uncontrollably through natural ecosystems. How do you balance effectiveness with safety?",
    "scenarios": [
        ("Controlled Lab Degradation", "Set ideal Environmental Temperature, Oxygen, and pH with high Substrate Concentration and maximum Containment Level — observe Degradation Rate under optimal controlled conditions"),
        ("Ocean Deployment Scenario", "Set Environmental Temperature to 15°C (ocean average), limited Oxygen, pH 8.1, with reduced Containment Level — observe how real-world conditions reduce Degradation Rate"),
        ("Optimized Field Release", "Balance Enzyme Activity Level and Metabolic Pathway Efficiency against Containment Level — find the configuration that maximizes plastic removal while maintaining biosafety")
    ],
    "sim_scenarios": [
        ("Controlled Lab", "Ideal conditions, maximum containment", "What Degradation Rate do you predict under perfect laboratory conditions with unlimited resources?"),
        ("Ocean Deployment", "Real ocean conditions, reduced containment", "How much do you predict real-world ocean conditions reduce Degradation Rate compared to lab performance?"),
        ("Optimized Field Release", "Balanced performance and safety", "What do you predict is the maximum achievable Degradation Rate that maintains acceptable Containment Level and Byproduct Toxicity?")
    ],
    "discoveries": [
        "The gap between laboratory enzyme performance and real-world degradation is enormous — enzymes optimized for lab conditions lose 80-95% of their activity in environmental conditions (cold ocean water, variable pH, limited oxygen)",
        "Incomplete plastic breakdown can generate toxic intermediates — optimizing enzyme activity without optimizing the complete metabolic pathway can make the pollution problem WORSE by converting plastic into soluble toxins",
        "The containment-effectiveness paradox is a fundamental challenge — organisms need to spread to where plastic accumulates, but uncontrolled spread of engineered organisms poses ecological risks we cannot fully predict",
        "Temperature is the critical limiting factor — most plastic-degrading enzymes have evolved or been engineered for warm conditions (30-65°C), but ocean temperatures average 15°C and much plastic accumulates in cold deep-sea environments"
    ],
    "answer": "Engineering organisms to eat plastic is technically achievable but far more complex than it initially appears. The discovery of PETase in Ideonella sakaiensis proved that biology CAN break down synthetic polymers. But the real challenges are environmental: cold ocean temperatures drastically slow enzyme activity; incomplete degradation generates toxic byproducts worse than the original plastic; and deploying self-replicating engineered organisms into open environments creates containment risks we cannot fully assess. Synthetic biology modeling allows researchers to optimize all ten parameters simultaneously — engineering enzymes for cold-tolerance, designing complete metabolic pathways that leave no toxic intermediates, and building biological containment systems that limit environmental spread while maintaining degradation capacity. This is systems-level synthetic design at its most challenging.",
    "stem_title": "Design a Plastic-Eating Organism for Ocean Cleanup",
    "stem_mission": "Design an engineered biological system that degrades ocean plastic waste at meaningful rates while maintaining rigorous biosafety containment.",
    "stem_scenario": "An environmental biotech company has received a $100 million grant to develop a biological plastic cleanup system for the Great Pacific Garbage Patch. Current mechanical cleanup methods remove only a fraction of the 80,000 tons of plastic accumulated there. Your synthetic biology team must design an organism-based system that can degrade plastic at scale in open ocean conditions while meeting regulatory biosafety requirements.",
    "stem_questions": [
        "What organism chassis would you use as your starting platform — bacteria, fungi, algae — and why?",
        "How would you engineer the organism to function in cold, salty, low-oxygen ocean conditions?",
        "What containment strategy would you use to prevent uncontrolled environmental spread?"
    ],
    "stem_design_qs": [
        "Would you deploy free-living organisms or attach them to floating degradation platforms?",
        "How would you handle the toxic byproducts generated during plastic breakdown?",
        "What genetic kill switches or auxotrophies would you engineer for containment?",
        "How would you monitor organism spread and degradation progress in the open ocean?"
    ],
    "career": "Synthetic Biologists design and engineer organisms with novel capabilities for applications in medicine, energy, materials, and environmental remediation. They work for biotech companies (Ginkgo Bioworks, Zymergen), environmental engineering firms, and academic research labs, earning $85,000–$170,000/year. Bioremediation Engineers who deploy biological cleanup systems earn $75,000–$140,000/year.",
    "images": {
        "cover": ("G09L3-L06-cover.png", "A photorealistic, cinematic image of diverse 14-15 year old students in an advanced synthetic biology lab examining engineered bacterial colonies on plates next to degrading plastic samples, with DNA design software and metabolic pathway diagrams on screens, green and blue laboratory lighting"),
        "landscape": ("G09L3-L06-landscape.png", "A diverse group of 14-15 year old students in a modern environmental biotech lab comparing plastic samples at various stages of biodegradation under microscopes, ocean pollution data on wall displays, clean high-tech lab"),
        "modeling": ("G09L3-L06-modeling.png", "A diverse group of 14-15 year old students building synthetic biology models on laptops showing metabolic pathway diagrams and enzyme kinetics curves, whiteboards with genetic circuit designs and containment strategy flowcharts"),
        "discussion": ("G09L3-L06-discussion.png", "A teacher leading a design discussion with diverse 14-15 year old students about engineering organisms for environmental cleanup, a metabolic pathway diagram and ocean pollution statistics on a smartboard, students debating containment strategies"),
        "stem": ("G09L3-L06-stem.png", "Diverse 14-15 year old students presenting engineered organism designs for ocean plastic cleanup with genetic circuit diagrams, containment strategy flowcharts, and deployment plans on large displays, professional biotech presentation setting")
    },
    "pre_assessment": [
        "Do you think any living organism can naturally break down plastic — and if not, why not?",
        "What would you need to change about a bacterium to make it capable of eating plastic?",
        "Draw a diagram showing how you imagine an engineered plastic-eating organism would work at the molecular level.",
        "What risks might come from releasing genetically engineered organisms into the ocean?"
    ],
    "extend_components": [
        ("Biofilm Formation Capacity", "The engineered organism's ability to form biofilms on plastic surfaces, which concentrates enzyme activity at the substrate interface and dramatically improves degradation efficiency compared to free-floating organisms"),
        ("Horizontal Gene Transfer Risk", "The probability that the engineered genes transfer from the designed organism to wild microbes through natural DNA exchange mechanisms — a containment breach that could create unintended environmental consequences"),
        ("Multi-Plastic Capability", "The breadth of plastic types the engineered organism can degrade — PET, polyethylene, polypropylene, polystyrene, and nylon all require different enzymes, and a single organism that handles multiple types would be far more practically useful")
    ],
    "reflections": [
        "How does your model reveal the gap between laboratory enzyme performance and real-world environmental degradation?",
        "What is the containment-effectiveness paradox, and how does your model help navigate it?",
        "Why is Metabolic Pathway Efficiency critical for preventing the cure from being worse than the disease?",
        "How would adding Biofilm Formation Capacity change the organism's environmental performance?",
        "What ethical responsibilities do synthetic biologists have when designing organisms intended for environmental release?"
    ],
    "dimensions": [
        ("Science Practice", "Developing and Using Models / Designing Solutions", "Students develop a synthetic biology model integrating enzyme kinetics, metabolic engineering, and environmental conditions to design an optimized biodegradation system."),
        ("Disciplinary Core Idea", "LS1.C Organization for Matter and Energy Flow / ETS1.B Developing Possible Solutions", "Organisms use energy from chemical reactions to build complex molecules and drive cellular processes; engineering solutions require breaking complex problems into manageable sub-problems."),
        ("Crosscutting Concept", "Energy and Matter / Systems and System Models", "Students trace matter and energy flow through the engineered metabolic pathway from plastic polymer to harmless end products, modeling the system across molecular, organism, and environmental scales.")
    ],
    "cast_items": [
        "Model the synthetic biology design process from enzyme engineering through metabolic pathway construction to organism-level environmental performance",
        "Analyze the trade-offs between degradation rate, byproduct toxicity, and containment safety in engineered bioremediation systems",
        "Evaluate how environmental conditions (temperature, pH, oxygen) limit the translation of laboratory enzyme performance to real-world applications"
    ],
    "cast_questions": [
        ("Multiple Choice:", "An engineered plastic-eating bacterium shows excellent degradation in the lab at 37°C but is deployed in ocean water at 15°C. Based on your model, what is the most likely outcome?"),
        ("Constructed Response:", "Using your synthetic biology model, explain why simply engineering a faster enzyme does not solve the ocean plastic problem. Discuss at least three other model components that must be optimized simultaneously and the trade-offs between them.")
    ],
    "background_intro": "This lesson introduces students to synthetic biology and metabolic engineering in the context of plastic bioremediation — one of the most exciting applications of engineered organisms. Biotech skill focus: Synthetic design and systems biology. The discovery of natural plastic-degrading enzymes opened a new frontier in environmental biotechnology, but translating laboratory breakthroughs to real-world solutions requires systems-level synthetic design.",
    "background_sections": [
        ("The Plastic Pollution Crisis", "Humans have produced approximately 8.3 billion metric tons of plastic since 1950. Of this, only 9% has been recycled, 12% incinerated, and 79% accumulated in landfills or the natural environment. An estimated 8 million tons enter the oceans annually. The Great Pacific Garbage Patch alone contains 80,000 tons across 1.6 million square kilometers. Conventional plastics are synthetic polymers — long chains of repeating chemical units — that no organism evolved to degrade because they didn't exist in nature until the 20th century. PET (polyethylene terephthalate — drink bottles), polyethylene (bags, packaging), polypropylene (food containers), and polystyrene (foam) each have different chemical structures requiring different degradation enzymes. The environmental persistence of these materials ranges from hundreds to thousands of years."),
        ("The PETase Discovery", "In 2016, researchers at the Kyoto Institute of Technology discovered Ideonella sakaiensis — a bacterium from a Japanese recycling plant that had evolved the ability to break down PET plastic using a novel enzyme called PETase. This was the first confirmed example of a naturally evolved enzyme capable of degrading a synthetic polymer. PETase works by hydrolyzing the ester bonds in PET, producing terephthalic acid and ethylene glycol as breakdown products. A second enzyme, MHETase, completes the degradation of an intermediate compound. However, natural PETase is slow — it takes weeks to significantly degrade a thin plastic film at the enzyme's optimal temperature of 30°C. Protein engineering has created 'supercharged' PETase variants (like FAST-PETase, developed at UT Austin in 2022) that work 5-10x faster and at higher temperatures, but significant challenges remain for real-world deployment."),
        ("Metabolic Engineering for Complete Degradation", "Breaking PET into terephthalic acid and ethylene glycol is only the first step — the organism must then metabolize these products completely, or they accumulate as pollutants. Complete degradation requires engineering a multi-enzyme metabolic pathway: PETase breaks PET into MHET, MHETase converts MHET to terephthalic acid and ethylene glycol, additional enzymes convert terephthalic acid through protocatechuate to central metabolism (TCA cycle), and ethylene glycol is oxidized to glycolate and enters central metabolism. If any step in this pathway is inefficient, intermediate compounds accumulate — and some of these intermediates (particularly oxidized ethylene glycol derivatives) are more toxic than the original plastic. This is the critical lesson: optimizing one enzyme without optimizing the complete pathway can make the pollution problem worse."),
        ("The Containment Challenge", "Releasing engineered organisms into the environment is the most controversial aspect of synthetic biology. Containment strategies include: (1) Auxotrophies — engineering the organism to require a synthetic amino acid or nutrient not found in nature, so it dies without laboratory supplementation; (2) Kill switches — genetic circuits that kill the organism in response to environmental signals (temperature change, absence of an inducer chemical); (3) Genetic firewalls — recoding the organism's genetic code so its genes cannot function if transferred to wild microbes; (4) Physical containment — deploying organisms in enclosed bioreactor systems rather than as free-living environmental releases. Each strategy has limitations: kill switches can be mutated, auxotrophies can be bypassed by horizontal gene transfer, and physical containment limits deployment scale. The field of biosafety engineering is dedicated to making containment robust enough for real-world deployment.")
    ],
    "lever_L": "Students identify ten components spanning enzyme biochemistry (Enzyme Activity Level), metabolic engineering (Metabolic Pathway Efficiency, Byproduct Toxicity), organism biology (Organism Growth Rate, pH Tolerance), environmental conditions (Substrate Concentration, Environmental Temperature, Oxygen Requirements), and biosafety (Degradation Rate, Containment Level).",
    "lever_E": "Students determine that Substrate Concentration, Environmental Temperature, Oxygen Requirements, Scaffold Structure, and Containment Level are the controllable inputs — while Enzyme Activity Level, Metabolic Pathway Efficiency, Byproduct Toxicity, Organism Growth Rate, pH Tolerance, and Degradation Rate emerge as biological responses to the environmental conditions and genetic engineering decisions.",
    "lever_V": "Students build a synthetic biology model connecting enzyme performance to metabolic pathway function to organism-level environmental degradation, visualizing how lab-optimized parameters translate (or fail to translate) to real-world performance.",
    "lever_Ev": "Students run controlled-lab, ocean-deployment, and optimized-field-release scenarios to quantify the performance gap between laboratory and environmental conditions and find the design specifications that balance effectiveness with safety.",
    "lever_R": "Students add Biofilm Formation Capacity, Horizontal Gene Transfer Risk, or Multi-Plastic Capability to explore more sophisticated and realistic synthetic biology designs.",
    "slides_guide": [
        {"num": "Slide 1", "title": "Cover", "visual": "Title slide with dramatic ocean plastic pollution imagery alongside molecular enzyme structures", "say": "Every minute, a garbage truck's worth of plastic enters the ocean. We can't clean it up fast enough with machines. But what if we could engineer a living organism that eats it?", "do": "Show the scale of ocean plastic pollution with a visual comparison. Ask: Why can't we just scoop it all out?", "time": "2 min"},
        {"num": "Slide 2", "title": "Learning Objectives", "visual": "Learning goals and synthetic biology vocabulary", "say": "Today you're synthetic biologists. Your job is to design a living organism from scratch — one that can do something no natural organism has ever done: break down plastic.", "do": "Pre-teach synthetic biology and metabolic engineering. Show the Ideonella sakaiensis discovery story as a 1-minute intro.", "time": "3 min"},
        {"num": "Slide 3", "title": "Big Question", "visual": "Can we engineer life to clean up our plastic mess?", "say": "Plastic has only existed for about 70 years. No organism evolved to eat it because it never existed in nature before. But in 2016, scientists found a bacterium in a recycling plant that had EVOLVED to eat PET plastic. What if we could make it better?", "do": "Think-pair-share: Students brainstorm what you'd need to engineer into an organism to make it eat plastic effectively in the ocean. Compile ideas.", "time": "3 min"},
        {"num": "Slide 4", "title": "LEVER Framework", "visual": "LEVER steps with synthetic design context", "say": "We're going to design an organism from the enzyme level up — like programming a biological machine with ten interacting parts. This is synthetic biology in action.", "do": "Preview LEVER steps. Emphasize the multi-scale design challenge: molecular (enzymes) → cellular (metabolism) → organism (growth) → environmental (deployment).", "time": "2 min"},
        {"num": "Slide 5", "title": "Activity 1: Components", "visual": "Ten component cards spanning enzyme, organism, environment, and safety scales", "say": "Four of these ten components are environmental conditions you can choose where to deploy. One is a safety feature you engineer in. Five are biological responses. Sort them.", "do": "Guide sorting of external versus internal components. Discuss the containment paradox: you want the organism to spread to plastic but NOT spread everywhere else.", "time": "8 min"},
        {"num": "Slide 6", "title": "Activity 2: Connections", "visual": "Metabolic pathway from plastic polymer to harmless end products with safety constraints", "say": "Here's the trap: if you optimize the enzyme to chew up plastic faster but the metabolic pathway can't keep up, you convert solid plastic into dissolved toxins. The cure becomes worse than the disease.", "do": "Students trace the complete degradation pathway. Identify where incomplete degradation produces toxic intermediates. Map the containment-effectiveness trade-off.", "time": "8 min"},
        {"num": "Slide 7", "title": "Activity 3: Simulation", "visual": "Performance comparison across lab, ocean, and optimized scenarios", "say": "Run your organism in the lab, then drop it in the ocean. Watch what happens to performance. Then try to redesign it for real-world conditions.", "do": "Students predict lab-to-field performance drop, then verify with simulations. Challenge: find the design that works in real ocean conditions while maintaining containment.", "time": "10 min"},
        {"num": "Slide 8", "title": "Discoveries", "visual": "Key synthetic biology findings and real-world design constraints", "say": "You just learned the first rule of synthetic biology: what works in the lab almost never works in the real world without major redesign. But the gap is shrinking — and your generation might close it.", "do": "Connect model findings to the real FAST-PETase breakthrough. Discuss remaining challenges and timelines for real-world deployment.", "time": "5 min"},
        {"num": "Slide 9", "title": "STEM Challenge", "visual": "Ocean plastic cleanup biological system design challenge", "say": "You have $100 million and the world's best synthetic biology tools. Design the organism — or organism system — that cleans up the Great Pacific Garbage Patch. Go.", "do": "Groups design complete biological cleanup systems including organism design, deployment strategy, containment plan, and monitoring system. Present proposals.", "time": "12 min"}
    ],
    "sort_reasoning": "Substrate Concentration, Environmental Temperature, Oxygen Requirements, and Containment Level are external components because they represent conditions that engineers select through deployment decisions (where and how the organism is used) and genetic design choices (containment features). Scaffold Structure is also external as an engineered design parameter. Enzyme Activity Level, Metabolic Pathway Efficiency, Byproduct Toxicity, Organism Growth Rate, pH Tolerance, and Degradation Rate are internal components because they emerge from the organism's biology interacting with environmental conditions — they are consequences of the design, not directly settable parameters.",
    "relationships": [
        ("Substrate Concentration to Degradation Rate", "POSITIVE (+)", "Higher plastic substrate concentration provides more material for the engineered enzyme to process, increasing the overall Degradation Rate up to the enzyme's saturation point."),
        ("Enzyme Activity Level to Degradation Rate", "POSITIVE (+)", "More efficient enzymes process more plastic molecules per second, directly increasing the rate at which plastic substrate is converted to breakdown products."),
        ("Environmental Temperature to Enzyme Activity Level", "POSITIVE (+) up to optimum, then NEGATIVE (-)", "Enzyme activity increases with temperature up to the optimum (30-65°C for most PETase variants) then drops sharply as the enzyme denatures — critical for ocean deployment where temperatures are far below optimum."),
        ("Metabolic Pathway Efficiency to Byproduct Toxicity", "NEGATIVE (-)", "More efficient metabolic pathways convert plastic breakdown products completely to harmless end products (CO2, biomass), reducing the accumulation of toxic intermediate compounds."),
        ("Organism Growth Rate to Degradation Rate", "POSITIVE (+)", "Faster organism proliferation increases the total enzyme concentration in the environment, amplifying the system-wide Degradation Rate as the microbial population expands."),
        ("Containment Level to Organism Growth Rate", "NEGATIVE (-)", "Stronger containment features (kill switches, auxotrophies) impose metabolic costs on the organism and limit its ability to proliferate freely, reducing the population density achievable in the environment.")
    ],
    "sim_answers": [
        ("Controlled Lab Scenario", "Under ideal laboratory conditions (37°C, optimal pH, high oxygen, high substrate concentration), the engineered organism shows impressive performance. Enzyme Activity Level is high, Metabolic Pathway Efficiency processes breakdown products efficiently, and Byproduct Toxicity remains low. Degradation Rate peaks at the system's theoretical maximum. However, Containment Level is maximum — the organism is fully contained in a bioreactor. This represents the best-case benchmark but not a realistic deployment scenario."),
        ("Ocean Deployment Scenario", "When deployed in real ocean conditions (15°C average, pH 8.1, limited oxygen in deeper waters), performance drops dramatically. Enzyme Activity Level decreases by 80-95% because PETase variants are optimized for warm temperatures. Organism Growth Rate is slow in cold, nutrient-poor ocean water. Degradation Rate is a fraction of lab performance. The model starkly reveals why laboratory breakthroughs don't automatically translate to environmental solutions — the gap between lab and field is the central challenge of environmental synthetic biology.")
    ],
    "reflection_exemplars": [
        ("What is the containment-effectiveness paradox?", "The model reveals a fundamental tension: containment features (kill switches, nutrient dependencies) reduce the organism's environmental fitness, limiting its ability to grow and degrade plastic in the real world. But WITHOUT containment, an engineered organism could spread uncontrollably, potentially disrupting natural ecosystems in ways we cannot predict. You want the organism to be GOOD ENOUGH at surviving to do its job, but NOT SO GOOD that it outcompetes natural organisms. Finding this balance is the core design challenge of environmental synthetic biology."),
        ("Why can optimizing enzyme activity make the pollution problem worse?", "If Enzyme Activity Level is increased without proportionally improving Metabolic Pathway Efficiency, the enzyme breaks plastic into intermediate compounds faster than the cell can metabolize them. These intermediates — particularly oxidized ethylene glycol derivatives and partially hydrolyzed PET oligomers — can be more soluble, mobile, and toxic than the original solid plastic. The model shows that optimizing one step without optimizing the entire pathway converts visible plastic pollution into invisible chemical pollution — potentially worse for marine ecosystems.")
    ],
    "stem_intro": "Present the challenge: An environmental biotech company has received a $100 million grant to develop biological plastic cleanup for the Great Pacific Garbage Patch. Mechanical cleanup removes only a fraction of the 80,000 tons accumulated there. Your synthetic biology team must design an organism-based system that degrades plastic at meaningful rates in open ocean conditions while meeting regulatory biosafety requirements.",
    "stem_concepts": [
        ("Chassis Organism Selection", "The 'chassis' is the base organism into which new genetic capabilities are engineered. Options include E. coli (well-characterized, easy to engineer, but poor ocean survivor), Vibrio species (native ocean bacteria, salt-tolerant, but less engineering toolkit), and marine fungi (can attach to plastic surfaces, produce diverse enzymes, but slower growing). The choice of chassis determines the environmental performance envelope."),
        ("Genetic Circuit Design", "Kill switches, auxotrophies, and containment features are implemented as genetic circuits — DNA-encoded logic gates that respond to environmental signals. A well-designed kill switch might activate cell death when the organism drifts away from the deployment zone (sensing temperature, salinity, or a specific chemical signal from the deployment platform)."),
        ("Deployment Platform Engineering", "Rather than releasing free-living organisms, some designs use floating platforms or enclosed mesh systems that concentrate organisms near plastic accumulations while providing physical containment. These platforms can also supply nutrients, maintain temperature, and collect degradation byproducts for processing.")
    ],
    "stem_eval": [
        ("Expert (4)", "Design includes justified chassis selection, complete metabolic pathway, multi-layer containment strategy, deployment platform, monitoring plan, and analysis of environmental risks, supported by model-derived performance predictions"),
        ("Proficient (3)", "Design includes organism engineering, containment strategy, and deployment approach with reasoning connected to model findings"),
        ("Developing (2)", "Design covers basic organism engineering but lacks detail on containment, deployment logistics, or environmental risk assessment"),
        ("Beginning (1)", "Design is incomplete or does not connect organism engineering decisions to the synthetic biology model")
    ],
    "support": [
        "Provide a simplified metabolic pathway diagram showing PET → MHET → TPA + EG → central metabolism, with toxic intermediates highlighted",
        "Use a lab-vs-field performance comparison template where students can predict and then verify the performance gap for each parameter",
        "Scaffold synthetic design: 'My organism needs to ___ (function) in ___ (environment), so I will engineer ___ (genetic feature) because ___.'"
    ],
    "extensions": [
        "Research the FAST-PETase enzyme developed at UT Austin — what engineering modifications made it faster and more thermostable than natural PETase?",
        "Investigate the emerging field of plastic-eating fungi (like Pestalotiopsis microspora) and compare fungal versus bacterial approaches to bioremediation",
        "Design a closed-loop system where the engineered organism not only degrades plastic but converts the breakdown products into useful chemicals (upcycling) — like converting PET into vanillin (vanilla flavoring)"
    ],
    "cross_curr": [
        ("Math", "Calculate enzyme kinetics using Michaelis-Menten equations to predict Degradation Rate as a function of Substrate Concentration and Enzyme Activity Level"),
        ("ELA", "Write a regulatory submission document arguing for FDA/EPA approval of an engineered organism for environmental release, addressing safety, efficacy, and containment evidence"),
        ("Environmental Science", "Conduct a life cycle analysis comparing biological plastic remediation to mechanical cleanup, chemical recycling, and landfill disposal in terms of energy use, cost, and environmental impact")
    ],
    "misconceptions": [
        ("We can just release bacteria into the ocean and the plastic problem is solved", "Releasing engineered organisms into the ocean faces enormous challenges the model reveals: cold temperatures slow enzyme activity by 80-95%, nutrient-poor ocean water limits organism growth, UV radiation damages DNA, and the organisms must somehow find and attach to widely dispersed plastic particles. Additionally, the sheer scale of ocean plastic (80,000+ tons in the Pacific alone) would require organism populations of astronomical size. Bioremediation is a tool that complements other approaches — it's not a magic bullet.", "Scale it: If each bacterium degrades 1 microgram of plastic per day, how many bacteria would you need to clean up 80,000 tons? (Answer: ~8 × 10^16 — about 80 quadrillion bacteria.)"),
        ("Engineered organisms are inherently dangerous and should never be released", "Risk assessment of engineered organisms must be evidence-based, not fear-based. Billions of engineered bacteria are already used safely in industrial fermentation (producing insulin, enzymes, vitamins). The key is containment engineering — multiple redundant safety systems that prevent the organism from surviving outside its intended deployment context. The model's Containment Level component shows that well-designed safety features can dramatically reduce environmental risk while maintaining useful function.", "Compare: We release billions of engineered yeast cells into the environment every time we bake bread or brew beer. What's different about releasing an engineered bacterium into the ocean?"),
        ("Plastic is just a chemistry problem — biology is too slow", "While chemical recycling can process plastic faster than biological degradation, it requires high temperatures, harsh chemicals, and centralized infrastructure. Biology offers something chemistry cannot: self-replication and self-deployment. An engineered organism can reproduce, spread to plastic-contaminated sites, and adapt to local conditions — potentially providing continuous, self-sustaining cleanup in remote locations where chemical processing infrastructure doesn't exist.", "Think about it: Would you rather build a chemical recycling plant on every beach in the world, or deploy an organism that goes where the plastic is?")
    ]
}

L07 = {
    "id": "G09L3-L07",
    "title": "Metabolic Engineering for Biofuels",
    "subtitle": "Pathway Optimization and Flux Balancing in Microbial Fuel Production",
    "ngss": "HS-LS1-5, HS-ETS1-3",
    "ngss_desc": "Use a model to illustrate how photosynthesis transforms light energy into stored chemical energy; optimize the design of a solution to a complex real-world problem by considering trade-offs among criteria and constraints.",
    "big_question": "We burn 100 million barrels of oil every day. Can we engineer microbes to brew fuel instead of drilling for it — and can we make it economically competitive?",
    "objectives": [
        "Build a metabolic engineering model that traces carbon flux from substrate input through engineered enzymatic pathways to biofuel product output",
        "Analyze how substrate concentration, enzyme kinetics, cofactor recycling, and metabolic burden interact to determine overall pathway efficiency",
        "Optimize pathway flux and fermentation conditions to maximize product yield while maintaining cell viability and growth",
        "Evaluate the economic and environmental trade-offs between fossil fuel extraction and engineered biofuel production"
    ],
    "vocabulary": [
        ("Metabolic Flux", "The rate at which metabolites flow through a biochemical pathway — measured in moles per gram of cells per hour — which determines how efficiently an organism converts substrate into desired product versus biomass or byproducts"),
        ("Cofactor Recycling", "The regeneration of essential helper molecules (NAD+/NADH, NADP+/NADPH, ATP/ADP, CoA) that enzymes require to catalyze reactions — if cofactors are consumed faster than they are recycled, the entire pathway stalls regardless of enzyme activity"),
        ("Metabolic Burden", "The fitness cost imposed on a cell by expressing engineered pathway enzymes — diverting cellular resources (ribosomes, amino acids, ATP) from growth and maintenance to foreign protein production, which can slow growth or kill the cell"),
        ("Fermentation Titer", "The final concentration of desired product (e.g., ethanol, butanol, fatty acid esters) achieved in the fermentation broth at the end of a production run — the key economic metric that determines whether a biofuel process is commercially viable")
    ],
    "components": [
        ("Substrate Concentration", "The amount of fermentable carbon source (glucose, xylose, glycerol, or lignocellulosic hydrolysate) available to the engineered microbe — the raw material input that feeds the entire metabolic pathway", True),
        ("Enzyme Activity", "The catalytic efficiency of the key engineered pathway enzymes, determined by protein expression level, folding efficiency, and kinetic parameters (kcat and Km) — the molecular machines that perform each conversion step", False),
        ("Pathway Flux", "The overall rate of carbon flow through the engineered biofuel pathway from substrate to product, measured in mmol per gram dry cell weight per hour — limited by the slowest enzymatic step (the bottleneck)", False),
        ("Cofactor Availability", "The intracellular pool of essential cofactors (NADH, NADPH, ATP, CoA) available to support pathway enzyme reactions — cofactor imbalance is one of the most common reasons engineered pathways fail in practice", False),
        ("Metabolic Burden", "The total resource cost the cell pays for expressing the engineered pathway — measured as the fraction of cellular protein synthesis, ATP production, and precursor metabolites diverted from native functions to foreign pathway enzymes", False),
        ("Cell Growth Rate", "The doubling time of the engineered microbial population during fermentation — faster growth increases total bioreactor productivity but competes with product formation for cellular resources", False),
        ("Product Yield", "The mass of biofuel produced per mass of substrate consumed — expressed as a percentage of the theoretical maximum yield, which is set by the stoichiometry of the biochemical conversion", False),
        ("Byproduct Accumulation", "The buildup of unwanted metabolic side products (acetate, lactate, ethanol in non-ethanol pathways, organic acids) that divert carbon away from the desired product and can inhibit cell growth at high concentrations", False),
        ("Fermentation Efficiency", "The overall process performance integrating Product Yield, volumetric productivity (grams per liter per hour), and final titer — the composite metric that determines whether the biofuel is economically competitive with petroleum", False)
    ],
    "think_about_it": "Here's the central paradox of metabolic engineering: you want the cell to be a biofuel factory, but the cell wants to be a cell. Every enzyme you add to the biofuel pathway steals resources (ribosomes, ATP, amino acids) from the cell's own growth and maintenance — that's Metabolic Burden. Push the pathway too hard and Cell Growth Rate crashes, meaning fewer cells producing less total product. But push too gently and Product Yield is low because the cell diverts carbon to Byproduct Accumulation and biomass instead. Meanwhile, Cofactor Availability can collapse if the pathway consumes NADH or ATP faster than the cell regenerates them. How do you balance a factory that doesn't want to be a factory?",
    "scenarios": [
        ("Baseline Fermentation", "Set Substrate Concentration to standard glucose levels with wild-type-level enzyme expression — observe baseline Pathway Flux, Product Yield, and Cell Growth Rate balance"),
        ("Maximum Pathway Expression", "Increase Enzyme Activity to maximum by overexpressing all pathway genes — observe how Metabolic Burden increases, Cell Growth Rate drops, and whether Product Yield actually improves or crashes"),
        ("Optimized Balanced Design", "Tune Enzyme Activity to balance Pathway Flux against Metabolic Burden — find the expression level that maximizes Fermentation Efficiency by maintaining healthy Cell Growth Rate while pushing carbon toward product")
    ],
    "sim_scenarios": [
        ("Baseline Fermentation", "Standard substrate, moderate enzyme expression", "What do you predict the ratio of Product Yield to Byproduct Accumulation will be without pathway optimization?"),
        ("Maximum Expression", "All pathway enzymes at maximum expression", "What do you predict happens to Cell Growth Rate when every ribosome in the cell is making pathway enzymes instead of growth-essential proteins?"),
        ("Balanced Optimization", "Tuned expression with cofactor engineering", "Do you predict that reducing enzyme expression from maximum can actually INCREASE total Fermentation Efficiency?")
    ],
    "discoveries": [
        "Maximum enzyme expression does NOT produce maximum product yield — excessive Metabolic Burden crashes Cell Growth Rate, resulting in fewer cells and lower total productivity than a moderately-expressed pathway",
        "Cofactor imbalance is a silent killer of engineered pathways — a pathway that looks perfect on paper fails in practice because it consumes NADH faster than the cell can regenerate it from central metabolism",
        "Byproduct accumulation is both a carbon sink and a toxin — acetate and organic acid byproducts divert 15-40% of substrate carbon while simultaneously inhibiting cell growth at concentrations above 5-10 g/L",
        "The economic breakeven for microbial biofuel production requires achieving at least 85% of theoretical maximum yield at titers above 50 g/L — most laboratory strains achieve 30-60% of maximum yield at 10-20 g/L, highlighting the engineering gap"
    ],
    "answer": "Engineering microbes to produce biofuels is a metabolic tug-of-war between what the engineer wants (maximum fuel production) and what the cell needs (growth, maintenance, and survival). The nine components of this model capture the fundamental trade-offs: Substrate Concentration feeds carbon into the system, but Enzyme Activity must be precisely balanced to maintain Pathway Flux without overwhelming the cell with Metabolic Burden. Cofactor Availability acts as a hidden constraint — if the pathway drains NAD+, NADPH, or ATP faster than the cell regenerates them, flux stalls regardless of enzyme levels. Cell Growth Rate competes directly with Product Yield for the same carbon and energy. Byproduct Accumulation represents both lost carbon and metabolic toxicity. Fermentation Efficiency — the composite metric that determines commercial viability — requires simultaneously optimizing all eight upstream components. This is why metabolic engineering is sometimes called 'the art of compromise' — the best biofuel strain is never the one with the most enzyme, but the one with the most balanced metabolism.",
    "stem_title": "Design a Next-Generation Biofuel Production Strain",
    "stem_mission": "Design an engineered microbial strain and fermentation process that produces advanced biofuel at commercially competitive yields, titers, and productivities.",
    "stem_scenario": "A renewable energy startup has secured $50 million in venture capital to develop a microbial biofuel that can replace jet fuel. Current petroleum-based jet fuel costs $0.60 per liter to produce. Your metabolic engineering team must design a microbial strain and fermentation process that produces a drop-in jet fuel replacement at competitive cost — which means achieving high Product Yield, high titer (above 50 g/L), and high volumetric productivity (above 1 g/L/hr).",
    "stem_questions": [
        "Which host organism (E. coli, yeast, Clostridium, cyanobacteria) would you choose as your chassis and why?",
        "How would you balance Enzyme Activity levels across the pathway to avoid the Metabolic Burden trap?",
        "What cofactor engineering strategy would you use to prevent NADH/NADPH imbalance from stalling the pathway?"
    ],
    "stem_design_qs": [
        "Would you use a batch, fed-batch, or continuous fermentation process — and how does this choice affect Substrate Concentration management?",
        "How would you engineer the strain to tolerate high product concentrations that are typically toxic to the cell?",
        "What genetic stability strategies would you implement to prevent the production pathway from mutating out during long fermentations?",
        "How does the carbon footprint of your biofuel compare to petroleum when you account for substrate production, fermentation energy, and downstream processing?"
    ],
    "career": "Metabolic Engineers design and optimize microbial production pathways for fuels, chemicals, and pharmaceuticals. They work for biotech companies (Amyris, Ginkgo Bioworks, LanzaTech, Genomatica), renewable energy startups, and national laboratories, earning $90,000-$175,000/year. Fermentation Scientists who scale up lab strains to industrial production earn $80,000-$150,000/year.",
    "images": {
        "cover": ("G09L3-L07-cover.png", "A photorealistic, cinematic image of diverse 14-15 year old students in an advanced biotech fermentation lab examining bioreactor vessels with fluorescent-green cultures, metabolic pathway diagrams and flux analysis charts on screens, warm industrial lighting with steel and glass equipment"),
        "landscape": ("G09L3-L07-landscape.png", "A diverse group of 14-15 year old students in a modern metabolic engineering lab monitoring fermentation progress on multiple bioreactor displays showing growth curves and product titer graphs, industrial biotech setting with stainless steel equipment"),
        "modeling": ("G09L3-L07-modeling.png", "A diverse group of 14-15 year old students building metabolic flux models on laptops showing pathway diagrams with flux arrows of varying thickness, whiteboards with enzyme kinetics equations and cofactor balance calculations"),
        "discussion": ("G09L3-L07-discussion.png", "A teacher leading a discussion with diverse 14-15 year old students about metabolic flux optimization, a metabolic pathway map showing carbon flow from glucose to biofuel product on a smartboard with bottleneck steps highlighted in red"),
        "stem": ("G09L3-L07-stem.png", "Diverse 14-15 year old students presenting biofuel strain designs with metabolic pathway maps, fermentation optimization data, and economic analysis charts on large displays, professional biotech presentation setting")
    },
    "pre_assessment": [
        "What do you think happens inside a yeast cell when it ferments sugar into alcohol — and how is that related to making fuel?",
        "Why do you think we can't just grow corn and turn it all into ethanol to replace gasoline?",
        "Draw a diagram showing how you think a cell converts sugar into a useful chemical product — where does the carbon go?",
        "What does 'metabolic engineering' mean to you and how might it differ from genetic engineering?"
    ],
    "extend_components": [
        ("Product Toxicity Threshold", "The concentration of biofuel product at which it begins to damage the producing cell's membrane and proteins — ethanol tolerance in yeast is 12-15% while butanol kills most bacteria above 2%, making product toxicity one of the most critical limitations in biofuel fermentation"),
        ("Feedstock Flexibility", "The range of carbon substrates the engineered organism can utilize — strains that can co-ferment glucose AND xylose from lignocellulosic biomass access 40% more available carbon than glucose-only strains, dramatically improving process economics"),
        ("Genetic Stability Index", "The probability that the engineered production pathway maintains full function over extended fermentation runs — cells under high Metabolic Burden face selective pressure to mutate and inactivate costly pathway enzymes, causing production to decline over time")
    ],
    "reflections": [
        "How does your model demonstrate the fundamental trade-off between Cell Growth Rate and Product Yield — and why can't you simply maximize both?",
        "Why is Cofactor Availability often called the 'silent killer' of engineered metabolic pathways?",
        "What did you learn about the relationship between Enzyme Activity levels and Metabolic Burden — why doesn't 'more enzyme' always mean 'more product'?",
        "How would adding Product Toxicity Threshold change your optimization strategy for Fermentation Efficiency?",
        "What are the environmental justice implications of siting large biofuel fermentation facilities — who benefits and who bears the costs?"
    ],
    "dimensions": [
        ("Science Practice", "Developing and Using Models / Using Mathematics and Computational Thinking", "Students develop a metabolic flux model integrating enzyme kinetics, cofactor balance, and growth-production trade-offs, using quantitative analysis to optimize pathway performance."),
        ("Disciplinary Core Idea", "LS1.C Organization for Matter and Energy Flow / ETS1.C Optimizing the Design Solution", "Matter and energy flow through metabolic pathways following conservation laws; engineering design requires iterative optimization of multiple competing criteria and constraints."),
        ("Crosscutting Concept", "Energy and Matter / Stability and Change", "Students trace carbon and energy flow from substrate through metabolic pathways to product, analyzing how perturbations in one pathway component cascade through the system to affect overall stability and output.")
    ],
    "cast_items": [
        "Model metabolic flux from substrate through engineered enzymatic pathways to biofuel product, identifying rate-limiting steps and cofactor constraints",
        "Optimize the balance between enzyme expression level, metabolic burden, and cell growth to maximize overall fermentation efficiency",
        "Evaluate the economic feasibility of microbial biofuel production by analyzing the gap between laboratory yields and commercially competitive targets"
    ],
    "cast_questions": [
        ("Multiple Choice:", "An engineered E. coli strain producing butanol shows high Enzyme Activity but Fermentation Efficiency is declining over a 48-hour fermentation. Based on your model, which factor is most likely responsible?"),
        ("Constructed Response:", "Using your metabolic engineering model, explain why doubling the expression of every enzyme in a biofuel pathway does NOT double the Product Yield. Reference at least three model components and describe the trade-offs involved.")
    ],
    "background_intro": "This lesson introduces students to metabolic engineering — the systematic design and optimization of cellular metabolic pathways for industrial production. Biotech skill focus: Pathway flux balancing and multi-variable optimization. The global energy crisis demands alternatives to fossil fuels, and engineered microorganisms represent one of the most promising routes to sustainable liquid fuels.",
    "background_sections": [
        ("The Energy Challenge and Biofuels", "Global civilization consumes approximately 100 million barrels of crude oil per day — roughly 15.9 billion liters. Transportation fuels (gasoline, diesel, jet fuel) account for about 60% of this consumption. First-generation biofuels (corn ethanol, biodiesel from vegetable oil) have demonstrated the concept of biological fuel production but face fundamental limitations: they compete with food production for agricultural land, their energy return on investment (EROI) is marginal (1.3:1 for corn ethanol versus 15:1 for conventional oil), and ethanol has only 67% the energy density of gasoline. Advanced biofuels — produced by engineered microorganisms from non-food feedstocks like agricultural waste, forestry residues, or CO2 — could overcome these limitations if metabolic engineering can close the gap between laboratory yields and commercial requirements."),
        ("Metabolic Pathway Design", "Engineering a microbial biofuel pathway involves three fundamental challenges. First, pathway selection: choosing the biochemical route from substrate to product. For example, fatty acid-derived biodiesel requires a pathway from glucose through acetyl-CoA to fatty acid synthesis to ester formation — a 12+ enzyme cascade. Butanol production through the Clostridial ABE pathway requires 7 enzymes. Each route has a different theoretical maximum yield set by biochemical stoichiometry and thermodynamics. Second, enzyme balancing: each enzyme in the pathway must be expressed at the right level. Too little of the bottleneck enzyme limits flux; too much of any enzyme wastes cellular resources. Third, cofactor engineering: most biosynthetic pathways consume reducing equivalents (NADH or NADPH) and ATP. If the pathway drains these cofactors faster than central metabolism regenerates them, flux stalls regardless of enzyme levels."),
        ("The Metabolic Burden Problem", "Every protein a cell makes costs resources: ribosomes to translate the mRNA, amino acids to build the protein, ATP to fold it, and chaperones to maintain it. When metabolic engineers introduce 5-15 foreign enzymes at high expression levels, the total protein production burden can consume 20-40% of the cell's biosynthetic capacity. This 'metabolic burden' manifests as slower growth, reduced stress tolerance, and paradoxically lower product yield because the cell cannot maintain healthy metabolism while running the production pathway at full capacity. The solution is dynamic pathway regulation — genetic circuits that sense the cell's metabolic state and adjust enzyme expression in real time, similar to how natural metabolic regulation works. Strategies include growth-coupled production (linking product formation to essential metabolic pathways so cells cannot grow without producing), quorum sensing-based induction (delaying pathway activation until cell density is high), and stress-responsive promoters."),
        ("From Laboratory to Industrial Scale", "The gap between laboratory biofuel production and commercial viability is measured in three metrics: yield (grams of product per gram of substrate — must be above 85% of theoretical maximum), titer (final product concentration — must exceed 50 g/L for economical downstream processing), and productivity (grams per liter per hour — determines bioreactor capital costs). Most laboratory strains achieve 30-60% of theoretical yield at titers of 10-20 g/L, well below commercial requirements. Scale-up introduces additional challenges: oxygen transfer limitations in large bioreactors (which can be 200,000+ liters), contamination risks during multi-day fermentations, the cost of sterilizing and cooling large volumes, and genetic stability over hundreds of generations. Companies like Amyris, LanzaTech, and Genomatica have spent over a decade and billions of dollars bridging this gap for specific products.")
    ],
    "lever_L": "Students identify nine components spanning substrate input (Substrate Concentration), enzyme-level function (Enzyme Activity), pathway-level dynamics (Pathway Flux, Cofactor Availability), cell-level constraints (Metabolic Burden, Cell Growth Rate), and process-level outcomes (Product Yield, Byproduct Accumulation, Fermentation Efficiency).",
    "lever_E": "Students determine that Substrate Concentration is the primary external input, while Enzyme Activity, Pathway Flux, Cofactor Availability, Metabolic Burden, Cell Growth Rate, Product Yield, Byproduct Accumulation, and Fermentation Efficiency emerge as interconnected internal responses — recognizing that Enzyme Activity is partially controllable through genetic engineering but ultimately constrained by cellular resources.",
    "lever_V": "Students build a metabolic flux model connecting substrate input through enzymatic conversion steps to product output, visualizing how carbon flows partition between desired product, biomass, and unwanted byproducts.",
    "lever_Ev": "Students run baseline, maximum-expression, and balanced-optimization scenarios to discover that maximum enzyme expression does not produce maximum Fermentation Efficiency due to Metabolic Burden effects.",
    "lever_R": "Students add Product Toxicity Threshold, Feedstock Flexibility, or Genetic Stability Index to explore more realistic industrial constraints on microbial biofuel production.",
    "slides_guide": [
        {"num": "Slide 1", "title": "Cover", "visual": "Title slide with dramatic imagery of bioreactors alongside petroleum refineries", "say": "We burn 100 million barrels of oil every day. What if, instead of drilling it out of the ground, we could brew it in a vat — using engineered microbes that convert sugar into fuel? That's metabolic engineering.", "do": "Display the scale comparison: barrels of oil consumed daily versus current biofuel production. Let the gap sink in.", "time": "2 min"},
        {"num": "Slide 2", "title": "Learning Objectives", "visual": "Learning goals and metabolic engineering vocabulary", "say": "Today you're metabolic engineers. You're going to design a microbial fuel factory — and discover why the biggest challenge isn't the chemistry, it's the biology.", "do": "Pre-teach metabolic flux and cofactor recycling. Use the analogy: a factory assembly line where every worker needs specific tools (cofactors) to do their job.", "time": "3 min"},
        {"num": "Slide 3", "title": "Big Question", "visual": "Can engineered microbes replace petroleum?", "say": "Yeast has been converting sugar to ethanol for 10,000 years — that's beer and wine. But ethanol is a lousy fuel. What if we could redirect that metabolism to make jet fuel, diesel, or gasoline — drop-in replacements?", "do": "Think-pair-share: Why is ethanol a poor fuel compared to gasoline? (Energy density, water miscibility, corrosion.) What properties would an ideal biofuel have?", "time": "3 min"},
        {"num": "Slide 4", "title": "LEVER Framework", "visual": "LEVER steps with metabolic engineering context", "say": "We're going to trace carbon from a sugar molecule all the way through an engineered metabolic pathway to a fuel molecule. Every step has constraints, trade-offs, and potential failure points.", "do": "Preview LEVER steps. Emphasize: this model captures the fundamental tension between making the cell a factory and keeping the cell alive.", "time": "2 min"},
        {"num": "Slide 5", "title": "Activity 1: Components", "visual": "Nine component cards spanning molecular, cellular, and process scales", "say": "Only ONE of these nine components is something the engineer fully controls from outside. The rest are biological responses. Which one?", "do": "Guide identification of Substrate Concentration as the primary external input. Discuss how Enzyme Activity is partially controllable through genetic engineering but constrained by Metabolic Burden.", "time": "8 min"},
        {"num": "Slide 6", "title": "Activity 2: Connections", "visual": "Metabolic flux map from substrate through pathway to product with competing drains", "say": "Here's the problem: every carbon atom that enters the cell has three possible fates — it becomes fuel (what you want), biomass (what the cell wants), or byproduct (what neither of you wants). Trace the competition.", "do": "Students map carbon flow from Substrate through Pathway Flux to the three-way split: Product Yield, Cell Growth Rate (biomass), and Byproduct Accumulation. Identify Cofactor Availability as the hidden constraint.", "time": "8 min"},
        {"num": "Slide 7", "title": "Activity 3: Simulation", "visual": "Fermentation performance dashboards comparing three scenarios", "say": "Run scenario 2 first — maximum enzyme expression. Watch what happens. Then figure out why 'more enzyme' made things WORSE. Then design the fix.", "do": "Students predict, then simulate. The counter-intuitive result — maximum expression crashes growth and total production — drives the key insight about Metabolic Burden. Challenge them to find the optimal balance.", "time": "10 min"},
        {"num": "Slide 8", "title": "Discoveries", "visual": "Key metabolic engineering insights and industrial benchmark data", "say": "You just discovered the first law of metabolic engineering: the cell is not a beaker. It's a living system with its own agenda, and you have to negotiate with it, not dictate to it.", "do": "Connect findings to real industrial data. Show the gap between lab yields and commercial targets. Discuss what it takes to close that gap.", "time": "5 min"},
        {"num": "Slide 9", "title": "STEM Challenge", "visual": "Biofuel strain and process design challenge", "say": "A startup just gave your team $50 million. Design the strain, the pathway, and the fermentation process that makes jet fuel at $0.60 per liter. Can you compete with petroleum?", "do": "Groups design complete biofuel production systems: host organism selection, pathway engineering strategy, fermentation process, and economic analysis. Present and defend designs.", "time": "12 min"}
    ],
    "sort_reasoning": "Substrate Concentration is the primary external component because it represents the amount of carbon feedstock supplied to the fermentation — a process parameter fully under the engineer's control. All other eight components are internal: Enzyme Activity is partially controllable through genetic engineering but ultimately constrained by the cell's protein synthesis capacity and Metabolic Burden. Pathway Flux, Cofactor Availability, Cell Growth Rate, Product Yield, Byproduct Accumulation, and Fermentation Efficiency are emergent properties of the biological system responding to substrate input and genetic modifications.",
    "relationships": [
        ("Substrate Concentration to Pathway Flux", "POSITIVE (+)", "Higher substrate concentration provides more carbon molecules to enter the engineered pathway, increasing flux through the first enzymatic step up to the enzyme's saturation point."),
        ("Enzyme Activity to Pathway Flux", "POSITIVE (+)", "More active pathway enzymes process intermediates faster, increasing the overall flux of carbon through the pathway toward the desired biofuel product."),
        ("Enzyme Activity to Metabolic Burden", "POSITIVE (+)", "Higher enzyme expression diverts more cellular resources (ribosomes, amino acids, ATP) from growth to foreign protein production, increasing the fitness cost on the cell."),
        ("Metabolic Burden to Cell Growth Rate", "NEGATIVE (-)", "Greater metabolic burden slows cell division by depleting resources needed for DNA replication, membrane synthesis, and essential protein production."),
        ("Pathway Flux to Cofactor Availability", "NEGATIVE (-)", "Faster pathway flux consumes cofactors (NADH, NADPH, ATP) more rapidly, depleting intracellular pools and potentially stalling the pathway and other essential cellular processes."),
        ("Pathway Flux to Product Yield", "POSITIVE (+)", "Higher pathway flux directs more carbon atoms toward the desired biofuel product rather than allowing them to be diverted to competing metabolic routes or byproducts.")
    ],
    "sim_answers": [
        ("Baseline Fermentation Scenario", "With standard substrate and moderate enzyme expression, the engineered strain shows a workable but suboptimal balance. Pathway Flux is moderate — limited by the lowest-expressed enzyme (the bottleneck). Cofactor Availability remains adequate because the pathway isn't consuming cofactors faster than central metabolism regenerates them. Cell Growth Rate is near wild-type levels because Metabolic Burden is low. However, Product Yield is only 30-40% of theoretical maximum because significant carbon is diverted to Byproduct Accumulation (acetate, CO2) and biomass. Fermentation Efficiency is below commercial thresholds."),
        ("Balanced Optimization Scenario", "With tuned enzyme expression and cofactor engineering, the results are counter-intuitive: LOWER enzyme expression at certain steps can produce HIGHER total product. By reducing the expression of non-bottleneck enzymes, Metabolic Burden decreases significantly while Pathway Flux drops only marginally (because the bottleneck enzyme, not the reduced ones, was limiting flux). Cell Growth Rate recovers, producing more total biomass and therefore more total enzyme and more total product. Cofactor engineering (adding a heterologous NADH regeneration pathway) prevents cofactor depletion. The result: 60-75% of theoretical yield with adequate titer, approaching commercial viability.")
    ],
    "reflection_exemplars": [
        ("Why doesn't maximum enzyme expression produce maximum product yield?", "The model reveals that enzyme expression and product yield have a non-linear, non-monotonic relationship mediated by Metabolic Burden. At moderate expression levels, increasing enzyme activity increases Pathway Flux and Product Yield. But above a threshold, the cellular resources consumed by foreign protein production (Metabolic Burden) begin to crash Cell Growth Rate. Fewer cells, each growing slower and under metabolic stress, actually produce LESS total product than a moderately-expressing, healthy population. This is why metabolic engineers often use weak or tunable promoters rather than maximum-strength ones — the art is finding the expression sweet spot."),
        ("How does Cofactor Availability act as a hidden constraint?", "Cofactors like NADH and NADPH are required by many pathway enzymes but are present in limited intracellular pools. The model shows that when Pathway Flux is high, these cofactors are consumed faster than central metabolism regenerates them. The result is a metabolic traffic jam: enzymes have substrate available but cannot catalyze reactions without their required cofactor, so flux drops despite adequate enzyme levels. This is why cofactor engineering (adding heterologous cofactor regeneration pathways) is often more effective at increasing Product Yield than simply adding more pathway enzyme.")
    ],
    "stem_intro": "Present the challenge: A renewable energy startup needs your metabolic engineering team to design a microbial strain and process that produces drop-in jet fuel replacement at commercially competitive cost ($0.60/liter). Current petroleum-based jet fuel sets the price target. Your design must specify the host organism, pathway, fermentation strategy, and economic projections.",
    "stem_concepts": [
        ("Host Organism Selection", "Different chassis organisms offer different advantages: E. coli (fast growth, well-characterized genetics, limited solvent tolerance), S. cerevisiae (ethanol tolerance up to 15%, GRAS status, eukaryotic protein folding), Clostridium (natural butanol producer, anaerobic, difficult genetics), and cyanobacteria (photosynthetic — can use CO2 directly, but slow growth). The choice of host determines the engineering strategy and process constraints."),
        ("Dynamic Pathway Regulation", "Rather than expressing pathway enzymes at a constant level, dynamic regulation uses biosensors and genetic circuits to adjust expression based on the cell's metabolic state. For example: induce pathway enzymes only after cells reach high density (quorum sensing), reduce expression when cofactor pools drop below a threshold (metabolite-responsive promoters), or link production to essential metabolism so cells cannot grow without producing (growth-coupled design)."),
        ("Techno-Economic Analysis", "Commercial biofuel viability depends on three numbers: yield (determines substrate cost per unit product), titer (determines downstream processing cost — distillation and purification below 50 g/L is prohibitively expensive), and productivity (determines bioreactor capital cost per unit product). A complete techno-economic analysis also includes substrate sourcing, utility costs (steam, cooling, aeration), labor, and waste treatment.")
    ],
    "stem_eval": [
        ("Expert (4)", "Design includes justified host selection, balanced pathway with cofactor strategy, dynamic regulation plan, fermentation process design, techno-economic projections, and evidence from model simulations"),
        ("Proficient (3)", "Design includes host organism, pathway engineering approach, and fermentation strategy with reasoning connected to model trade-offs"),
        ("Developing (2)", "Design covers basic pathway engineering but lacks detail on cofactor balance, metabolic burden management, or economic feasibility"),
        ("Beginning (1)", "Design is incomplete or does not connect engineering decisions to the metabolic model's trade-offs")
    ],
    "support": [
        "Provide a visual metabolic map showing carbon flow from glucose through central metabolism to the biofuel product, with branch points and competing pathways highlighted",
        "Use a cofactor balance sheet template: 'Pathway step ___ consumes ___ NADH. Total NADH consumed per cycle: ___. NADH regenerated by central metabolism: ___. Balance: ___'",
        "Scaffold the growth-production trade-off: 'If 100 carbon atoms enter the cell, ___ go to biomass, ___ go to product, and ___ go to byproducts. To increase product, I need to redirect carbon FROM ___'"
    ],
    "extensions": [
        "Research how LanzaTech engineers bacteria to convert industrial waste gases (CO and CO2) directly into ethanol and jet fuel — how does gas fermentation differ from sugar fermentation?",
        "Investigate the concept of 'consolidated bioprocessing' (CBP) where a single organism both breaks down cellulose AND ferments the sugars — why is this the 'holy grail' of biofuel production?",
        "Compare the energy return on investment (EROI) of corn ethanol (1.3:1), cellulosic ethanol (5:1), petroleum (15:1), and solar electricity (10:1) — what does this tell you about the true sustainability of different energy sources?"
    ],
    "cross_curr": [
        ("Math", "Calculate theoretical maximum yield using stoichiometric equations: C6H12O6 to 2 C2H5OH + 2 CO2 gives 51% mass yield — then compare to actual fermentation yields and calculate the 'yield gap' as a percentage"),
        ("ELA", "Write an investor pitch for a biofuel startup that explains the metabolic engineering strategy in non-technical language while honestly addressing the yield-titer-productivity challenges"),
        ("Environmental Science", "Conduct a life cycle assessment comparing the greenhouse gas emissions of petroleum jet fuel versus microbial biofuel from three feedstocks: corn sugar, agricultural waste, and captured CO2")
    ],
    "misconceptions": [
        ("More enzyme expression always means more product", "This is the most common and most dangerous misconception in metabolic engineering. The model clearly demonstrates that increasing Enzyme Activity beyond a critical threshold DECREASES total product output because Metabolic Burden crashes Cell Growth Rate. Fewer, sicker cells produce less total product than a moderate number of healthy cells expressing enzymes at balanced levels. The relationship between enzyme expression and product yield is a curve with a peak — and the peak is almost never at maximum expression.", "Model it: Increase Enzyme Activity from moderate to maximum and watch Cell Growth Rate, total cell count, and cumulative Product Yield. The total yield curve rises, peaks, then falls — maximum enzyme is past the peak."),
        ("Biofuels are automatically carbon-neutral because they come from plants", "The carbon accounting for biofuels is far more complex than 'plants absorb CO2, we burn biofuel, CO2 goes back to plants.' A full life cycle analysis must include: fossil energy used to grow and harvest the feedstock (tractors, fertilizer from natural gas, irrigation), energy to transport biomass to the biorefinery, energy to pretreat and sterilize the feedstock, energy for fermentation (aeration, cooling, mixing), energy for product separation and purification, and land use change emissions (clearing forest for agriculture releases stored carbon). When all these are counted, corn ethanol reduces greenhouse gas emissions by only 20-40% compared to gasoline — far from carbon-neutral.", "Calculate: If making 1 gallon of biofuel requires 0.7 gallons-equivalent of fossil energy input, what's the net energy gain? What if we could reduce that fossil input to 0.3 gallons?"),
        ("We can just scale up the lab strain and it will work in a big fermenter", "Scale-up from a laboratory flask (milliliters) to an industrial bioreactor (hundreds of thousands of liters) changes almost everything about the microbial environment. Oxygen transfer becomes limited because bubbles can't reach all cells in a thick broth. Temperature gradients develop because heat from metabolism can't be removed fast enough. Mixing creates shear forces that damage cells. pH varies across the vessel. Contamination risk increases with longer fermentation times. And genetic instability means the production pathway mutates and degrades over hundreds of generations. The model's Fermentation Efficiency captures these scale-up losses, which typically reduce performance by 30-50% compared to laboratory results.", "Analogy: A recipe that works perfectly in your kitchen doesn't automatically scale to a restaurant serving 1,000 people. What changes when you multiply everything by 1,000?")
    ]
}

L08 = {
    "id": "G09L3-L08",
    "title": "Gene Regulatory Networks",
    "subtitle": "From Transcription Factor to Phenotype — Modeling the Logic of Gene Expression",
    "ngss": "HS-LS3-1, HS-LS1-4",
    "ngss_desc": "Ask questions to clarify relationships about the role of DNA and chromosomes in coding the instructions for characteristic traits passed from parents to offspring; use a model to illustrate the role of cellular division in producing and maintaining complex organisms.",
    "big_question": "Your body has 20,000 genes but every cell only uses a fraction of them. Who decides which genes turn on, which stay off, and when — and what happens when that decision-making system breaks?",
    "objectives": [
        "Build a gene regulatory network model that traces signal flow from transcription factor binding through mRNA production and protein synthesis to emergent cellular behavior",
        "Analyze how promoter binding affinity, transcription and translation rates, and degradation kinetics interact to determine steady-state protein levels",
        "Optimize regulatory network parameters to achieve desired gene expression patterns — including switches, oscillators, and dose-response curves",
        "Evaluate how disruptions in regulatory network components lead to disease states including cancer, developmental disorders, and autoimmune conditions"
    ],
    "vocabulary": [
        ("Transcription Factor", "A protein that binds to specific DNA sequences (promoter and enhancer regions) to increase or decrease the transcription rate of a target gene — the molecular decision-makers that control which genes are expressed in a given cell at a given time"),
        ("Promoter Binding Affinity", "The strength of the physical interaction between a transcription factor protein and its DNA binding site — measured by the dissociation constant (Kd), where lower Kd means tighter binding and stronger transcriptional activation or repression"),
        ("Feedback Loop", "A regulatory circuit where the output of a gene expression pathway feeds back to influence its own input — negative feedback creates stable, self-correcting systems while positive feedback creates bistable switches that lock cells into distinct states"),
        ("Epigenetic Modification", "Chemical modifications to DNA (methylation) or histone proteins (acetylation, methylation, phosphorylation) that alter gene expression without changing the DNA sequence — these modifications can be inherited through cell division and represent a layer of gene regulation above the genetic code")
    ],
    "components": [
        ("Transcription Factor Concentration", "The intracellular abundance of the regulatory protein that initiates the gene expression cascade — determined by the transcription factor's own production rate, degradation rate, and any upstream signals that regulate its activity", True),
        ("Promoter Binding Affinity", "The strength of the molecular interaction between the transcription factor and its target promoter DNA sequence — determined by the complementarity of protein-DNA surfaces, measured in nanomolar dissociation constant (Kd)", False),
        ("mRNA Transcription Rate", "The speed at which RNA polymerase synthesizes messenger RNA from the target gene template — dependent on Transcription Factor Concentration, Promoter Binding Affinity, and the availability of RNA polymerase and nucleotide precursors", False),
        ("mRNA Degradation Rate", "The speed at which cellular ribonucleases break down messenger RNA molecules — mRNA half-lives range from 2 minutes (bacteria) to hours (mammalian cells), and degradation rate is a critical determinant of steady-state mRNA levels", False),
        ("Ribosome Availability", "The fraction of the cell's ribosome pool that is free to translate the target mRNA — in rapidly growing cells, up to 80% of ribosomes may already be occupied translating other essential proteins, limiting translational capacity", False),
        ("Protein Translation Rate", "The speed at which ribosomes synthesize the target protein from the mRNA template — dependent on mRNA stability, Ribosome Availability, codon usage efficiency, amino acid supply, and translation initiation signal strength", False),
        ("Protein Degradation Rate", "The speed at which the target protein is broken down by cellular proteases (proteasome, autophagy) — protein half-lives range from minutes (cell cycle regulators) to days (structural proteins), and degradation is a key control point for rapid responses", False),
        ("Feedback Signal Strength", "The intensity of the regulatory signal sent from the protein product back to influence its own transcription — in negative feedback, the protein represses its own gene; in positive feedback, the protein activates its own gene, creating fundamentally different dynamic behaviors", False),
        ("Epigenetic Modification", "The degree of chromatin accessibility at the target gene locus — determined by DNA methylation, histone modifications, and chromatin remodeling enzyme activity, which set the baseline potential for gene activation regardless of transcription factor presence", True),
        ("Regulatory Network Stability", "The overall robustness of the gene expression output to perturbations in any individual component — a well-designed regulatory network maintains consistent output despite molecular noise, environmental fluctuations, and stochastic variation in component levels", False)
    ],
    "think_about_it": "Gene expression is not a simple on-off switch — it's a multi-layer cascade with degradation at every level. Even when Transcription Factor Concentration is high and Promoter Binding Affinity is strong, the resulting mRNA is constantly being destroyed by mRNA Degradation Rate. Any mRNA that survives must compete for limited Ribosome Availability to be translated into protein. The protein itself is constantly being degraded by Protein Degradation Rate. And the Feedback Signal Strength from the protein product loops back to change Transcription Factor Concentration or Promoter Binding Affinity — creating dynamic circuits that can oscillate, switch, or maintain precise steady states. Meanwhile, Epigenetic Modification acts as a master dimmer switch — if the chromatin is closed, nothing else matters. How does the cell maintain precise protein levels when every step is subject to production AND destruction simultaneously?",
    "scenarios": [
        ("Steady-State Gene Expression", "Set Transcription Factor Concentration to a stable moderate level with open chromatin — observe how the balance of production rates and degradation rates at every level determines the final steady-state protein output"),
        ("Positive Feedback Switch", "Increase Feedback Signal Strength in positive mode — observe how the network transitions from a graded response to a bistable switch that locks into either a high or low expression state"),
        ("Epigenetic Silencing", "Increase Epigenetic Modification to close the chromatin — observe how upstream Transcription Factor Concentration becomes irrelevant when the gene is physically inaccessible, mimicking developmental gene silencing")
    ],
    "sim_scenarios": [
        ("Steady-State Expression", "Moderate transcription factor, open chromatin, negative feedback", "What do you predict determines the final protein level — the production rates or the degradation rates?"),
        ("Positive Feedback Switch", "Strong positive autoregulation", "What do you predict happens when a protein activates its own gene — does expression stabilize at a higher level or does something more interesting happen?"),
        ("Epigenetic Silencing", "Closed chromatin, high transcription factor", "Do you predict that a high concentration of Transcription Factor can overcome epigenetic silencing of the target gene?")
    ],
    "discoveries": [
        "Steady-state protein levels are determined by the RATIO of production to degradation at every level — doubling transcription rate doubles mRNA only if mRNA Degradation Rate stays constant, and doubling mRNA doubles protein only if Ribosome Availability and Protein Degradation Rate remain unchanged",
        "Positive feedback loops create bistable switches — the network flips between two stable states (high expression and low expression) with a sharp threshold, explaining how genetically identical cells can adopt completely different fates during development",
        "Epigenetic modifications act as a master override — when chromatin is closed by DNA methylation or repressive histone marks, no amount of Transcription Factor Concentration can activate the gene, explaining why a liver cell and a neuron have identical DNA but completely different gene expression profiles",
        "Negative feedback loops create stability and noise reduction — the protein represses its own gene, creating a self-correcting circuit that maintains consistent output despite random fluctuations in any individual component"
    ],
    "answer": "Your genome is not a simple blueprint — it's a dynamic regulatory network where 20,000 genes are controlled by thousands of transcription factors, each binding to specific promoter sequences with specific affinities, producing mRNA that is simultaneously being synthesized and degraded, translated by ribosomes that are a limited shared resource, producing proteins that are themselves being actively destroyed — and many of these proteins feed back to regulate their own genes and others. The ten components of this model capture the core logic: Transcription Factor Concentration and Promoter Binding Affinity determine how fast mRNA is made, mRNA and Protein Degradation Rates determine how fast molecules are destroyed, the balance creates steady-state levels, Feedback Signal Strength creates dynamic circuits (switches, oscillators, homeostats), and Epigenetic Modification sets the master accessibility of the entire locus. When this regulatory logic breaks — a transcription factor mutates, a feedback loop is disrupted, an epigenetic mark is lost — the consequence is disease: uncontrolled cell division (cancer), failed cell differentiation (developmental disorders), or misdirected immune responses (autoimmunity).",
    "stem_title": "Design a Synthetic Gene Circuit for Biosensing",
    "stem_mission": "Design a synthetic gene regulatory circuit that detects an environmental signal (toxin, pathogen, pollutant) and produces a visible output (fluorescent protein, color change, electronic signal) for use as a living biosensor.",
    "stem_scenario": "A water quality monitoring agency needs a low-cost, deployable biosensor that can detect heavy metal contamination (lead, arsenic, mercury) in drinking water supplies across rural communities where laboratory testing is unavailable. Your synthetic biology team must design a gene regulatory circuit that senses the presence of heavy metals and produces a visible fluorescent signal proportional to contamination level. The biosensor must be sensitive, specific, and stable.",
    "stem_questions": [
        "What natural metal-responsive transcription factor would you use as your sensor element, and what Promoter Binding Affinity characteristics would you need?",
        "How would you engineer the circuit to produce a signal proportional to contamination level rather than a simple on/off response?",
        "What Feedback Signal Strength and type (positive or negative) would you include to improve sensitivity and reduce noise?"
    ],
    "stem_design_qs": [
        "How would you ensure the biosensor remains functional in variable environmental conditions (temperature, pH, salinity)?",
        "What output signal would be most practical for field deployment — fluorescence, color change, or electronic signal — and why?",
        "How would you calibrate the biosensor so that fluorescence intensity can be converted to a quantitative contamination reading?",
        "What biocontainment strategy would you use to prevent the engineered bacteria from escaping into the water supply being tested?"
    ],
    "career": "Systems Biologists and Synthetic Biologists design and analyze gene regulatory networks for applications in medicine, biosensing, and biomanufacturing. They work for biotech companies (Ginkgo Bioworks, Twist Bioscience), pharmaceutical companies, academic research labs, and government agencies, earning $85,000-$180,000/year. Bioinformaticians who computationally model gene regulatory networks earn $80,000-$160,000/year.",
    "images": {
        "cover": ("G09L3-L08-cover.png", "A photorealistic, cinematic image of diverse 14-15 year old students in an advanced molecular biology lab examining gene regulatory network diagrams on holographic displays, with fluorescent-labeled gene expression experiments visible under UV illumination, dramatic blue and violet laboratory lighting"),
        "landscape": ("G09L3-L08-landscape.png", "A diverse group of 14-15 year old students in a modern genomics lab analyzing gene expression data on multiple monitors showing network graphs and expression heatmaps, with DNA and chromatin models visible on desks"),
        "modeling": ("G09L3-L08-modeling.png", "A diverse group of 14-15 year old students building gene regulatory network models on laptops showing circuit diagrams with arrows representing activation and repression, whiteboards with differential equations and feedback loop diagrams"),
        "discussion": ("G09L3-L08-discussion.png", "A teacher leading a sophisticated discussion with diverse 14-15 year old students about gene regulation and feedback loops, a gene regulatory network diagram with positive and negative feedback arrows displayed on a smartboard"),
        "stem": ("G09L3-L08-stem.png", "Diverse 14-15 year old students presenting synthetic gene circuit designs with logic gate diagrams, dose-response curves, and biosensor schematics on large displays, professional synthetic biology presentation setting")
    },
    "pre_assessment": [
        "If every cell in your body has the same DNA, why is a brain cell so different from a skin cell?",
        "What do you think controls which genes are turned on or off in a particular cell at a particular time?",
        "Draw a diagram showing how you think a cell 'reads' a gene and makes the protein it codes for — include as many steps as you can.",
        "What do you think happens when a gene that should be turned off gets stuck in the 'on' position?"
    ],
    "extend_components": [
        ("MicroRNA Regulation", "Small non-coding RNA molecules (18-25 nucleotides) that bind to complementary sequences in mRNA and either block translation or trigger mRNA degradation — adding a powerful post-transcriptional layer of gene regulation that affects over 60% of human genes"),
        ("Chromatin Remodeling Activity", "The activity of ATP-dependent chromatin remodeling complexes (SWI/SNF, ISWI, CHD, INO80) that physically reposition nucleosomes to expose or hide gene promoters — the molecular machines that execute epigenetic decisions about gene accessibility"),
        ("Stochastic Noise Level", "The inherent randomness in gene expression caused by the probabilistic nature of molecular interactions — when key regulatory molecules are present in low copy numbers (10-100 per cell), random fluctuations can cause genetically identical cells to express genes at dramatically different levels")
    ],
    "reflections": [
        "How does your model demonstrate that gene expression is not a simple on-off switch but a dynamic balance of production and degradation at every level?",
        "What is the functional difference between negative feedback and positive feedback in gene regulatory circuits — and what happens to Regulatory Network Stability in each case?",
        "Why does Epigenetic Modification act as a master override that can silence a gene regardless of Transcription Factor Concentration?",
        "How would adding Stochastic Noise Level to your model change predictions about cell-to-cell variation in gene expression?",
        "What are the medical implications when gene regulatory networks malfunction — and how does your model help explain diseases like cancer?"
    ],
    "dimensions": [
        ("Science Practice", "Developing and Using Models / Asking Questions and Defining Problems", "Students develop a multi-scale gene regulatory model that connects molecular interactions (transcription factor-DNA binding) to cellular outcomes (protein levels, cell fate), asking questions about how regulatory logic creates emergent biological behavior."),
        ("Disciplinary Core Idea", "LS3.A Inheritance of Traits / LS1.A Structure and Function", "DNA contains instructions for protein production regulated by transcription factors and epigenetic modifications; cellular function emerges from the coordinated expression of gene regulatory networks."),
        ("Crosscutting Concept", "Cause and Effect / Systems and System Models", "Students trace causal chains from transcription factor binding through mRNA and protein dynamics to cellular phenotype, analyzing the gene regulatory network as a complex system with emergent properties including switches, oscillators, and stability.")
    ],
    "cast_items": [
        "Model the multi-step cascade from transcription factor binding through mRNA production, translation, and protein degradation to final steady-state protein levels",
        "Analyze how positive and negative feedback loops create fundamentally different regulatory behaviors — bistable switches versus homeostatic stability",
        "Evaluate how epigenetic modifications override transcriptional regulation to create and maintain cell identity during development"
    ],
    "cast_questions": [
        ("Multiple Choice:", "A mutation increases the mRNA Degradation Rate of a tumor suppressor gene by 5-fold while leaving Transcription Rate unchanged. Based on your model, what is the most likely consequence for steady-state protein level and cell behavior?"),
        ("Constructed Response:", "Using your gene regulatory network model, explain how two genetically identical cells can have completely different gene expression profiles and become different cell types. Reference at least three model components — including Epigenetic Modification and Feedback Signal Strength — in your explanation.")
    ],
    "background_intro": "This lesson introduces students to gene regulatory networks — the molecular logic circuits that control which genes are expressed in every cell. Biotech skill focus: Network dynamics and feedback circuit analysis. Understanding gene regulation is fundamental to both basic biology (how does a fertilized egg become a complete organism?) and biotechnology (how do we engineer cells to produce desired proteins or behaviors?).",
    "background_sections": [
        ("The Central Dogma and Its Regulation", "The flow of genetic information from DNA to RNA to protein — the central dogma of molecular biology — is regulated at every step. Transcriptional regulation (which genes are copied into mRNA) is controlled by transcription factors that bind to promoter and enhancer regions of DNA, either recruiting or blocking RNA polymerase. Post-transcriptional regulation controls mRNA processing (splicing, capping, polyadenylation), mRNA stability (degradation by ribonucleases and microRNAs), and mRNA localization. Translational regulation controls how efficiently ribosomes convert mRNA into protein, influenced by initiation factor availability, codon usage, and ribosome density. Post-translational regulation controls protein folding, modification (phosphorylation, ubiquitination, glycosylation), localization, and degradation. Each regulatory layer adds complexity but also adds control points that the cell — or the engineer — can exploit."),
        ("Feedback Loops: The Logic of Biological Circuits", "Gene regulatory networks use feedback loops to create sophisticated dynamic behaviors from simple molecular interactions. Negative feedback occurs when a gene's protein product represses its own transcription — this creates a self-correcting homeostatic circuit that maintains stable protein levels despite perturbations. If protein level rises above the setpoint, increased repression reduces transcription; if it falls below, reduced repression increases transcription. Positive feedback occurs when a gene's protein product activates its own transcription — this creates a bistable switch with two stable states (high expression or low expression) and a sharp threshold for switching between them. Positive feedback is how cells make irreversible fate decisions during development: once a master regulator crosses the threshold and activates its own gene, the cell locks into a new identity. Combined negative and positive feedback creates oscillators — circuits that rhythmically pulse gene expression, underlying circadian clocks, cell cycle progression, and somite segmentation in embryonic development."),
        ("Epigenetic Regulation: Above the Genome", "Epigenetic modifications add a layer of gene regulation that operates above the DNA sequence level — modifying gene accessibility without changing the genetic code. DNA methylation adds methyl groups to cytosine bases in CpG dinucleotides, which recruits repressive protein complexes that condense chromatin and silence gene expression. Histone modifications — acetylation (generally activating), methylation (activating or repressing depending on position), phosphorylation, and ubiquitination — alter the physical structure of chromatin, determining whether DNA is accessible to transcription factors and RNA polymerase. These modifications are maintained through cell division by dedicated maintenance enzymes, allowing a liver cell and a neuron to maintain their distinct gene expression profiles through hundreds of cell divisions despite having identical DNA. Epigenetic dysregulation is increasingly recognized as a driver of cancer (global hypomethylation and focal hypermethylation of tumor suppressor genes), aging, and developmental disorders."),
        ("Gene Regulatory Networks and Disease", "Many diseases result from disruptions in gene regulatory networks rather than mutations in the protein-coding genes themselves. Cancer frequently involves mutations in transcription factors (p53, MYC, RB) that disrupt the regulatory circuits controlling cell division — a single mutation in the p53 gene disrupts the network that senses DNA damage, arrests the cell cycle, and triggers apoptosis, removing a critical safety brake on cell proliferation. Developmental disorders like holoprosencephaly result from mutations in the Sonic Hedgehog (SHH) signaling pathway's regulatory elements — the gene itself is intact, but the regulatory network that controls where and when it's expressed is disrupted. Autoimmune diseases involve dysregulation of the transcription factor FOXP3, which controls regulatory T-cell differentiation — without proper FOXP3 expression, the immune system attacks the body's own tissues. Understanding gene regulatory network architecture is therefore essential for understanding disease mechanisms and designing therapeutic interventions.")
    ],
    "lever_L": "Students identify ten components spanning signal input (Transcription Factor Concentration), molecular interaction (Promoter Binding Affinity), mRNA dynamics (Transcription Rate, Degradation Rate), translation dynamics (Ribosome Availability, Translation Rate), protein dynamics (Degradation Rate), regulatory feedback (Feedback Signal Strength), epigenetic context (Epigenetic Modification), and system-level outcome (Regulatory Network Stability).",
    "lever_E": "Students determine that Transcription Factor Concentration and Epigenetic Modification are the primary external/upstream inputs — one representing the signal and the other representing chromatin accessibility — while all other components emerge as dynamic responses to these inputs and to each other through production-degradation balances and feedback loops.",
    "lever_V": "Students build a gene regulatory network model connecting signal input through the transcription-translation cascade to protein output, with feedback loops that create dynamic behaviors (steady state, switching, or oscillation) depending on circuit architecture.",
    "lever_Ev": "Students run steady-state, positive-feedback-switch, and epigenetic-silencing scenarios to discover how the same molecular components create fundamentally different behaviors depending on feedback structure and chromatin state.",
    "lever_R": "Students add MicroRNA Regulation, Chromatin Remodeling Activity, or Stochastic Noise Level to explore post-transcriptional regulation, chromatin dynamics, and the role of molecular noise in cell fate decisions.",
    "slides_guide": [
        {"num": "Slide 1", "title": "Cover", "visual": "Title slide with dramatic visualization of a gene regulatory network — nodes and edges with activation/repression arrows", "say": "You have 20,000 genes. A brain cell uses about 8,000 of them. A skin cell uses a different 8,000. Same DNA, completely different cells. Who decides?", "do": "Display an image comparing cell types from the same organism. Ask: If they have the same DNA, why are they different? What controls which genes are active?", "time": "2 min"},
        {"num": "Slide 2", "title": "Learning Objectives", "visual": "Learning goals with gene regulation vocabulary", "say": "Today you're building the control system that runs every cell in your body. Transcription factors are the decision-makers, feedback loops are the logic circuits, and epigenetics is the master switch.", "do": "Pre-teach transcription factor and feedback loop. Use the analogy: a transcription factor is like a key for a specific lock on a gene — no key, gene stays closed.", "time": "3 min"},
        {"num": "Slide 3", "title": "Big Question", "visual": "How does the same genome produce 200+ different cell types?", "say": "Here's the paradox: your liver cells and neurons have identical DNA. But a liver cell makes albumin and a neuron makes dopamine. Something BESIDES DNA is deciding which genes to use. What is it?", "do": "Think-pair-share: Students brainstorm mechanisms that could make the same DNA produce different cell types. Collect ideas — they'll verify these against the model.", "time": "3 min"},
        {"num": "Slide 4", "title": "LEVER Framework", "visual": "LEVER steps with gene regulation context", "say": "We're modeling the entire pipeline from a regulatory signal arriving at a gene to the final protein product — and the feedback loops that make this pipeline intelligent.", "do": "Preview LEVER steps. Emphasize that gene expression is not a one-way street — the output feeds back to change the input, creating circuits with logic.", "time": "2 min"},
        {"num": "Slide 5", "title": "Activity 1: Components", "visual": "Ten component cards spanning signal, transcription, translation, degradation, feedback, and epigenetic levels", "say": "Ten components. Two are upstream inputs that set the stage. Eight are dynamic responses. But here's the twist — some of those responses loop BACK to become inputs through feedback.", "do": "Guide sorting of external (Transcription Factor Concentration, Epigenetic Modification) versus internal components. Discuss how Feedback Signal Strength blurs the line between input and output.", "time": "8 min"},
        {"num": "Slide 6", "title": "Activity 2: Connections", "visual": "Gene expression cascade diagram with production and degradation arrows at every level, plus feedback loops", "say": "At every level — mRNA and protein — there's a race between production and destruction. Steady-state levels depend on the ratio. And the feedback loops make this cascade self-aware.", "do": "Students trace the cascade: TF binds promoter, mRNA is made AND destroyed, surviving mRNA is translated AND protein is destroyed, protein feeds back. Map positive versus negative feedback consequences.", "time": "8 min"},
        {"num": "Slide 7", "title": "Activity 3: Simulation", "visual": "Gene expression dynamics showing steady state, bistable switching, and epigenetic silencing", "say": "Run all three scenarios. In scenario 1, the gene reaches a stable level. In scenario 2, it switches to an entirely different behavior — same components, different circuit architecture. In scenario 3, nothing works at all. Why?", "do": "Students predict, then simulate each scenario. The positive feedback switch is the key discovery — understanding how the same parts create qualitatively different behaviors depending on circuit wiring.", "time": "10 min"},
        {"num": "Slide 8", "title": "Discoveries", "visual": "Key regulatory network insights with medical implications", "say": "You just modeled the logic that controls every cell in your body. When this logic breaks — when a feedback loop fails or an epigenetic mark is lost — the result is disease. Cancer, developmental disorders, autoimmunity — they're all regulatory network failures.", "do": "Connect each scenario to a disease mechanism. Positive feedback stuck ON = cancer (constitutively active oncogene). Epigenetic silencing of tumor suppressor = cancer. Feedback loop disrupted = autoimmune disease.", "time": "5 min"},
        {"num": "Slide 9", "title": "STEM Challenge", "visual": "Synthetic gene circuit biosensor design challenge", "say": "A water agency needs a cheap biosensor for lead contamination. Design a living gene circuit — using the regulatory components you just modeled — that detects lead in water and glows green. This is real synthetic biology.", "do": "Groups design synthetic gene circuits: sensor element (metal-responsive TF), circuit logic (feedback for sensitivity), output (fluorescent protein), and calibration strategy. Present designs.", "time": "12 min"}
    ],
    "sort_reasoning": "Transcription Factor Concentration and Epigenetic Modification are the two external/upstream components. Transcription Factor Concentration represents the regulatory signal arriving at the gene — determined by upstream signaling pathways, cellular environment, and developmental context, not by the target gene itself. Epigenetic Modification represents the chromatin accessibility state of the target locus, established during development and cell differentiation. All other eight components are internal: Promoter Binding Affinity, mRNA Transcription Rate, mRNA Degradation Rate, Ribosome Availability, Protein Translation Rate, Protein Degradation Rate, Feedback Signal Strength, and Regulatory Network Stability emerge from the molecular interactions between components.",
    "relationships": [
        ("Transcription Factor Concentration to mRNA Transcription Rate", "POSITIVE (+)", "Higher Transcription Factor Concentration increases the probability of promoter occupancy, recruiting more RNA polymerase molecules to the gene and increasing the rate of mRNA synthesis."),
        ("Promoter Binding Affinity to mRNA Transcription Rate", "POSITIVE (+)", "Stronger Promoter Binding Affinity means each transcription factor molecule stays bound longer and recruits RNA polymerase more effectively, amplifying the transcriptional response at any given transcription factor concentration."),
        ("mRNA Degradation Rate to Protein Translation Rate", "NEGATIVE (-)", "Faster mRNA degradation reduces the steady-state pool of translatable mRNA molecules, meaning fewer templates are available for ribosomes to produce protein, reducing the overall translation output."),
        ("Ribosome Availability to Protein Translation Rate", "POSITIVE (+)", "More available ribosomes means more mRNA molecules can be simultaneously translated, increasing the rate of protein production from the available mRNA pool."),
        ("Protein Degradation Rate to Feedback Signal Strength", "NEGATIVE (-)", "Faster protein degradation reduces the steady-state protein pool available to generate feedback signals, weakening the feedback loop and reducing the circuit's ability to self-regulate."),
        ("Epigenetic Modification to mRNA Transcription Rate", "NEGATIVE (-) when silencing", "Repressive epigenetic marks (DNA methylation, H3K27 trimethylation) compact chromatin structure and block transcription factor access to the promoter, reducing mRNA Transcription Rate to near zero regardless of Transcription Factor Concentration.")
    ],
    "sim_answers": [
        ("Steady-State Expression Scenario", "With moderate Transcription Factor Concentration, open chromatin (low repressive Epigenetic Modification), and negative Feedback Signal Strength, the gene expression cascade reaches a predictable steady state. mRNA Transcription Rate produces mRNA at a constant rate; mRNA Degradation Rate destroys it at a proportional rate; the balance determines steady-state mRNA level. Similarly, Protein Translation Rate produces protein while Protein Degradation Rate removes it. The negative feedback loop stabilizes the system: if protein rises above the setpoint, it represses its own transcription, reducing mRNA production and bringing protein back down. The result is remarkably stable protein output despite fluctuations in individual components."),
        ("Epigenetic Silencing Scenario", "When Epigenetic Modification is set to repressive (closed chromatin), the result is dramatic: mRNA Transcription Rate drops to near-zero regardless of Transcription Factor Concentration. Even with high TF levels and strong Promoter Binding Affinity, the gene is physically inaccessible because nucleosomes block the promoter and DNA methylation prevents TF binding. Existing mRNA and protein are degraded without replacement, and steady-state levels approach zero. This demonstrates why Epigenetic Modification acts as a master override — it controls gene accessibility at a level above transcription factor regulation, explaining how cell identity is maintained through division.")
    ],
    "reflection_exemplars": [
        ("How does the production-degradation balance determine steady-state levels?", "The model reveals a fundamental principle: steady-state molecule levels are determined not by production alone, but by the RATIO of production to degradation. Doubling mRNA Transcription Rate doubles steady-state mRNA only if mRNA Degradation Rate is unchanged. If the cell simultaneously increases mRNA Degradation Rate (which often happens as a compensatory response), the steady-state mRNA level may not change at all. This is why cells can respond quickly to signals — they don't need to 'turn off' mRNA production; they simply increase degradation rate. It also explains why protein half-lives matter so much: a protein with a 2-minute half-life can be eliminated 50x faster than one with a 2-hour half-life, enabling rapid regulatory responses."),
        ("What makes positive feedback create a bistable switch?", "Positive feedback creates bistability because the protein product activates its own transcription, creating a self-reinforcing loop. Below a critical threshold of Transcription Factor Concentration, the positive feedback is too weak to sustain itself and expression remains low. Above the threshold, positive feedback amplifies expression rapidly until it saturates at a high stable state. Between these states, the system is unstable — it must commit to one or the other. This creates a binary decision: ON or OFF, with a sharp transition. This is exactly how cells make irreversible fate decisions during development — once a master regulator crosses the threshold and activates its own expression, the cell locks into its new identity permanently.")
    ],
    "stem_intro": "Present the challenge: A water quality monitoring agency needs a low-cost, deployable living biosensor that detects heavy metal contamination in drinking water. Your synthetic biology team will design a gene regulatory circuit that senses lead or arsenic in water and produces a fluorescent signal proportional to contamination level — using the exact regulatory components you modeled in class.",
    "stem_concepts": [
        ("Biosensor Circuit Design", "A living biosensor has three modules: (1) Sensor — a metal-responsive transcription factor (like PbrR for lead or ArsR for arsenic) that changes conformation when it binds the target metal, altering its DNA-binding properties; (2) Processor — the regulatory circuit that converts the sensor signal into an amplified, dose-proportional output, potentially using feedback loops to improve sensitivity; (3) Reporter — the output gene (GFP, luciferase, or a chromogenic enzyme like LacZ) whose expression level is proportional to metal concentration."),
        ("Signal Amplification and Noise Filtering", "Raw biosensor signals are weak and noisy because transcription factor-metal binding is stochastic at low concentrations. Positive feedback can amplify weak signals but also amplifies noise. Negative feedback reduces noise but also reduces sensitivity. The optimal circuit uses a combination: positive feedback for signal amplification with a downstream negative feedback filter to suppress false positives. This is a fundamental engineering trade-off between sensitivity and specificity."),
        ("Calibration and Quantitation", "For a biosensor to be useful, fluorescence intensity must map to a specific metal concentration. This requires: a dose-response calibration curve (fluorescence vs. metal concentration), knowledge of the circuit's dynamic range (minimum and maximum detectable concentrations), understanding of environmental interferences (pH, temperature, other metals that might cross-react), and a standardized measurement protocol that accounts for cell number, growth phase, and measurement timing.")
    ],
    "stem_eval": [
        ("Expert (4)", "Circuit design includes justified sensor element, signal processing logic with feedback architecture, output reporter, calibration strategy, biocontainment plan, and analysis of sensitivity-specificity trade-offs supported by model predictions"),
        ("Proficient (3)", "Circuit design includes sensor, processor, and reporter modules with reasoning connected to regulatory network model principles"),
        ("Developing (2)", "Circuit design covers basic sensor-reporter connection but lacks signal processing logic, calibration strategy, or analysis of noise and specificity"),
        ("Beginning (1)", "Circuit design is incomplete or does not connect to gene regulatory network principles from the model")
    ],
    "support": [
        "Provide a visual template showing the three biosensor modules (Sensor, Processor, Reporter) with empty boxes for students to fill in component choices and connections",
        "Use a simplified feedback diagram: 'Signal IN -> [Sensor TF] -> [Promoter] -> [mRNA] -> [Protein/Reporter] -> Signal OUT. Where would you add feedback? What kind? Why?'",
        "Scaffold dose-response thinking: 'At 0 ppb lead, the sensor produces ___. At 15 ppb (EPA action level), the sensor produces ___. At 100 ppb, the sensor produces ___. Is this response linear, switch-like, or something else?'"
    ],
    "extensions": [
        "Research the iGEM (International Genetically Engineered Machine) competition — find a team that built a biosensor and analyze their gene regulatory circuit design using the components from your model",
        "Investigate how CRISPR-based gene regulatory tools (CRISPRi and CRISPRa) allow programmable activation or repression of any gene — how does this change the design space for synthetic gene circuits?",
        "Compare the gene regulatory networks controlling pluripotency in stem cells (OCT4, SOX2, NANOG) with the networks controlling differentiation — what circuit architecture keeps stem cells in their undifferentiated state?"
    ],
    "cross_curr": [
        ("Math", "Model the steady-state mRNA concentration using the equation [mRNA]ss = Transcription Rate / Degradation Rate, then calculate how changing each parameter by 2-fold affects the steady state — verify predictions with the simulation"),
        ("ELA", "Write a patient-accessible explanation of how a gene regulatory network malfunction leads to cancer — specifically, how a mutation in the p53 transcription factor disables the DNA damage feedback loop, using language a high school student's parent would understand"),
        ("Computer Science", "Compare gene regulatory network logic (AND gates, OR gates, NOT gates, feedback loops) to digital electronic circuit logic — are biological circuits fundamentally similar to computer circuits, or fundamentally different?")
    ],
    "misconceptions": [
        ("Genes are either 'on' or 'off' like a light switch", "While some gene regulatory circuits DO behave as switches (positive feedback bistable systems), most gene expression is graded — genes can be expressed at any level from barely detectable to maximum capacity. The model demonstrates that steady-state expression is determined by the balance of production and degradation rates at every level, producing a continuous range of output levels. Even 'switch-like' genes have intermediate states during transitions. The light switch analogy is especially misleading because it implies gene regulation is simple — in reality, a single gene can be regulated by dozens of transcription factors, each binding with different affinity, creating a complex dose-response landscape.", "Model it: Gradually increase Transcription Factor Concentration from zero to maximum and graph the protein output. Is the response a step function (switch) or a graded curve? Now add positive feedback and repeat — how does the curve change?"),
        ("DNA methylation permanently silences genes forever", "While DNA methylation is relatively stable and heritable through cell division, it is NOT permanent or irreversible. Cells express TET enzymes (TET1, TET2, TET3) that actively demethylate DNA, and passive demethylation occurs when maintenance methyltransferases fail to copy methylation patterns during DNA replication. During embryonic development, there are two waves of global demethylation (in the early embryo and in primordial germ cells) where most methylation marks are erased and re-established. In cancer, aberrant demethylation of silenced oncogenes and aberrant methylation of active tumor suppressors both contribute to disease. Epigenetic therapy drugs (5-azacytidine, decitabine) work by blocking DNA methyltransferases, demonstrating that methylation is reversible.", "Ask: If DNA methylation were truly permanent, how would a fertilized egg (one cell type with one methylation pattern) give rise to 200+ cell types, each with different methylation patterns?"),
        ("More transcription factor always means more gene expression", "The relationship between Transcription Factor Concentration and gene expression is NOT linear — it follows a sigmoidal (S-shaped) saturation curve. At low TF concentrations, promoter occupancy is minimal and expression is low. At intermediate concentrations, small changes in TF produce large changes in expression (the sensitive range). At high concentrations, the promoter is fully occupied and adding more TF has no effect (saturation). Furthermore, if Epigenetic Modification has closed the chromatin, no amount of TF will activate the gene. And in circuits with negative feedback, increasing TF concentration is partially counteracted by the feedback loop, producing a smaller net increase in expression than expected.", "Experiment: In the simulation, increase Transcription Factor Concentration from 10% to 90% and record the protein output at each step. Plot the data — is the relationship linear, logarithmic, or sigmoidal? Where is the steepest part of the curve?")
    ]
}

L09 = {
    "id": "G09L3-L09",
    "title": "Vaccine Design Optimization",
    "subtitle": "Modeling Immune Response Engineering from Antigen Selection to Population-Level Protection",
    "ngss": "HS-LS1-4, HS-LS4-2",
    "ngss_desc": "Use a model to illustrate the role of cellular division in producing and maintaining complex organisms; construct an explanation based on evidence that the process of evolution primarily results from four factors.",
    "big_question": "COVID-19 vaccines were developed in under a year — a process that usually takes 10-15 years. How do computational models of the immune system make it possible to design vaccines faster, and can we design a universal vaccine that works against a virus that keeps mutating?",
    "objectives": [
        "Build an immune response model that traces the cascade from antigen presentation through immune cell activation to antibody production, memory formation, and population-level protection",
        "Analyze how antigen selection, adjuvant strength, and pathogen mutation rate interact to determine vaccine effectiveness and duration of immunity",
        "Optimize vaccine design parameters to maximize population coverage while accounting for viral evolution and immune diversity",
        "Evaluate the trade-offs between vaccine specificity (targeting one strain precisely) and cross-reactivity (providing broader but weaker protection against multiple variants)"
    ],
    "vocabulary": [
        ("Antigen", "A molecular structure (protein, glycoprotein, or polysaccharide) from a pathogen that the immune system recognizes as foreign — vaccine antigens are carefully selected pieces of the pathogen that trigger a protective immune response without causing disease"),
        ("Adjuvant", "A substance added to a vaccine to enhance the immune response to the antigen — adjuvants activate innate immune cells, increase antigen presentation, and promote stronger adaptive immunity, allowing lower antigen doses to achieve protective immunity"),
        ("Immunological Memory", "The ability of the adaptive immune system to 'remember' a pathogen it has previously encountered — mediated by long-lived memory B cells and memory T cells that mount a faster, stronger response upon re-exposure, providing lasting protection"),
        ("Antigenic Drift", "The gradual accumulation of mutations in pathogen surface proteins (especially in RNA viruses like influenza and SARS-CoV-2) that allows the pathogen to partially evade existing immune responses — the primary reason seasonal flu vaccines must be redesigned annually")
    ],
    "components": [
        ("Antigen Selection", "The choice of which pathogen molecular target to include in the vaccine — ideally a surface protein that is essential for pathogen function (so it cannot easily mutate away), highly immunogenic (triggers strong immune responses), and conserved across variants (so immunity is broadly protective)", True),
        ("Adjuvant Strength", "The potency of the immune-stimulating compound included in the vaccine formulation — stronger adjuvants produce more robust immune responses but also increase the risk of inflammation and side effects (reactogenicity)", True),
        ("Immune Cell Activation", "The degree to which innate immune cells (dendritic cells, macrophages) process and present the vaccine antigen to adaptive immune cells (T cells, B cells) — the critical bridge between innate recognition and adaptive immunity", False),
        ("Antibody Production Rate", "The speed and magnitude of antibody secretion by activated B cells (plasma cells) — determines how quickly protective antibody levels are reached after vaccination and the peak antibody titer achieved", False),
        ("Memory Cell Formation", "The differentiation of activated B cells and T cells into long-lived memory cells that persist for years to decades — the key determinant of how long vaccine-induced immunity lasts", False),
        ("Pathogen Mutation Rate", "The speed at which the target pathogen accumulates mutations in its surface proteins — RNA viruses mutate 100-1000x faster than DNA viruses, creating new variants that may escape vaccine-induced immunity", True),
        ("Cross-Reactivity", "The degree to which antibodies generated against the vaccine antigen also recognize and neutralize variant strains of the pathogen — broader cross-reactivity provides protection against future variants but typically with lower potency per variant", False),
        ("Duration of Immunity", "The length of time that vaccine-induced protection remains above the threshold needed to prevent infection or severe disease — determined by memory cell longevity, antibody half-life, and the rate of pathogen antigenic drift", False),
        ("Population Coverage", "The fraction of a genetically diverse population that achieves protective immunity from the vaccine — influenced by human genetic variation in immune response genes (HLA diversity), age-related immune differences, and immunocompromised individuals", False)
    ],
    "think_about_it": "Vaccine design is a multi-dimensional optimization problem with no perfect solution. You want high Antibody Production Rate, but if Adjuvant Strength is too high, the side effects become unacceptable and people refuse the vaccine. You want strong Memory Cell Formation for long Duration of Immunity, but Pathogen Mutation Rate can outrun even robust memory responses — look at influenza, which requires a new vaccine every year. You want maximum Cross-Reactivity to cover all variants, but broader Cross-Reactivity usually means weaker response to any specific variant. And Population Coverage varies because of human genetic diversity in immune system genes (HLA types). How do you design a vaccine that balances all of these competing constraints — especially against a pathogen that is actively evolving to escape your vaccine?",
    "scenarios": [
        ("Strain-Specific Vaccine", "Select a highly specific antigen targeting the dominant circulating strain with moderate adjuvant — observe high Antibody Production Rate but limited Cross-Reactivity against emerging variants"),
        ("Broadly Protective Vaccine", "Select a conserved antigen region shared across multiple variants with strong adjuvant — observe how Cross-Reactivity increases but Antibody Production Rate against any single variant decreases"),
        ("High-Mutation Pathogen Challenge", "Set Pathogen Mutation Rate to maximum (RNA virus level) — observe how quickly Duration of Immunity erodes as new variants escape the vaccine-induced immune response")
    ],
    "sim_scenarios": [
        ("Strain-Specific", "Dominant strain antigen, moderate adjuvant", "What do you predict happens to vaccine effectiveness when a new variant emerges with mutations in the target antigen?"),
        ("Broadly Protective", "Conserved region antigen, strong adjuvant", "Do you predict that targeting a conserved region provides better long-term protection despite lower peak antibody levels?"),
        ("High-Mutation Challenge", "Fast-mutating pathogen, any vaccine design", "How quickly do you predict the pathogen will evolve to escape vaccine-induced immunity at maximum Pathogen Mutation Rate?")
    ],
    "discoveries": [
        "There is a fundamental trade-off between vaccine specificity and breadth — vaccines targeting strain-specific epitopes generate stronger antibody responses but are vulnerable to antigenic drift, while vaccines targeting conserved regions are more durable but less potent",
        "Adjuvant strength has diminishing returns — moderate adjuvant produces significantly better immune responses than no adjuvant, but very strong adjuvant increases side effects faster than it increases protection, reducing real-world uptake and Population Coverage",
        "Memory Cell Formation is the most critical component for long-term protection — even when circulating antibodies wane, robust immunological memory enables rapid recall responses that prevent severe disease upon re-exposure",
        "Population Coverage is limited by human genetic diversity — HLA (human leukocyte antigen) variation means the same vaccine antigen is presented differently to immune cells in different people, making universal vaccine design for genetically diverse populations inherently challenging"
    ],
    "answer": "Vaccine design is fundamentally an optimization problem with competing constraints. The nine components of this model capture the core trade-offs: Antigen Selection determines what the immune system learns to recognize — too specific and variants escape, too conserved and the response is weak. Adjuvant Strength amplifies the immune response but with side-effect trade-offs. Immune Cell Activation bridges innate and adaptive immunity. Antibody Production Rate and Memory Cell Formation determine short-term and long-term protection respectively. Pathogen Mutation Rate is the adversary — constantly generating variants that test the breadth of vaccine-induced immunity. Cross-Reactivity is the defense against mutation, but it comes at the cost of per-variant potency. Duration of Immunity depends on the race between memory persistence and antigenic drift. And Population Coverage reflects the reality that human immune systems are genetically diverse, meaning no single vaccine design is optimal for every individual. Computational modeling allows vaccinologists to simulate thousands of antigen-adjuvant combinations against evolving pathogen populations in diverse human genetics — identifying the design sweet spot before committing to expensive clinical trials.",
    "stem_title": "Design a Universal Influenza Vaccine Strategy",
    "stem_mission": "Design a vaccine strategy that provides broad, long-lasting protection against influenza — eliminating the need for annual reformulation by targeting conserved viral elements.",
    "stem_scenario": "The WHO has launched a $1 billion initiative to develop a universal influenza vaccine — one that works against all flu strains and doesn't need to be redesigned every year. Current seasonal flu vaccines are only 20-60% effective because they target rapidly-mutating surface proteins (hemagglutinin head). Your immunology team must design a vaccine strategy that targets conserved viral elements to provide durable, broadly protective immunity.",
    "stem_questions": [
        "Which conserved influenza proteins or protein regions would you target, and what is the trade-off between conservation and immunogenicity?",
        "What adjuvant and delivery platform (mRNA, protein subunit, viral vector, nanoparticle) would you use, and why?",
        "How would you test whether your vaccine provides Cross-Reactivity against historically diverse influenza strains?"
    ],
    "stem_design_qs": [
        "Would you use a single antigen or a cocktail of multiple conserved antigens — and how does this affect manufacturing complexity?",
        "How would you design clinical trials to demonstrate broad protection against strains that haven't emerged yet?",
        "What booster schedule would maximize Duration of Immunity while remaining practical for population-wide implementation?",
        "How would you address immune imprinting (original antigenic sin) — the tendency of the immune system to preferentially recall responses to the first flu strain encountered, even when vaccinated against new strains?"
    ],
    "career": "Vaccine Immunologists and Vaccinologists design and evaluate vaccines using computational modeling, animal studies, and clinical trials. They work for pharmaceutical companies (Pfizer, Moderna, GSK), biotech startups, government agencies (NIH, CDC, BARDA), and global health organizations (WHO, CEPI, Gavi), earning $100,000-$220,000/year. Computational Immunologists who model immune responses earn $90,000-$180,000/year.",
    "images": {
        "cover": ("G09L3-L09-cover.png", "A photorealistic, cinematic image of diverse 14-15 year old students in an advanced immunology lab examining 3D models of antibody-antigen interactions on holographic displays, with vaccine vials and immune cell microscopy images visible, dramatic blue and white laboratory lighting"),
        "landscape": ("G09L3-L09-landscape.png", "A diverse group of 14-15 year old students in a modern vaccine research lab analyzing immune response data on multiple screens showing antibody titer curves and viral mutation maps, with molecular models of spike proteins on desks"),
        "modeling": ("G09L3-L09-modeling.png", "A diverse group of 14-15 year old students building immune response models on laptops showing cascading diagrams from antigen presentation through B cell activation to antibody production, whiteboards with vaccine design optimization parameters"),
        "discussion": ("G09L3-L09-discussion.png", "A teacher leading a sophisticated discussion with diverse 14-15 year old students about vaccine design trade-offs, a diagram showing cross-reactivity versus specificity with variant phylogenetic trees on a smartboard"),
        "stem": ("G09L3-L09-stem.png", "Diverse 14-15 year old students presenting universal vaccine designs with antigen selection rationale, adjuvant comparison charts, and population coverage projections on large displays, professional biomedical presentation setting")
    },
    "pre_assessment": [
        "How do you think a vaccine 'teaches' your immune system to fight a disease it has never encountered?",
        "Why do you think you need a new flu vaccine every year but only one measles vaccine for life?",
        "Draw a diagram showing how you think the immune system responds when it encounters a pathogen for the first time versus the second time.",
        "What challenges do you think scientists face when designing vaccines against rapidly-mutating viruses like influenza or COVID-19?"
    ],
    "extend_components": [
        ("T Cell Response Quality", "The robustness of the cytotoxic T cell (killer T cell) response to the vaccine — while antibodies prevent infection, T cells destroy already-infected cells, providing a critical second line of defense that is often more durable and cross-reactive than antibody responses"),
        ("Delivery Platform Efficiency", "The technology used to present the antigen to the immune system — mRNA (rapid design, strong response, cold storage required), protein subunit (stable, well-understood, weaker response), viral vector (strong response, anti-vector immunity limits boosting), and nanoparticle (multivalent display, complex manufacturing)"),
        ("Immune Imprinting Effect", "The tendency of the immune system to preferentially recall its first response to a pathogen family rather than mounting a de novo response to new variants — original antigenic sin can reduce the effectiveness of updated vaccines by biasing the immune response toward the original strain")
    ],
    "reflections": [
        "How does your model demonstrate the fundamental trade-off between vaccine specificity and cross-reactivity breadth?",
        "Why is Pathogen Mutation Rate the most challenging component for long-term vaccine design — and how does Antigen Selection strategy affect vulnerability to antigenic drift?",
        "What did the model reveal about the relationship between Adjuvant Strength and real-world Population Coverage — why doesn't 'stronger adjuvant' always mean 'better vaccine'?",
        "How would adding Immune Imprinting Effect change your model's predictions about booster vaccine effectiveness?",
        "What ethical considerations arise when optimizing vaccine design for population-level protection versus individual-level protection?"
    ],
    "dimensions": [
        ("Science Practice", "Developing and Using Models / Constructing Explanations", "Students develop an immune response model that connects molecular antigen-antibody interactions to cellular immune activation to population-level epidemiological outcomes, constructing explanations for vaccine design trade-offs."),
        ("Disciplinary Core Idea", "LS1.A Structure and Function / LS4.C Adaptation", "Immune system cells have specialized structures that enable antigen recognition, antibody production, and immunological memory; pathogen adaptation through mutation creates an evolutionary arms race that constrains vaccine design."),
        ("Crosscutting Concept", "Cause and Effect / Structure and Function", "Students trace causal chains from antigen molecular structure through immune cell recognition to antibody specificity and population-level protection, analyzing how pathogen structural evolution disrupts vaccine-induced immunity.")
    ],
    "cast_items": [
        "Model the immune response cascade from vaccine antigen presentation through immune cell activation to antibody production, memory formation, and duration of protection",
        "Analyze the specificity-breadth trade-off in antigen selection and its implications for protection against evolving pathogens",
        "Evaluate vaccine design strategies for maximizing population coverage across genetically diverse human populations facing rapidly-mutating pathogens"
    ],
    "cast_questions": [
        ("Multiple Choice:", "A new SARS-CoV-2 variant emerges with 15 mutations in the spike protein receptor-binding domain. Based on your model, which vaccine design strategy would maintain the most protection against this variant?"),
        ("Constructed Response:", "Using your immune response model, explain why a vaccine that produces very high antibody levels against one influenza strain might fail to protect against a new strain that emerges 6 months later. Reference at least three model components including Pathogen Mutation Rate, Cross-Reactivity, and Antigen Selection in your answer.")
    ],
    "background_intro": "This lesson introduces students to computational vaccine design — one of the most important applications of immunological modeling. Biotech skill focus: Multi-objective optimization against an evolving target. The COVID-19 pandemic demonstrated both the power of rapid vaccine development and the challenges of designing durable protection against a mutating pathogen.",
    "background_sections": [
        ("How Vaccines Work: The Immune Response Cascade", "Vaccines exploit the adaptive immune system's ability to learn and remember. When a vaccine antigen is injected, innate immune cells (dendritic cells, macrophages) engulf and process it, presenting peptide fragments on their surface via MHC (major histocompatibility complex) molecules. Helper T cells recognize these presented peptides and activate, releasing cytokines that drive B cell activation. Activated B cells with receptors that match the antigen undergo clonal expansion (rapid division) and affinity maturation (mutation and selection for tighter antigen binding). Some activated B cells differentiate into plasma cells that secrete large quantities of antibodies; others become long-lived memory B cells. Simultaneously, cytotoxic T cells are activated to kill cells displaying the target peptides. The entire process takes 1-2 weeks for a primary response but only 1-3 days for a secondary (memory) response — which is why vaccines work: the memory response is fast enough to clear the pathogen before it causes disease."),
        ("Antigen Selection: The Foundation of Vaccine Design", "The choice of antigen determines everything else about a vaccine. An ideal antigen is: immunodominant (strongly recognized by diverse immune systems), essential for pathogen function (the pathogen cannot easily mutate it without losing fitness), surface-exposed (accessible to antibodies), and conserved across variants (mutations in this region are rare). In practice, these criteria often conflict. The SARS-CoV-2 spike protein receptor-binding domain (RBD) is highly immunodominant and surface-exposed but also rapidly mutating because it is under intense immune selection pressure. The spike protein's fusion machinery (S2 subunit) is more conserved but less immunodominant. The internal nucleoprotein is highly conserved but not accessible to antibodies (though T cells can target it). Computational modeling allows vaccinologists to evaluate thousands of potential antigen designs against simulated pathogen evolution, identifying targets that balance immunogenicity with conservation."),
        ("Adjuvants and Immune Amplification", "Purified protein antigens alone often produce weak immune responses — the adaptive immune system needs 'danger signals' from the innate immune system to mount a full response. Adjuvants provide these danger signals. Aluminum salts (alum) — the oldest and most common adjuvant — create a depot effect that prolongs antigen exposure and activate inflammasome pathways. AS01B (used in the Shingrix shingles vaccine) combines a toll-like receptor agonist with a saponin to produce exceptionally strong immune responses. MF59 (an oil-in-water emulsion) enhances antigen uptake by dendritic cells. mRNA vaccines use the lipid nanoparticle delivery system as a built-in adjuvant because the mRNA itself activates innate immune sensors. The choice of adjuvant determines the magnitude, quality, and durability of the immune response — but stronger adjuvants also produce more local and systemic reactogenicity (injection site pain, fever, fatigue), which affects public acceptance and population-level uptake."),
        ("The Evolutionary Arms Race: Pathogen Mutation and Immune Escape", "Vaccination creates a selection pressure on the pathogen: viral variants that can evade vaccine-induced immunity have a fitness advantage and become dominant. This is antigenic drift — the gradual accumulation of mutations in immune-targeted surface proteins. Influenza A virus mutates its hemagglutinin (HA) surface protein at a rate of approximately 4-6 amino acid substitutions per year, sufficient to require annual vaccine reformulation. SARS-CoV-2 demonstrated even faster antigenic evolution, with new variants of concern emerging every few months during the pandemic. The fundamental challenge for vaccine design is that the pathogen is not a static target — it is an evolving adversary that actively adapts to escape immune pressure. Computational models that co-simulate vaccine-induced immune responses AND pathogen evolution are essential for designing vaccines that maintain effectiveness over time.")
    ],
    "lever_L": "Students identify nine components spanning vaccine design inputs (Antigen Selection, Adjuvant Strength, Pathogen Mutation Rate), immune response dynamics (Immune Cell Activation, Antibody Production Rate, Memory Cell Formation), and protection outcomes (Cross-Reactivity, Duration of Immunity, Population Coverage).",
    "lever_E": "Students determine that Antigen Selection, Adjuvant Strength, and Pathogen Mutation Rate are external inputs — two under the vaccinologist's control and one representing the evolutionary adversary — while Immune Cell Activation, Antibody Production Rate, Memory Cell Formation, Cross-Reactivity, Duration of Immunity, and Population Coverage emerge as biological responses.",
    "lever_V": "Students build an immune response model connecting vaccine inputs through immune cell activation and antibody production to protection outcomes, visualizing the trade-offs between specificity and breadth, potency and safety, and short-term and long-term protection.",
    "lever_Ev": "Students run strain-specific, broadly-protective, and high-mutation-challenge scenarios to discover how antigen selection strategy determines vulnerability to pathogen evolution.",
    "lever_R": "Students add T Cell Response Quality, Delivery Platform Efficiency, or Immune Imprinting Effect to explore additional dimensions of vaccine design optimization.",
    "slides_guide": [
        {"num": "Slide 1", "title": "Cover", "visual": "Title slide with dramatic imagery of vaccine vials, viral particles, and antibody structures", "say": "COVID-19 vaccines went from genetic sequence to emergency authorization in 11 months. The previous record was 4 years. How did computational modeling make this possible — and can we design vaccines that never need updating?", "do": "Display the timeline comparison: traditional vaccine development (10-15 years) versus COVID-19 (11 months). Ask: What changed? What role did modeling play?", "time": "2 min"},
        {"num": "Slide 2", "title": "Learning Objectives", "visual": "Learning goals with immunology vocabulary", "say": "Today you're vaccine designers. You'll learn why vaccine design is one of the hardest optimization problems in biology — because your target is literally evolving to escape you.", "do": "Pre-teach antigen and adjuvant. Use the analogy: an antigen is a 'wanted poster' that teaches your immune system what to look for; an adjuvant is the megaphone that makes sure the immune system pays attention.", "time": "3 min"},
        {"num": "Slide 3", "title": "Big Question", "visual": "Can we design a universal vaccine that outruns viral evolution?", "say": "You need a new flu vaccine every year because the virus mutates its surface proteins. But you only need one measles vaccine for life. What's different about measles? Can we make flu behave more like measles?", "do": "Think-pair-share: Why do some vaccines last a lifetime while others need annual updating? What properties of the virus and the vaccine determine durability? Collect hypotheses.", "time": "3 min"},
        {"num": "Slide 4", "title": "LEVER Framework", "visual": "LEVER steps with immunology and evolutionary biology context", "say": "We're modeling the full cascade: from what you put in the vaccine to how the immune system responds to whether protection lasts when the virus mutates. And the virus IS mutating — that's the adversary in this model.", "do": "Preview LEVER steps. Emphasize the unique challenge: this model has an adversarial component (Pathogen Mutation Rate) that actively works against the vaccine design.", "time": "2 min"},
        {"num": "Slide 5", "title": "Activity 1: Components", "visual": "Nine component cards spanning vaccine design, immune response, and protection outcome levels", "say": "Three of these nine components are inputs. Two you control (Antigen Selection, Adjuvant Strength). One you DON'T control (Pathogen Mutation Rate) — and it's working against you. Sort them.", "do": "Guide sorting of external versus internal components. Emphasize the adversarial nature of Pathogen Mutation Rate as an uncontrollable external input that actively undermines vaccine effectiveness.", "time": "8 min"},
        {"num": "Slide 6", "title": "Activity 2: Connections", "visual": "Immune response cascade from vaccine injection through memory formation to population protection", "say": "The specificity-breadth trade-off is the central tension. A sniper rifle (strain-specific) or a shotgun (broadly protective)? Each has advantages. Each has costs.", "do": "Students map the immune cascade from antigen presentation through B cell and T cell activation to antibody and memory cell outputs. Trace how Antigen Selection choice propagates through Cross-Reactivity to Duration of Immunity.", "time": "8 min"},
        {"num": "Slide 7", "title": "Activity 3: Simulation", "visual": "Vaccine effectiveness over time under different mutation pressures", "say": "Design your vaccine. Now watch what happens when the virus starts mutating. Which design strategy holds up best over 2 years of viral evolution?", "do": "Students design their preferred vaccine strategy, predict performance, then simulate all three scenarios. The high-mutation challenge is the key insight — demonstrating how quickly strain-specific immunity erodes.", "time": "10 min"},
        {"num": "Slide 8", "title": "Discoveries", "visual": "Key vaccine design insights and real-world applications", "say": "You just discovered why we still don't have a universal flu vaccine after 80 years of trying — and why the mRNA platform that made COVID vaccines possible might finally crack this problem.", "do": "Connect model findings to real vaccine development challenges. Discuss mRNA platform advantages for rapid variant-updated vaccine design.", "time": "5 min"},
        {"num": "Slide 9", "title": "STEM Challenge", "visual": "Universal influenza vaccine design challenge", "say": "The WHO just gave your lab a billion dollars. Design the universal flu vaccine that ends annual flu shots forever. What do you target? How do you prove it works? Go.", "do": "Groups design universal influenza vaccine strategies: antigen selection rationale, adjuvant choice, delivery platform, clinical trial design, and projections for cross-reactivity breadth. Present and defend.", "time": "12 min"}
    ],
    "sort_reasoning": "Antigen Selection, Adjuvant Strength, and Pathogen Mutation Rate are the three external components. Antigen Selection and Adjuvant Strength are design decisions made by the vaccinologist — which piece of the pathogen to include and how strongly to stimulate the immune response. Pathogen Mutation Rate is an external biological reality determined by the virus's replication fidelity and population dynamics — it is not under the vaccine designer's control but profoundly affects vaccine performance. All other six components are internal: Immune Cell Activation, Antibody Production Rate, Memory Cell Formation, Cross-Reactivity, Duration of Immunity, and Population Coverage emerge as biological responses to the vaccine design interacting with human immune physiology and pathogen evolution.",
    "relationships": [
        ("Antigen Selection to Immune Cell Activation", "POSITIVE (+)", "More immunogenic antigens (those that are well-recognized by human immune system components) produce stronger dendritic cell activation and more effective antigen presentation to T cells, amplifying the downstream adaptive response."),
        ("Adjuvant Strength to Immune Cell Activation", "POSITIVE (+)", "Stronger adjuvants activate more innate immune cells and induce higher levels of co-stimulatory molecules and cytokines, amplifying antigen presentation and lowering the activation threshold for adaptive immune cells."),
        ("Immune Cell Activation to Antibody Production Rate", "POSITIVE (+)", "Greater immune cell activation produces more activated helper T cells, which provide stronger signals for B cell clonal expansion and differentiation into antibody-secreting plasma cells."),
        ("Memory Cell Formation to Duration of Immunity", "POSITIVE (+)", "More robust memory cell differentiation creates larger and more diverse pools of long-lived memory B cells and T cells, enabling faster and stronger recall responses for longer periods after vaccination."),
        ("Pathogen Mutation Rate to Duration of Immunity", "NEGATIVE (-)", "Faster pathogen mutation generates variants that escape vaccine-induced immune recognition more quickly, eroding the effective Duration of Immunity even when memory cells remain functional — because the virus changes, not the memory."),
        ("Cross-Reactivity to Population Coverage", "POSITIVE (+)", "Broader cross-reactivity means the vaccine provides at least partial protection against more pathogen variants, increasing the fraction of the population that encounters a variant covered by their vaccine-induced immunity.")
    ],
    "sim_answers": [
        ("Strain-Specific Vaccine Scenario", "With a highly specific antigen targeting the dominant circulating strain, Immune Cell Activation and Antibody Production Rate are high — the immune system generates a strong, focused response. Cross-Reactivity is low because the antibodies precisely fit only the target strain's epitopes. Initially, this vaccine provides excellent protection with high efficacy. However, when Pathogen Mutation Rate generates new variants with changes in the targeted epitope, Duration of Immunity drops sharply. The vaccine becomes ineffective against the new variant within 6-18 months, requiring reformulation — exactly the problem with current seasonal flu vaccines."),
        ("High-Mutation Pathogen Challenge Scenario", "At maximum Pathogen Mutation Rate, the adversarial nature of viral evolution is starkly visible. Regardless of initial vaccine design, the pathogen generates escape variants on a timeline of months. Strain-specific vaccines lose efficacy first. Broadly protective vaccines maintain partial protection longer due to Cross-Reactivity, but even conserved regions accumulate some variation over time. The model demonstrates that no single vaccination event can provide permanent protection against a rapidly-evolving pathogen — ongoing surveillance, updated formulations, or universal vaccine approaches targeting highly conserved essential structures are necessary.")
    ],
    "reflection_exemplars": [
        ("What is the specificity-breadth trade-off in vaccine design?", "The model reveals a fundamental immunological trade-off: antibodies that bind one specific epitope with very high affinity (high specificity) typically cannot bind variant epitopes with different shapes (low cross-reactivity). Conversely, antibodies that recognize a broader range of variant structures (high cross-reactivity) typically bind each individual variant with lower affinity (lower per-variant potency). This is because antibody binding sites are shaped to be complementary to their target — the more precisely they fit one target, the less they fit related but different targets. Vaccine Antigen Selection determines where on this spectrum the immune response falls: strain-specific antigens drive high-affinity, narrow responses; conserved-region antigens drive lower-affinity, broader responses."),
        ("Why does Pathogen Mutation Rate erode immunity even when Memory Cell Formation is strong?", "Memory cells remember the SPECIFIC antigen they were trained on. When the pathogen mutates its surface proteins, the memory cells still remember the old version perfectly — but the new version looks different enough that memory cell recognition is weakened or lost entirely. This is not a failure of immunological memory; it's a success of pathogen evolution. The model shows that Duration of Immunity depends not just on how well the immune system remembers, but on whether the pathogen remains recognizable to what the immune system remembers. This is why targeting highly conserved, functionally essential regions is the key strategy for durable protection — the pathogen cannot mutate these regions without losing fitness.")
    ],
    "stem_intro": "Present the challenge: The WHO has launched a $1 billion initiative to develop a universal influenza vaccine that eliminates the need for annual reformulation. Current flu vaccines are only 20-60% effective because they target rapidly-mutating surface proteins. Your immunology team will design a vaccine strategy targeting conserved viral elements for durable, broadly protective immunity.",
    "stem_concepts": [
        ("Conserved Antigen Targeting", "Influenza has several conserved protein regions that cannot easily mutate without losing viral fitness: the hemagglutinin stalk domain (required for membrane fusion), the M2 ion channel ectodomain (required for viral uncoating), and internal proteins like nucleoprotein (NP) and matrix protein (M1) that are essential for replication. Each has different advantages: HA stalk antibodies can neutralize the virus directly; M2e antibodies recruit immune cells to kill infected cells; NP-specific T cells provide cross-reactive cellular immunity. A multi-antigen approach may be necessary."),
        ("mRNA Platform Advantages", "mRNA vaccine technology offers unique advantages for universal vaccine design: rapid sequence modification (weeks versus months for protein vaccines), ability to encode multiple antigens in one formulation, strong activation of both antibody and T cell responses, and self-adjuvanting properties of the lipid nanoparticle delivery system. mRNA vaccines can be quickly updated when new conserved antigen designs are identified through computational modeling."),
        ("Clinical Trial Design for Broadly Protective Vaccines", "Proving that a universal vaccine works is uniquely challenging because you need to demonstrate protection against strains that haven't emerged yet. Strategies include: testing against historically diverse archived strains in laboratory neutralization assays, animal challenge studies with multiple divergent strains, human challenge studies with controlled infection, and computational modeling of predicted protection against simulated future variants based on known evolutionary trajectories.")
    ],
    "stem_eval": [
        ("Expert (4)", "Strategy includes justified conserved antigen selection with evolutionary analysis, platform rationale, multi-antigen design consideration, clinical trial plan for broad protection, and population coverage analysis supported by model predictions"),
        ("Proficient (3)", "Strategy includes antigen selection targeting conserved regions with reasoning connected to model trade-offs and basic clinical validation approach"),
        ("Developing (2)", "Strategy identifies conserved targets but lacks detail on platform selection, breadth validation, or population coverage considerations"),
        ("Beginning (1)", "Strategy is incomplete or does not connect antigen selection to the immune response model's specificity-breadth trade-off")
    ],
    "support": [
        "Provide a visual diagram of the immune response cascade from vaccine injection through antigen presentation, T cell and B cell activation, to antibody production and memory formation",
        "Use an antigen comparison table: 'Antigen: ___, Conservation level: ___/10, Immunogenicity: ___/10, Surface accessible: Y/N, Cross-reactivity prediction: ___'",
        "Scaffold the evolutionary trade-off: 'If I target the most immunogenic epitope, it will mutate in ___ months. If I target the most conserved epitope, my antibody levels will be ___% lower. The optimal strategy is ___'"
    ],
    "extensions": [
        "Research the history of universal influenza vaccine attempts — what strategies have been tried, what failed, and what current candidates show the most promise?",
        "Investigate how computational protein design (like RosettaDesign) is being used to create 'designer antigens' — artificial protein structures that present conserved epitopes in highly immunogenic conformations",
        "Compare the immune evasion strategies of influenza (antigenic drift/shift), HIV (extreme variability, latency), and measles (antigenic stability) — what determines whether a virus can escape vaccine-induced immunity?"
    ],
    "cross_curr": [
        ("Math", "Calculate the probability that a virus with mutation rate M will generate an escape variant within T months, given N circulating viruses — model this as a Poisson process and determine the expected time to vaccine failure"),
        ("ELA", "Write a public health communication explaining why a universal flu vaccine would be one of the most important medical advances of the century — using data from your model to quantify the impact on global health"),
        ("Social Studies/Ethics", "Analyze the ethical frameworks for vaccine distribution during a pandemic — utilitarian (maximize lives saved), egalitarian (equal access), prioritarian (prioritize the vulnerable) — and how Population Coverage optimization relates to each framework")
    ],
    "misconceptions": [
        ("Vaccines give you a weakened version of the disease", "While some historical vaccines used weakened (attenuated) live virus, most modern vaccines do NOT contain any live pathogen. Subunit vaccines contain only purified proteins. mRNA vaccines contain instructions for the body to make one viral protein (not the whole virus). Inactivated vaccines contain killed virus that cannot replicate. None of these can cause the disease they protect against. The immune system responds to the molecular shape of the antigen, not to the disease process itself.", "Categorize: List 5 vaccines and their type (live attenuated, inactivated, subunit, mRNA, viral vector). Which ones contain live virus? Which cannot possibly cause infection? How does the immune response compare?"),
        ("If a vaccine doesn't prevent infection 100%, it doesn't work", "Vaccines provide a SPECTRUM of protection, not a binary shield. Even when a vaccine doesn't prevent infection entirely, it typically: reduces symptom severity by 70-90%, reduces hospitalization by 80-95%, reduces death by 90-99%, and reduces transmission by 40-60%. The model's Population Coverage component shows that even partially effective vaccines dramatically reduce disease burden at the population level through herd immunity effects and reduced transmission.", "Calculate: If a vaccine is 70% effective at preventing infection and 95% effective at preventing hospitalization, what happens to hospital overcrowding during a pandemic if 80% of the population is vaccinated versus 20%?"),
        ("Natural immunity is always better than vaccine immunity", "Natural infection sometimes produces stronger immunity than vaccination — but at the cost of suffering the actual disease, with its risks of hospitalization, long-term complications, and death. The model shows that vaccines can be designed to optimize specific aspects of immunity (like Memory Cell Formation and Cross-Reactivity) that natural infection may not optimally stimulate. Adjuvants and delivery platforms can direct the immune response toward the most protective pathways. Furthermore, vaccines can target conserved epitopes that natural infection may not prominently expose to the immune system.", "Thought experiment: If natural COVID infection gives stronger antibodies but also has a 1% chance of killing you, and the vaccine gives somewhat weaker antibodies with a 0.001% chance of serious side effects — which is the better population-level strategy? At what risk level would natural immunity become preferable?")
    ]
}

L10 = {
    "id": "G09L3-L10",
    "title": "Climate-Ecosystem Coupled Models",
    "subtitle": "Modeling Feedback Loops Between Climate Change, Ecosystems, and Human Society",
    "ngss": "HS-ESS3-5, HS-LS2-6",
    "ngss_desc": "Analyze geoscience data and the results from global climate models to make an evidence-based forecast of the current rate of global or regional climate change; evaluate claims, evidence, and reasoning that the complex interactions in ecosystems maintain relatively consistent numbers and types of organisms in stable conditions, but changing conditions may result in a new ecosystem.",
    "big_question": "Climate change doesn't just heat the planet — it triggers cascading feedback loops through every ecosystem on Earth. When permafrost melts and releases methane, which accelerates warming, which melts more permafrost, which releases more methane — how do you model a system where the output becomes the input?",
    "objectives": [
        "Build a coupled climate-ecosystem model that traces feedback loops between atmospheric CO2, temperature, ocean absorption, permafrost methane release, and biological carbon sequestration",
        "Analyze how positive and negative feedback loops create tipping points, runaway effects, and nonlinear system behavior in the Earth's climate-ecosystem system",
        "Predict the cascading consequences of climate change across ecological, agricultural, and societal systems using multi-variable simulation",
        "Evaluate the effectiveness and trade-offs of different adaptation and mitigation strategies using model-derived evidence"
    ],
    "vocabulary": [
        ("Positive Feedback Loop", "A circular causal process where the output of a system amplifies its own input — in climate, warming melts ice, which reduces reflectivity (albedo), which absorbs more sunlight, which causes more warming — positive feedbacks accelerate change and can push systems past tipping points"),
        ("Carbon Sequestration", "The process of capturing and storing atmospheric carbon dioxide — forests sequester carbon through photosynthesis (storing it in biomass and soil), oceans absorb CO2 into surface waters and deep circulation, and engineered systems can capture CO2 from industrial emissions or directly from the air"),
        ("Tipping Point", "A critical threshold in a system beyond which a small additional change triggers a large, often irreversible shift in system state — like permafrost crossing a temperature threshold that triggers self-sustaining methane release regardless of future human emissions reductions"),
        ("Coupled Model", "A computational model that connects two or more interacting systems — climate-ecosystem coupled models link atmospheric physics, ocean chemistry, terrestrial ecology, and human activity, allowing each system's outputs to become inputs to the others through feedback loops")
    ],
    "components": [
        ("Atmospheric CO2", "The concentration of carbon dioxide in the atmosphere, measured in parts per million (ppm) — currently ~425 ppm and rising approximately 2.5 ppm/year due to fossil fuel combustion, deforestation, and industrial processes, driving the greenhouse effect that warms the planet", True),
        ("Global Temperature", "The average surface temperature of the Earth relative to pre-industrial levels — currently approximately 1.2 degrees C above pre-industrial baseline, with projections of 1.5-4.5 degrees C increase by 2100 depending on emission trajectories", False),
        ("Ocean Absorption", "The rate at which the ocean absorbs CO2 from the atmosphere and heat from the climate system — the ocean has absorbed approximately 30% of anthropogenic CO2 and over 90% of excess heat, but absorption capacity decreases as the ocean warms and acidifies", False),
        ("Permafrost Methane Release", "The rate at which thawing Arctic permafrost releases trapped methane (CH4) and CO2 — permafrost contains approximately 1,500 gigatons of organic carbon (twice the current atmospheric carbon), and methane is 80x more potent than CO2 as a greenhouse gas over 20 years", False),
        ("Forest Carbon Sequestration", "The net rate at which global forests absorb CO2 from the atmosphere through photosynthesis minus the rate they release it through respiration, decomposition, and fire — currently forests absorb approximately 2.6 gigatons of CO2 per year, but this sink is declining as forests face heat stress, drought, fire, and deforestation", False),
        ("Species Migration Rate", "The speed at which plant and animal species shift their geographic ranges in response to changing climate conditions — many species must move poleward or to higher elevations to maintain suitable habitat, but migration speed is limited by dispersal ability, habitat fragmentation, and physical barriers", False),
        ("Crop Yield Change", "The percentage change in global agricultural productivity resulting from temperature increases, altered precipitation patterns, increased CO2 fertilization, and changing pest and disease pressure — moderate warming may benefit some crops temporarily while severe warming reduces yields for most staple crops", False),
        ("Sea Level Rise", "The increase in global mean sea level caused by thermal expansion of ocean water and melting of land-based ice (glaciers, Greenland, and Antarctic ice sheets) — currently rising approximately 3.6 mm/year and accelerating, with 0.5-2.0 meters projected by 2100", False),
        ("Extreme Weather Frequency", "The rate of occurrence of extreme weather events (hurricanes, heatwaves, droughts, floods, wildfires) relative to historical baselines — warmer atmosphere holds 7% more water vapor per degree C of warming, intensifying the hydrological cycle and amplifying weather extremes", False),
        ("Societal Adaptation Capacity", "The ability of human societies to adjust to climate change impacts through infrastructure, technology, policy, economic resources, and institutional capacity — wealthy nations can build sea walls and develop drought-resistant crops while vulnerable nations face disproportionate climate risk with fewer resources to adapt", True)
    ],
    "think_about_it": "This model is fundamentally different from the others because it contains MULTIPLE feedback loops — and some of them are positive (self-amplifying). Atmospheric CO2 increases Global Temperature through the greenhouse effect. Higher temperature reduces Ocean Absorption capacity (warm water holds less CO2). Higher temperature thaws Permafrost, which releases more greenhouse gases, which increases Global Temperature further — a classic positive feedback loop. But higher CO2 also increases photosynthesis (CO2 fertilization), which increases Forest Carbon Sequestration — a negative feedback that partially counteracts the warming. Meanwhile, higher temperatures cause Species Migration, Crop Yield Change, Sea Level Rise, and Extreme Weather Frequency — all of which affect Societal Adaptation Capacity, which determines whether human societies can respond effectively. The question isn't just 'how much will it warm?' — it's 'when do we cross tipping points where the feedbacks become self-sustaining regardless of what we do?'",
    "scenarios": [
        ("Paris Agreement Compliance", "Set Atmospheric CO2 trajectory to limit warming to 1.5-2.0 degrees C — observe which feedback loops remain manageable and which ecosystem impacts are still unavoidable"),
        ("Business-As-Usual Emissions", "Set Atmospheric CO2 to high-emission trajectory (RCP 8.5 / SSP5-8.5) — observe positive feedback loop activation, tipping point crossings, and cascading ecosystem and societal impacts"),
        ("Tipping Point Analysis", "Gradually increase Global Temperature and identify the threshold where Permafrost Methane Release becomes self-sustaining — the point of no return where reducing emissions can no longer prevent continued warming")
    ],
    "sim_scenarios": [
        ("Paris Compliance", "Limited warming to 1.5-2.0 degrees C", "At 1.5 degrees C warming, which ecosystem impacts do you predict are still unavoidable even with aggressive emission reductions?"),
        ("Business-As-Usual", "High emission trajectory, 3-4 degrees C warming", "What do you predict happens to Permafrost Methane Release and Forest Carbon Sequestration when Global Temperature reaches 3 degrees C above pre-industrial?"),
        ("Tipping Point Search", "Gradual temperature increase", "At what Global Temperature do you predict the permafrost positive feedback loop becomes self-sustaining — adding more warming than emission reductions can offset?")
    ],
    "discoveries": [
        "The climate system contains multiple positive feedback loops that can amplify warming beyond what CO2 emissions alone would produce — permafrost methane release, reduced ocean absorption, and forest die-off can each become self-reinforcing above critical temperature thresholds",
        "Forest Carbon Sequestration is a negative feedback that partially counteracts warming, but it has a tipping point — above approximately 2.5-3.0 degrees C of warming, widespread forest die-off from heat stress, drought, and wildfire converts forests from carbon sinks to carbon sources, flipping the feedback from negative to positive",
        "Sea Level Rise and Extreme Weather Frequency are lagging indicators — they continue to accelerate for decades after emissions peak because of thermal inertia in the ocean and committed ice sheet melting, meaning current commitments have already locked in significant future impacts",
        "Societal Adaptation Capacity is the most unequally distributed component — nations that have contributed the least to atmospheric CO2 (sub-Saharan Africa, South Pacific island nations) face the most severe impacts with the fewest resources to adapt, creating a fundamental climate justice challenge"
    ],
    "answer": "Climate change is not a simple linear process — it's a complex system of interacting feedback loops that connect atmospheric chemistry, ocean physics, terrestrial ecology, and human society. The ten components of this coupled model reveal the cascading nature of climate impacts: Atmospheric CO2 drives Global Temperature through the greenhouse effect, but the response is amplified by positive feedback loops (permafrost methane release, reduced ocean absorption capacity, forest die-off) and partially counteracted by negative feedbacks (ocean absorption, forest sequestration, CO2 fertilization). These feedbacks create tipping points — critical thresholds beyond which the system transitions to a new state regardless of future human action. The downstream consequences — Species Migration Rate, Crop Yield Change, Sea Level Rise, Extreme Weather Frequency — cascade through ecological and societal systems in ways that disproportionately affect the most vulnerable populations. Societal Adaptation Capacity determines whether communities survive these impacts, but adaptation has limits — no amount of adaptation can compensate for a fundamentally destabilized climate system. The model demonstrates that early, aggressive emission reduction is not just environmentally preferable but mathematically necessary to avoid crossing irreversible tipping points.",
    "stem_title": "Design a Regional Climate Adaptation and Mitigation Plan",
    "stem_mission": "Design an integrated climate adaptation and mitigation strategy for a specific vulnerable region, using model-derived evidence to prioritize interventions and project outcomes.",
    "stem_scenario": "A coastal city of 2 million people is projected to face 0.5-1.5 meters of sea level rise, a 40% increase in extreme weather events, and significant agricultural disruption by 2080. The city has hired your climate planning team to develop a 50-year integrated strategy that combines mitigation (reducing the city's carbon footprint), adaptation (preparing for unavoidable impacts), and resilience (ensuring recovery from extreme events). Your plan must be evidence-based, economically feasible, and equitable.",
    "stem_questions": [
        "Which climate impacts does your model predict are unavoidable regardless of mitigation efforts — and how would you prioritize adaptation spending for these impacts?",
        "What mitigation strategies would have the largest impact on the city's contribution to Atmospheric CO2, and what is the expected return on investment?",
        "How would you design the plan to protect the most vulnerable populations who have the least Societal Adaptation Capacity?"
    ],
    "stem_design_qs": [
        "Would you invest more in hard infrastructure (sea walls, flood barriers) or nature-based solutions (mangrove restoration, green infrastructure) — and what does your model predict about the long-term effectiveness of each?",
        "How would you design the plan to remain effective across the range of possible warming scenarios (1.5 degrees C to 4.0 degrees C)?",
        "What monitoring and early warning systems would you install to detect when tipping points are being approached?",
        "How would you fund the plan — carbon taxes, green bonds, federal disaster preparedness funding — and how does the financing strategy affect equity?"
    ],
    "career": "Climate Scientists and Earth System Modelers develop and run coupled climate-ecosystem models to project future climate conditions and ecosystem impacts. They work for government agencies (NOAA, NASA, EPA), national laboratories (NCAR, ORNL, PNNL), international organizations (IPCC, WMO), and university research centers, earning $80,000-$170,000/year. Climate Adaptation Planners who design community resilience strategies earn $70,000-$140,000/year.",
    "images": {
        "cover": ("G09L3-L10-cover.png", "A photorealistic, cinematic image of diverse 14-15 year old students in an advanced earth science lab examining climate model projections on multiple large screens showing temperature maps, sea level rise simulations, and ecosystem migration patterns, dramatic lighting with blue and green earth tones"),
        "landscape": ("G09L3-L10-landscape.png", "A diverse group of 14-15 year old students in a modern climate science center analyzing coupled model outputs showing feedback loop diagrams, carbon cycle data, and regional impact projections on wall-sized displays"),
        "modeling": ("G09L3-L10-modeling.png", "A diverse group of 14-15 year old students building climate-ecosystem models on laptops showing feedback loop diagrams with positive and negative arrows, whiteboards with carbon cycle equations and tipping point thresholds"),
        "discussion": ("G09L3-L10-discussion.png", "A teacher leading a discussion with diverse 14-15 year old students about climate feedback loops and tipping points, a coupled model diagram showing interconnected climate and ecosystem components on a smartboard"),
        "stem": ("G09L3-L10-stem.png", "Diverse 14-15 year old students presenting regional climate adaptation plans with sea level rise maps, mitigation strategy timelines, and equity analysis charts on large displays, professional climate policy presentation setting")
    },
    "pre_assessment": [
        "What do you think happens when Arctic permafrost melts — and why might this create a 'snowball effect' that makes climate change worse?",
        "Why do you think some regions of the world will be affected by climate change much more severely than others?",
        "Draw a diagram showing how you think CO2 emissions lead to rising sea levels — include as many intermediate steps as you can.",
        "What is a 'tipping point' in the climate system and why should we be concerned about crossing one?"
    ],
    "extend_components": [
        ("Albedo Feedback", "The reflectivity change caused by melting ice and snow cover — ice reflects 80-90% of solar radiation while open ocean absorbs 90%, creating a powerful positive feedback where ice loss causes more warming which causes more ice loss, particularly important in the Arctic where summer sea ice has declined 40% since 1979"),
        ("Ocean Acidification", "The decrease in ocean pH caused by dissolved CO2 reacting with water to form carbonic acid — currently 30% more acidic than pre-industrial levels, threatening coral reefs, shellfish, and marine food webs, with cascading effects on ocean carbon absorption capacity and marine ecosystem stability"),
        ("Climate Migration Pressure", "The displacement of human populations by climate impacts including sea level rise, extreme heat, drought, and agricultural collapse — currently 20+ million climate-displaced people annually, projected to reach 200+ million by 2050, creating political, economic, and humanitarian cascading effects")
    ],
    "reflections": [
        "How does your model demonstrate the difference between positive feedback loops (self-amplifying) and negative feedback loops (self-correcting) in the climate system — and why are the positive feedbacks winning?",
        "What did the tipping point analysis reveal about the relationship between Global Temperature and Permafrost Methane Release — and why is this threshold so consequential?",
        "Why does Forest Carbon Sequestration potentially flip from a negative feedback (absorbing CO2) to a positive feedback (releasing CO2) above a certain temperature threshold?",
        "How would adding Climate Migration Pressure to your model change the analysis of Societal Adaptation Capacity?",
        "What does the model reveal about climate justice — the relationship between who caused the emissions and who bears the consequences?"
    ],
    "dimensions": [
        ("Science Practice", "Developing and Using Models / Analyzing and Interpreting Data", "Students develop a coupled climate-ecosystem model with multiple interacting feedback loops, analyzing data from simulations to identify tipping points and project cascading consequences across natural and human systems."),
        ("Disciplinary Core Idea", "ESS3.D Global Climate Change / LS2.C Ecosystem Dynamics, Functioning, and Resilience", "Human activities affect global climate through greenhouse gas emissions; ecosystems respond to climate disruption through species migration, productivity changes, and potential collapse when adaptation limits are exceeded."),
        ("Crosscutting Concept", "Stability and Change / Cause and Effect", "Students analyze how positive and negative feedback loops determine whether the climate-ecosystem system maintains stability or undergoes irreversible transitions, tracing causal chains across atmospheric, oceanic, terrestrial, and societal systems.")
    ],
    "cast_items": [
        "Model the coupled feedback loops between atmospheric CO2, global temperature, ocean absorption, permafrost methane release, and forest carbon sequestration — identifying positive and negative feedbacks",
        "Analyze tipping point dynamics by identifying the temperature thresholds beyond which positive feedback loops become self-sustaining regardless of emission reductions",
        "Evaluate the cascading consequences of climate change across ecological (species migration, forest die-off), agricultural (crop yield), coastal (sea level rise), and societal (adaptation capacity) systems"
    ],
    "cast_questions": [
        ("Multiple Choice:", "Global Temperature increases by 3 degrees C above pre-industrial levels. Based on your model, which of the following feedback loops is most likely to become self-sustaining at this temperature, causing continued warming regardless of emission reductions?"),
        ("Constructed Response:", "Using your coupled climate-ecosystem model, explain why reducing Atmospheric CO2 emissions to zero today would NOT immediately stop climate change. Reference at least four model components and describe the lag effects and committed changes already locked into the system.")
    ],
    "background_intro": "This lesson introduces students to coupled climate-ecosystem modeling — the integration of atmospheric physics, ocean chemistry, terrestrial ecology, and human systems into a single interconnected model. Biotech skill focus: Multi-system feedback analysis and tipping point dynamics. Understanding the Earth as a coupled system is essential for making evidence-based decisions about climate mitigation and adaptation.",
    "background_sections": [
        ("The Carbon Cycle and Climate System", "The Earth's climate is regulated by the balance between incoming solar radiation and outgoing infrared radiation. Greenhouse gases — primarily CO2, methane (CH4), nitrous oxide (N2O), and water vapor — trap outgoing radiation, warming the surface. The carbon cycle moves carbon between four major reservoirs: the atmosphere (approximately 880 GtC), the ocean (approximately 38,000 GtC), terrestrial biomass and soil (approximately 4,000 GtC), and fossil fuels (approximately 10,000 GtC). Human activity has transferred approximately 440 GtC from the fossil fuel reservoir to the atmosphere since 1750, increasing atmospheric CO2 from 280 to 425 ppm. The ocean and terrestrial biosphere have absorbed approximately half of these emissions — but their absorption capacity is declining as the system warms."),
        ("Positive Feedback Loops and Tipping Points", "Several positive feedback loops in the climate system can amplify warming beyond what greenhouse gas emissions alone would produce. The ice-albedo feedback: warming melts reflective ice, exposing dark ocean or land that absorbs more solar radiation, causing more warming. The permafrost carbon feedback: warming thaws Arctic permafrost containing 1,500 GtC of frozen organic matter, releasing CO2 and methane as it decomposes, causing more warming. The water vapor feedback: warming evaporates more water, and water vapor is a greenhouse gas, causing more warming (this is the single largest amplifying feedback). The forest die-off feedback: extreme warming causes drought, heat stress, and wildfire that kill forests, releasing stored carbon and eliminating future sequestration capacity. Each feedback has a potential tipping point — a temperature threshold beyond which it becomes self-sustaining regardless of future emission reductions."),
        ("Ecosystem Responses to Climate Change", "Ecosystems respond to climate change through three primary mechanisms. Migration: species shift their ranges poleward (average 17 km per decade for terrestrial species) or to higher elevations (11 m per decade) to track suitable climate conditions. Adaptation: populations with genetic variation may evolve tolerance to new conditions over generations — but the rate of current climate change far exceeds the rate at which most species can adapt genetically. Collapse: when species cannot migrate fast enough or adapt, populations decline and ecosystems reorganize — coral reef bleaching (affecting 75% of global reefs), boreal forest die-off, and savanna desertification are already underway. Agricultural systems face the same pressures: moderate warming (1-2 degrees C) may increase yields for some temperate crops through longer growing seasons and CO2 fertilization, but warming beyond 2-3 degrees C reduces yields for most staple crops (wheat: -6% per degree C, corn: -7.4% per degree C globally)."),
        ("Climate Justice and Adaptation Inequality", "Climate change impacts are profoundly unequal. The nations that have contributed the most cumulative CO2 emissions (US, EU, China) are generally wealthier and better equipped to adapt — with resources for sea walls, disaster response, crop insurance, and technological innovation. The nations that have contributed the least (sub-Saharan Africa, South Pacific islands, Southeast Asia) face the most severe impacts — sea level rise threatening low-lying nations, extreme heat reducing agricultural productivity, and intensified tropical storms — with the fewest resources to adapt. This asymmetry between responsibility and vulnerability is the central challenge of climate justice. The model's Societal Adaptation Capacity component makes this inequality visible: a 0.5-meter sea level rise is manageable for the Netherlands (which has centuries of flood engineering expertise and trillions of dollars of GDP) but existential for Tuvalu (population 12,000, maximum elevation 4.6 meters, GDP $63 million).")
    ],
    "lever_L": "Students identify ten components spanning atmospheric drivers (Atmospheric CO2), climate responses (Global Temperature, Ocean Absorption, Permafrost Methane Release), ecosystem responses (Forest Carbon Sequestration, Species Migration Rate), human system impacts (Crop Yield Change, Sea Level Rise, Extreme Weather Frequency), and societal capacity (Societal Adaptation Capacity).",
    "lever_E": "Students determine that Atmospheric CO2 and Societal Adaptation Capacity are the two primary external inputs — one representing the driver of climate change (controllable through emission policy) and the other representing humanity's capacity to respond (controllable through investment, policy, and technology). All other eight components emerge as interconnected responses with critical feedback loops.",
    "lever_V": "Students build a coupled climate-ecosystem model with explicit positive and negative feedback loops, visualizing how warming cascades through atmospheric, oceanic, terrestrial, and societal systems with nonlinear dynamics and potential tipping points.",
    "lever_Ev": "Students run Paris-compliant, business-as-usual, and tipping-point-analysis scenarios to discover the temperature thresholds where positive feedbacks become self-sustaining and cascading consequences become unavoidable.",
    "lever_R": "Students add Albedo Feedback, Ocean Acidification, or Climate Migration Pressure to explore additional feedback loops and cascading consequences that increase model realism.",
    "slides_guide": [
        {"num": "Slide 1", "title": "Cover", "visual": "Title slide with split imagery: healthy and degraded ecosystems, Arctic ice then and now", "say": "Climate change doesn't just warm the planet. It triggers cascading feedback loops that can accelerate warming beyond our control. When permafrost melts and releases methane, which causes more warming, which melts more permafrost — that's a feedback loop. And some of them have tipping points.", "do": "Display before/after images of Arctic ice, coral reefs, and forests. Let the scale of change register before proceeding.", "time": "2 min"},
        {"num": "Slide 2", "title": "Learning Objectives", "visual": "Learning goals with climate and systems vocabulary", "say": "Today you're Earth system scientists. You're going to model the most complex system we've covered — the entire planet. Ten components, multiple feedback loops, and tipping points that could change everything.", "do": "Pre-teach positive feedback loop and tipping point. Use the analogy: a positive feedback is like a snowball rolling downhill, getting bigger and faster; a tipping point is the edge of the cliff.", "time": "3 min"},
        {"num": "Slide 3", "title": "Big Question", "visual": "When do climate feedbacks become self-sustaining?", "say": "Here's the terrifying question: Is there a point where climate change becomes self-sustaining — where even if we stopped all emissions tomorrow, the feedbacks would keep warming the planet? That's the tipping point question. Let's find out.", "do": "Think-pair-share: Students brainstorm what 'self-sustaining feedback' means in the climate system. What processes could cause warming to continue even after emissions stop? Collect and categorize ideas.", "time": "3 min"},
        {"num": "Slide 4", "title": "LEVER Framework", "visual": "LEVER steps with coupled climate-ecosystem context", "say": "We're coupling multiple systems — atmosphere, ocean, land, ecosystems, agriculture, and human society — into a single model. The output of each system becomes the input of another. This is what real climate models do.", "do": "Preview LEVER steps. Emphasize that this model has multiple feedback LOOPS, not just linear chains — outputs circle back to modify inputs.", "time": "2 min"},
        {"num": "Slide 5", "title": "Activity 1: Components", "visual": "Ten component cards spanning atmospheric, oceanic, terrestrial, and societal systems", "say": "Two of these components are under human control. Eight are responses. But some of those responses loop BACK to amplify or dampen the original driver. Find the feedback loops.", "do": "Guide sorting of external (Atmospheric CO2, Societal Adaptation Capacity) versus internal components. Then identify which internal components feed BACK to influence others — mapping the positive and negative feedback loops.", "time": "8 min"},
        {"num": "Slide 6", "title": "Activity 2: Connections", "visual": "Coupled model diagram with positive and negative feedback loops explicitly marked", "say": "The permafrost-methane-warming loop is the scariest positive feedback in the entire climate system. 1,500 gigatons of frozen carbon — twice what's currently in the atmosphere — waiting to be released if we warm the Arctic enough. Draw this loop.", "do": "Students trace each feedback loop: CO2 to temperature to permafrost to more CO2 (positive), CO2 to temperature to forest growth to less CO2 (negative, until tipping point). Identify which feedbacks are winning.", "time": "8 min"},
        {"num": "Slide 7", "title": "Activity 3: Simulation", "visual": "Climate projections under three emission scenarios with feedback loop dynamics", "say": "Run the three scenarios. In Paris compliance, can you keep the feedbacks manageable? In business-as-usual, what breaks first? And in the tipping point analysis — find the temperature where the permafrost feedback becomes unstoppable.", "do": "Students predict, then simulate. The tipping point analysis is the key discovery — finding the temperature threshold where the system crosses from reversible to irreversible. Discuss what this means for climate policy urgency.", "time": "10 min"},
        {"num": "Slide 8", "title": "Discoveries", "visual": "Key climate system insights, tipping point thresholds, and adaptation requirements", "say": "You just modeled the most important system on Earth. The feedback loops are real. The tipping points are real. And the unequal distribution of impacts is real. The question is: what do we do about it?", "do": "Connect model findings to real IPCC projections. Discuss climate justice — who is most affected, who has the least capacity to adapt, and who bears the most responsibility.", "time": "5 min"},
        {"num": "Slide 9", "title": "STEM Challenge", "visual": "Regional climate adaptation plan design challenge", "say": "A coastal city of 2 million people is facing a climate crisis. They need a 50-year plan. Mitigation, adaptation, resilience, equity — all of it. Use your model to design the plan that saves this city.", "do": "Groups design integrated climate strategies: emission reduction targets, infrastructure investments, nature-based solutions, vulnerable population protection, and monitoring systems. Present plans with model-derived evidence.", "time": "12 min"}
    ],
    "sort_reasoning": "Atmospheric CO2 and Societal Adaptation Capacity are the two external components. Atmospheric CO2 is the primary driver — determined by human emission decisions, which are policy and technology choices, not intrinsic properties of the climate system. Societal Adaptation Capacity is also external — determined by economic investment, technological development, policy decisions, and institutional capacity, not by the climate system itself. All other eight components are internal responses: Global Temperature, Ocean Absorption, Permafrost Methane Release, Forest Carbon Sequestration, Species Migration Rate, Crop Yield Change, Sea Level Rise, and Extreme Weather Frequency emerge from the physics, chemistry, biology, and geography of the Earth system responding to the CO2 forcing.",
    "relationships": [
        ("Atmospheric CO2 to Global Temperature", "POSITIVE (+)", "Higher atmospheric CO2 traps more outgoing infrared radiation through the greenhouse effect, increasing the planet's energy imbalance and raising Global Temperature — each doubling of CO2 produces approximately 3 degrees C of equilibrium warming (climate sensitivity)."),
        ("Global Temperature to Ocean Absorption", "NEGATIVE (-)", "Higher temperatures reduce the ocean's capacity to absorb CO2 because warm water holds less dissolved gas (Henry's Law) and because warming stratifies the ocean, reducing mixing between surface and deep layers that sequester carbon long-term."),
        ("Global Temperature to Permafrost Methane Release", "POSITIVE (+)", "Higher temperatures thaw Arctic permafrost, exposing frozen organic matter to microbial decomposition that releases CO2 and methane — this is a POSITIVE FEEDBACK because the released greenhouse gases cause additional warming that thaws more permafrost."),
        ("Forest Carbon Sequestration to Atmospheric CO2", "NEGATIVE (-)", "Greater forest growth and photosynthesis remove more CO2 from the atmosphere, reducing the atmospheric concentration — this is a NEGATIVE FEEDBACK that partially counteracts emissions, but it can reverse at high temperatures when forests die and release stored carbon."),
        ("Global Temperature to Extreme Weather Frequency", "POSITIVE (+)", "Higher temperatures intensify the hydrological cycle (warmer air holds 7% more water vapor per degree C), increase ocean heat content that fuels tropical storms, and create more extreme temperature events — all increasing the frequency and intensity of weather extremes."),
        ("Extreme Weather Frequency to Societal Adaptation Capacity", "NEGATIVE (-)", "More frequent extreme weather events damage infrastructure, displace populations, destroy crops, and consume disaster response resources, progressively degrading a society's capacity to adapt to ongoing and future climate impacts.")
    ],
    "sim_answers": [
        ("Paris Agreement Compliance Scenario", "With emissions limited to keep warming below 2.0 degrees C, the model shows that most feedback loops remain manageable. Permafrost Methane Release is activated but remains below the self-sustaining threshold. Ocean Absorption continues at reduced capacity. Forest Carbon Sequestration is stressed but maintains net negative carbon flux. However, even at 1.5-2.0 degrees C, significant impacts are unavoidable: Sea Level Rise of 0.3-0.6 meters is committed from thermal expansion and committed ice loss, Extreme Weather Frequency increases 20-30% above baseline, and coral reefs face severe bleaching. Societal Adaptation Capacity must be actively strengthened for vulnerable regions."),
        ("Tipping Point Analysis Scenario", "As Global Temperature gradually increases, the model reveals critical thresholds. At approximately 1.5-2.0 degrees C, Arctic summer sea ice disappears seasonally (albedo feedback fully activates). At approximately 2.0-3.0 degrees C, Permafrost Methane Release approaches the self-sustaining threshold where it adds 0.3-0.5 degrees C of warming independent of human emissions. At approximately 3.0-4.0 degrees C, Forest Carbon Sequestration reverses as widespread die-off converts forests from sinks to sources. The model demonstrates that these are not independent thresholds — crossing one tipping point makes crossing others more likely through cascading feedbacks, creating the potential for a 'tipping cascade' that pushes the system to a fundamentally different climate state.")
    ],
    "reflection_exemplars": [
        ("What makes positive feedback loops so dangerous in the climate system?", "The model reveals that positive feedback loops amplify change — small perturbations grow larger over time instead of being dampened. In the climate system, this means that a moderate amount of warming from CO2 emissions can trigger self-reinforcing processes (permafrost methane release, ice-albedo feedback, forest die-off) that produce ADDITIONAL warming beyond what the emissions alone would cause. The critical danger is tipping points: if a positive feedback loop becomes self-sustaining, it will continue to drive change even if the original perturbation (CO2 emissions) is removed. This is analogous to pushing a boulder uphill — you can stop pushing and it stays put (negative feedback), or you can push it past the hilltop and it rolls down the other side on its own (positive feedback past tipping point)."),
        ("Why is Societal Adaptation Capacity so unequally distributed?", "The model exposes a profound injustice: the nations that have contributed the most to Atmospheric CO2 (historically, the US and Europe; currently, China) generally have the highest Societal Adaptation Capacity — robust infrastructure, diversified economies, advanced technology, and strong institutions. The nations that have contributed the least (sub-Saharan Africa, South Pacific islands, low-lying South Asian countries) have the lowest Societal Adaptation Capacity and face the most severe impacts (sea level rise, extreme heat, agricultural disruption). This means that climate change transfers risk from those who caused it to those who didn't — a fundamental violation of fairness. Addressing this inequality through climate finance, technology transfer, and adaptation support is as essential as emission reductions.")
    ],
    "stem_intro": "Present the challenge: A coastal city of 2 million people faces projected sea level rise of 0.5-1.5 meters, a 40% increase in extreme weather, and significant agricultural disruption by 2080. Your climate planning team will design a 50-year integrated strategy combining mitigation (reducing emissions), adaptation (preparing for unavoidable impacts), and resilience (ensuring recovery from extreme events).",
    "stem_concepts": [
        ("Integrated Mitigation-Adaptation Planning", "Effective climate strategy requires BOTH reducing the driver (mitigation: cutting emissions, increasing carbon sequestration) AND preparing for the impacts that are already locked in (adaptation: sea walls, drought-resistant crops, early warning systems). Neither alone is sufficient: mitigation without adaptation ignores committed impacts; adaptation without mitigation faces ever-escalating challenges. The model shows which impacts are avoidable through mitigation and which require adaptation regardless."),
        ("Nature-Based Solutions", "Ecosystems can provide climate benefits alongside human infrastructure: mangrove forests reduce storm surge energy by 66% per kilometer of forest width, urban tree canopy reduces air temperatures by 2-5 degrees C, restored wetlands absorb floodwater and sequester carbon, and sustainable agriculture practices increase soil carbon storage while improving crop resilience. Nature-based solutions are often more cost-effective and provide co-benefits (biodiversity, water quality, recreation) that engineered infrastructure does not."),
        ("Equity-Centered Climate Planning", "Climate planning must center equity because climate impacts disproportionately affect low-income communities, communities of color, and coastal populations. Effective equity-centered planning includes: mapping vulnerability (who is most exposed and least resourced), prioritizing investments in frontline communities, ensuring meaningful community participation in planning decisions, and designing financial mechanisms that don't burden the most vulnerable with adaptation costs.")
    ],
    "stem_eval": [
        ("Expert (4)", "Plan integrates mitigation and adaptation with evidence from model scenarios, includes nature-based and engineered solutions, addresses equity explicitly with vulnerability mapping, and provides monitoring metrics with adaptive management triggers"),
        ("Proficient (3)", "Plan includes both mitigation and adaptation strategies with reasoning connected to model feedback loops and equity considerations"),
        ("Developing (2)", "Plan covers basic climate response strategies but lacks integration between mitigation and adaptation, or does not address equity"),
        ("Beginning (1)", "Plan is incomplete or does not connect strategies to the coupled climate-ecosystem model's feedback loop dynamics")
    ],
    "support": [
        "Provide a feedback loop diagram template with labeled positive (+) and negative (-) arrows, asking students to identify which loops are self-amplifying and which are self-correcting",
        "Use a climate impact matrix: 'At 1.5 degrees C warming: Sea Level Rise = ___, Extreme Weather = ___, Crop Yield = ___. At 3.0 degrees C warming: Sea Level Rise = ___, Extreme Weather = ___, Crop Yield = ___.'",
        "Scaffold adaptation planning: 'The unavoidable impacts for our city are ___. The most vulnerable populations are ___. The highest-priority adaptation investments are ___ because ___'"
    ],
    "extensions": [
        "Research the IPCC's latest Assessment Report and compare its warming projections to your model's predictions — where does your simplified model agree with and differ from the full Earth system models?",
        "Investigate the concept of 'carbon debt' — calculating the total historical CO2 emissions of each nation and comparing to current per-capita emissions — and design a climate finance framework based on historical responsibility",
        "Model a specific tipping cascade: Arctic ice loss triggers albedo feedback, which accelerates permafrost thaw, which releases methane, which warms the tropics, which kills coral reefs, which collapses fisheries — trace the causal chain and identify intervention points"
    ],
    "cross_curr": [
        ("Math", "Calculate the carbon budget remaining to keep warming below 1.5 degrees C (approximately 400 GtCO2 remaining at current rates) and determine how many years of current emissions (approximately 40 GtCO2/year) remain before the budget is exhausted"),
        ("ELA", "Write a policy brief for the city council arguing for an integrated climate adaptation plan, using model-derived evidence to demonstrate the cost of inaction versus the cost of preparation, and addressing climate justice principles"),
        ("Social Studies/Ethics", "Analyze the concept of 'loss and damage' in international climate negotiations — the argument that wealthy, high-emitting nations owe compensation to vulnerable, low-emitting nations for unavoidable climate impacts — and propose a fair mechanism for calculating and distributing climate reparations")
    ],
    "misconceptions": [
        ("Climate change is a gradual, linear process that we can slowly adjust to", "The model reveals that climate change contains TIPPING POINTS — critical thresholds beyond which the system shifts abruptly to a new state. These transitions are nonlinear, meaning the relationship between cause (CO2 emissions) and effect (climate impacts) is not proportional. A small additional temperature increase near a tipping point can trigger dramatically larger consequences than the same increase at lower temperatures. The permafrost methane feedback, ice sheet collapse, and forest die-off all have tipping point characteristics. This means that 'wait and see' approaches to climate policy risk crossing irreversible thresholds.", "Analogy: Imagine heating a pot of water. Temperature rises linearly until 100 degrees C — then the system abruptly transitions from liquid to gas. Climate tipping points are similar — gradual change until a threshold, then abrupt system shift. What's different: you can cool the water back down, but you can't easily refreeze 1,500 gigatons of permafrost."),
        ("Technology will solve climate change so we don't need to reduce emissions", "While technology is essential — renewable energy, carbon capture, energy storage — no technology can reverse the effects of positive feedback loops that have already been triggered. The model shows that once Permafrost Methane Release becomes self-sustaining, no amount of direct air carbon capture (currently removing approximately 0.01 Mt CO2/year) can compensate for the approximately 1-2 Gt CO2-equivalent/year of additional emissions. Technology COMPLEMENTS emission reduction — it cannot REPLACE it. The math is simple: we emit approximately 40 Gt CO2/year; the most optimistic carbon capture projections remove approximately 10 Gt CO2/year by 2050; we need to reduce emissions AND deploy capture simultaneously.", "Calculate: Current global emissions are approximately 40 GtCO2/year. The largest direct air capture plant removes 36,000 tons/year. How many of these plants would you need to offset current emissions? (Answer: over 1 million.) How much would this cost at $600/ton? (Answer: $24 trillion/year — roughly 25% of global GDP.)"),
        ("Climate change only affects polar bears and distant future generations", "The model's downstream components (Crop Yield Change, Extreme Weather Frequency, Sea Level Rise) demonstrate that climate change is affecting human systems NOW — 2023 was the hottest year in recorded history, extreme weather events have increased 5x since the 1970s, and agricultural disruptions are already reducing food security in vulnerable regions. Sea Level Rise is displacing communities in the Marshall Islands, Bangladesh, and Louisiana TODAY. The model shows that the impacts accelerate over time, meaning every year of delay in emission reduction commits future generations to worse outcomes. This is not a distant, abstract problem — it is a present, concrete reality with measurable human costs.", "Evidence: 2023 saw record global temperatures, Canadian wildfires that blanketed US cities in smoke, Mediterranean heat waves exceeding 48 degrees C, and flooding in Libya that killed 11,000 people. These are model predictions becoming measured reality.")
    ]
}

ALL_LESSONS = [L01, L02, L03, L04, L05, L06, L07, L08, L09, L10]
